Structural Characterization of Emerging Synthetic Drugs by Davidson, Jay Tyler
Graduate Theses, Dissertations, and Problem Reports 
2020 
Structural Characterization of Emerging Synthetic Drugs 
Jay Tyler Davidson 
West Virgina University, jtdavidson@mix.wvu.edu 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
 Part of the Analytical Chemistry Commons 
Recommended Citation 
Davidson, Jay Tyler, "Structural Characterization of Emerging Synthetic Drugs" (2020). Graduate Theses, 
Dissertations, and Problem Reports. 7584. 
https://researchrepository.wvu.edu/etd/7584 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research 
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is 
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain 
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license 
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, 
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. 





Structural Characterization of Emerging Synthetic Drugs 
 
J. Tyler Davidson 
 
Dissertation submitted to the Eberly College of Arts and Sciences  
at West Virginia University 
in partial fulfillment of the requirements for the degree of 
 
Doctor of Philosophy in 
Forensic Science 
 
Glen P. Jackson, Ph.D., Chair 
Luis E. Arroyo, Ph.D. 
Tatiana Trejos, Ph.D. 
Stephen J. Valentine, Ph.D. 
 
Department of Forensic and Investigative Science 
 
Morgantown, West Virginia 
2020 
 
Keywords: Structural characterization, Emerging synthetic drugs, Multi-
stage mass spectrometry (MSn), High-resolution mass spectrometry 
(HRMS), Synthetic cathinones, Fentanyl analogs 







Structural Characterization of Emerging Synthetic Drugs 
J. Tyler Davidson 
The identification of well-characterized seized drugs is performed thousands of times a day in the 
United States; however, the expanding use of emerging synthetic drugs is creating a growing 
problem for both toxicological and seized drug analyses. Two of the most rapidly growing areas 
of emerging synthetic drugs are synthetic cathinones and fentanyl-related compounds (FRCs). In 
this work we demonstrate the combination of multi-stage mass spectrometry (MSn), accurate mass 
measurements with high-resolution mass spectrometry (HRMS), and isotopic labeling for the 
structural characterization of synthetic cathinones and fentanyl analogs. The deliverables of this 
research include the identification of conserved fragmentation pathways for synthetic cathinones 
and fentanyl analogs, proposed mechanisms for the formation of characteristic ions through both 
protonated tandem mass spectrometry (MS/MS) and electron ionization mass spectrometry (EI-
MS), and a discussion about how to apply the broadened understanding of the fragmentation 
behavior to the identification of novel synthetic cathinones and fentanyl analogs.  
The first major finding about the fragmentation behavior of synthetic cathinones is that the 
tropylium ion (m/z 91), or substituted derivative thereof, forms through different oxygen-
containing intermediates that do not contain a formal C=O bond but instead contain a phthalane-
like core structure. The phthalane-like intermediates were elucidated through gas-phase ion 
spectroscopy measurements and density functional theory (DFT) calculations. Likewise, the use 
of stable isotope labeling revealed the unprecedented finding that, during collision-induced 
dissociation (CID) of α-pyrrolidinophenone synthetic cathinones, the α-carbon is retained almost 
exclusively in the tropylium ion and the carbonyl carbon is not retained in the tropylium ion. 
Isotope labeling also identified competitive pathways for the loss of CO and ethylene (C2H4) from 
a primary intermediate ion, which provides support for the direct loss of CO from the alkyl side 
chain.  
A second major finding was the identification of characteristic protonated MS/MS 
fragmentation pathways and proposed mechanistic origins for both protonated MS/MS and EI-MS 
fragmentation for α-pyrrolidinophenone and N-alkylated synthetic cathinones. For MS/MS spectra 
of protonated α-pyrrolidinophenone synthetic cathinones the dominant fragmentation pathways 
are through 4-center hydrogen rearrangements to produce pyrrolidine ring cleavage, characteristic 
iminium ions and diagnostic ions at m/z 91 and m/z 105. For EI mass spectra, radical-directed α-
cleavages result in dominant iminium ions. In contrast to α-pyrrolidinophenone synthetic 
cathinones, MS/MS of protonated N-alkylated synthetic cathinones provided abundant radical 
losses from both the N-alkylated and aliphatic side chains, a dominant loss of H2O for 2° amines 
and the formation of abundant alkylphenones for 3° amines. These findings help advance our 
current understanding of the MS/MS analysis of synthetic cathinones, and they help analysts better 





For FRC’s, a combination of isotope labeling, HRMS and MSn experiments identified a novel 
isobaric product ion at m/z 188, which is elementally distinct from the two previous known isobars 
at m/z 188 and forms through an intermediate product ion at m/z 216 (for fentanyl). These studies 
also confirmed the pathways through which the three nominal isobars are formed and how 
substitutions to the aniline ring and amide moieties result in remarkably conserved fragmentation 
pathways. In contrast, substitutions to the piperidine ring, the N-alkyl chain, and the cyclic 
substituent of FRCs resulted in distinct differences in fragmentation pathways, the abundance of 
which is related to the identity of the specific substitution. For example, the presence of a hydroxyl 
group on the N-alkyl chain results in the MS/MS spectrum being dominated by the neutral loss of 
water, whereas the presence of a methyl group favors the formation of the tropylium ion. By 
understanding the fragmentation behavior of fentanyl and the impact of substitutions to the core 
fentanyl structure, toxicologists and seized drug analysts will be better prepared to identify 
emerging FRCs, which are increasingly common and deadly adulterants in the growing opioid 
epidemic. 
The final major contribution from this work was the comparison between in-source CID and 
beam-type CID experiments of the same synthetic cathinones and FRCs on the same instrument. 
Whereas the relative abundance of certain fragments were often readily distinguishable between 
in-source CID and beam-type CID, the fragment m/z values and the overall pattern of 
fragmentation were sufficiently consistent that the spectra from the two different activation 
methods could serve as proxies for one another. However, because in-source CID involves 
fragmentation of all precursors from the source region of the mass spectrometer rather than through 
isolation and fragmentation in the collision cell, caution should be used when analyzing potential 
mixtures or complex biological samples where strict control of precursor ions present in the source 
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The identification of well-characterized seized drugs is performed thousands of times a day in 
the United States; however, the expanding use of emerging synthetic drugs is creating a growing 
problem for both toxicological and seized drug analyses. Not only are the effects and side-effects 
of most emerging synthetic drugs not known, but the clandestine suppliers continually tweak the 
chemical structures to keep one step ahead of the law. When forensic chemists and toxicologists 
attempt to identify these emerging synthetic drugs, the compounds of interest are often absent from 
the labs’ mass spectral database of known substances. As a result, the identities of these emerging 
synthetic drugs may remain a mystery until an expert in mass spectral interpretation can 
appropriately interpret the analytical results. 
Two of the most rapidly growing areas of emerging synthetic drugs are synthetic cathinones 
and fentanyl analogs. Synthetic cathinones are phenylalkylamine derivatives, closely related to 
amphetamines that produce stimulant-like pharmacological effects. In comparison, fentanyl and 
fentanyl analogs are synthetic opioids that have emerged as some of the deadliest compounds in 
the growing opioid epidemic in the United States. These two classes of emerging synthetic 
compounds present different, but equally important problems for their structural characterization. 
If information about the mass spectral interpretation rules and patterns were more-readily available 
to toxicologists and seized drug analysts, then analysts would be better equipped to elucidate the 
identity of emerging synthetic drugs. 
To enhance our current understanding of the fragmentation behavior of synthetic cathinones 
and fentanyl analogs, this work demonstrates the use of multi-stage mass spectrometry (MSn), 
accurate mass measurements with high-resolution mass spectrometry (HRMS), and isotopic 





helped determine the relationships between product ions along different fragmentation pathways. 
Accurate mass measurements with HRMS enabled the determination of the elemental formulas of 
each ion. Finally, the use of isotopic labeling enabled the tracking of specific regions of the 
molecule through the different fragmentation pathways and gave insight into the different 
structures and rearrangement mechanisms.  
The deliverables of this research include the identification of conserved fragmentation 
pathways for synthetic cathinones and fentanyl analogs, proposed mechanisms for the formation 
of characteristic ions in both protonated tandem mass spectrometry (MS/MS) and electron 
ionization mass spectrometry (EI-MS), and discussion about how to apply this new understanding 
to the identification of novel synthetic cathinones and fentanyl analogs. Chapters 1-3 focus on the 
mass spectral characterization of synthetic cathinones, Chapters 4-5 focus on fentanyl and it’s 
analogs and Chapter 6 combines both synthetic cathinones and fentanyl analogs.  
Chapter 1 describes an investigation into the tandem mass spectrometry of the α-
pyrrolidinophenone class of synthetic cathinones. Specifically, isotope labeling, ion spectroscopy, 
density functional theory (DFT) calculations, HRMS and MSn analysis of a total of 21 α-
pyrrolidinophenones provided insight into the fragmentation mechanisms that lead to the 
formation of the tropylium ion at m/z 91 or substituted tropylium ion such as at m/z 135 for 
methylenedioxy-substituted synthetic cathinones. The tropylium ion (m/z 91), or substituted 
derivative thereof, is among the most abundant product ions in the tandem mass spectra of 
protonated α-pyrrolidinophenone synthetic cathinones, yet the mechanism of formation has not 
been described and remains a mystery. The absence of a mechanism stems from the difficulty in 
explaining the elemental composition of the tropylium ion (C7H7
+) from the carbon-skeleton of the 





existing mechanisms to form the tropylium ion require a methyl or methylene group adjacent to 
the phenyl moiety. Our work demonstrates proposed fragmentation mechanisms to explain this 
phenomenon, which are supported through the use of MSn, HRMS, isotopic labeling, DFT 
calculations and gas-phase ion spectroscopy, the latter of which were conducted by our 
collaborators at Northern Illinois University in the US and at Radboud University in the 
Netherlands. Chapter 1 has been published in Forensic Chemistry. 
Chapter 2 describes the characterization of the α-pyrrolidinophenone class of synthetic 
cathinones using gas chromatography-electron ionization-mass spectrometry (GC-EI-MS), 
electrospray ionization-tandem mass spectrometry (ESI-MS/MS) and direct analysis in real time-
tandem mass spectrometry (DART-MS/MS). GC-EI-MS and ESI-MS/MS are prominent 
techniques in the field of seized drug analysis and toxicology, whereas DART-MS/MS is a 
developing ambient ionization-based technique designed for increased sample throughput. DART-
MS/MS is more prominent in federal laboratories as a fast screening technique. The key structural 
feature of the α-pyrrolidinophenone class of synthetic cathinones is the presence of a pyrrolidine 
ring on the amine nitrogen of the generic structure. Through this work we establish characteristic 
protonated tandem mass spectrometry fragmentation pathways and propose mechanistic origins of 
the EI-MS fragmentation observed for this class of synthetic cathinones. We also provide examples 
of how this knowledge can be applied to the identification of novel α-pyrrolidinophenone synthetic 
cathinones. Chapter 2 has been accepted for publication in the International Journal of Mass 
Spectrometry.  
Chapter 3 is a continuation of the methodologies applied in Chapter 2; however, the focus of 
Chapter 3 is the N-alkylated class of synthetic cathinones. The N-alkylated class of synthetic 





the generic phenylalkylamine structure to make secondary (2°) or tertiary (3°) amines, 
respectively. The compounds analyzed represent common substitutions to the core N-alkylated 
synthetic cathinone structure, including various numbers and lengths of N-alkyl and aromatic 
substitutions. The main outcomes of this project are the identification of characteristic protonated 
MS/MS fragmentation pathways and the generation of proposed mechanistic origins for both the 
observed protonated MS/MS fragmentation and EI-MS fragmentation. For example, we show that 
2° amines typically have a base peak corresponding to the loss of water, whereas 3° amines favor 
the formation of alkylphenones. Also, in contrast to α-pyrrolidinophenone synthetic cathinones, 
which rarely form odd-electron product ions, N-alkylated synthetic cathinones readily form radical 
cations from the even-electron [M+H]+ precursor. These results broaden the current knowledge 
about the fragmentation behavior of N-alkylated synthetic cathinones. Chapter 3 has been accepted 
for publication in the International Journal of Mass Spectrometry.  
Chapters 4-6 cover the second major branch of this work, which focusses on the mass-spectral 
characterization of fentanyl and fentanyl analogs. Chapter 4 centers on the composition of the 
product ions observed at nominal m/z 188 for fentanyl and its main synthetic precursor, 4-anilino-
N-phenethylpiperidine (4-ANPP). The significance of the product ion at nominal m/z 188 is that it 
is often used for both qualitative and quantitative determinations due to its dominant abundance in 
the tandem mass spectra of fentanyl and many fentanyl-related compounds (FRCs). We 
demonstrate the presence of at least three isobaric fentanyl product ions at nominal m/z 188, 
including a novel isobaric product ion that forms through a cross-ring cleavage of the piperidine 
ring. We also confirmed two previously described isobaric product ions and described their 
mechanisms of formation through the loss of methylketene (C3H4O) followed by aniline (C6H7N). 





Chapter 5 is an extension of the work from Chapter 4, wherein a series of FRCs that are 
substituted at five common regions of substitution to the core fentanyl structure were analyzed. 
The goal was to broaden our knowledge about the impact of substitutions on the core fentanyl 
structure to the tandem mass spectra. The regions of substitution include the aniline ring (R1), the 
amide moiety (R2), the piperidine ring (R3), the N-alkyl chain (R4) and the cyclic substituent (R5), 
which is typically a phenyl, thiol or tetrazole. The main finding from this project was that, relative 
to fentanyl, substitutions on R1 and R2 cause simple and predictable changes in the m/z values for 
peaks that contain substitutions different from fentanyl. For example, a methyl group on the aniline 
ring simply shifts all peaks that contain the aniline ring by 14 Da. In contrast, modifications to R3 
or R4 can cause dramatic alterations to the entire tandem mass spectra. For example, a hydroxyl 
group on the N-alkyl chain (R4) causes the MS/MS spectrum to be dominated by the neutral loss 
of water, but the presence of a methyl group favors the formation of the tropylium ion. These 
trends and mechanisms help inform practitioners about the relationship between the observed 
MS/MS spectra and substitutions to the core fentanyl structure, and hopefully places analysts in a 
better position to either defend their current casework or identify novel FRCs in future casework. 
Chapter 5 has been published in Drug Testing and Analysis. 
Chapter 6 describes the comparison between in-source CID and beam-type CID, as performed 
on a quadrupole time-of-flight (Q-TOF) mass spectrometer, for a series of previously characterized 
synthetic cathinones and FRCs. As the name implies, in-source CID involves the fragmentation 
within the differentially pumped region of the ion source and is accomplished without isolation of 
the precursor ions. For this reason, in-source CID is usually thought of as pseudo-tandem mass 
spectrometry. In contrast, beam-type CID involves the isolation of precursor ions in one 





spectrometer. Throughout the literature in-source CID is used to provide structurally informative 
product ions with single-stage HRMS instruments as a means of pseudo-tandem mass 
spectrometry. Our work shows that whereas it is possible to generate structurally diagnostic spectra 
that are typically very similar to beam-type tandem mass spectra, caution should be used when 
interpreting in-source CID spectra because there is no isolation step to ensure that the observed 
product ions only originate from a particular precursor. Chapter 6 has been submitted to Rapid 



















Chapter 1: Identification of novel fragmentation pathways and fragment ion structures in 
the tandem mass spectra of protonated synthetic cathinones 
Reproduced in part with permission from J.T. Davidson, E.L. Piacentino, Z.J. Sasiene, Y. 
Abiedalla, J. DeRuiter, C.R. Clark, G. Berden, J. Oomens, V. Ryzhov, G.P. Jackson, Forensic 
Chemistry, DOI: 10.1016/j.forc.2020.100245. 
1.1 Introduction 
Synthetic cathinones are members of a larger class of novel psychoactive substances (NPS) 
commonly referred to as “designer drugs” or “legal highs” [1]. They are phenylalkylamine 
derivatives, closely related to amphetamines, which produce stimulant-like pharmacological 
effects. These effects drive the recreational use of synthetic cathinones, which are often marketed 
as “not for human consumption” or “bath salts” to avoid legislative restrictions [1-4]. Cathinones 
are analogs of the natural psychoactive chemical cathinone, which is present in the leaves of the 
Catha edulis plant, commonly known as khat. This plant is native to the Horn of Africa and the 
Southwest Arabian Peninsula. Traditionally, khat leaves have been chewed for their stimulant-like 
effects and used in religious ceremonies such as funerals and weddings [1]. As trade routes 
expanded, knowledge about the stimulant-like properties of khat leaves extended to Europe and 
the Western world [5, 6]. 
The first synthetic cathinones to appear on the market in the early twentieth century were 
originally designed for therapeutic purposes, but recreational use has taken over in the last decade 
[6, 7]. Synthetic cathinones are sold in the form of white or yellow amorphous or crystalline 
powder or in capsules. The quantities usually range from 50 mg to 500 mg packages and the price 
varies between $25-$50 per 50 mg [4, 8, 9]. Common brand names include Bloom, Blue Silk, 





Once synthetic cathinones started to flood the market, countries began to enact legislative 
restrictions. By 2011 several synthetic cathinones were provisionally scheduled under Schedule I 
of the United States Controlled Substances Act [7, 10]. However, the regulation of synthetic 
cathinones is complicated by the sheer diversity of chemical modifications that are continuously 
adopted to avoid the regulations imposed on existing analogs [1]. Due to the lag in regulations 
behind the drugs currently available on the market it is imperative to recognize the characteristic 
fragmentation of synthetic cathinones and understand the fragmentation pathways through which 
mass spectra are generated. 
Four common families of synthetic cathinones can be identified based on the location of 
substitution to the core synthetic cathinone structure. The first family of synthetic cathinones are 
analogs that are N-alkylated at the amine moiety, some of which contain ring substituents [1, 11]. 
These substances were primarily derived for their therapeutic properties, such as antidepressants. 
A second family of synthetic cathinones is the pyrrolidinophenone-like family, which are 
characterized by a pyrrolidinyl substitution at the amine moiety [12]. Another family of synthetic 
cathinones involves methylation at the α-carbon adjacent to the amine nitrogen in the generic 
synthetic cathinone structure. The last family of synthetic cathinones has both the 3,4-
methylenedioxy ring substitution and the N-pyrrolidinyl moiety [7]. One common variation for all 
families of synthetic cathinones is varying lengths of the alkyl chains branching from the α-carbon. 
Whereas many laboratories and research articles conduct routine mass spectrometric analysis 
of synthetic cathinones, the underlying fragmentation mechanisms that lead to the observed 
fragment ions are rarely described or understood. However, analysts recognize that structural 
similarities of synthetic cathinones tend to provide mass-spectral similarities, which greatly assists 





The seized drug community typically employs gas chromatography-electron ionization-mass 
spectrometry (GC-EI-MS) to identify unknowns whereas the toxicological community often 
employs liquid chromatography with electrospray ionization and tandem mass spectrometry (LC-
ESI-MS/MS). Due to differences in the ionization mechanisms, EI primarily produces odd-
electron ions and ESI primarily produces even-electron ions. The differences in electron parity and 
energy deposition typically results in major differences in the fragment mass spectra, as has been 
demonstrated for a variety of synthetic cathinones [13-18]. For example, Sauer et al. [19] and 
Abiedalla et al. [20] report the absence of ions at m/z 91 and m/z 135 for α-PVP and 3,4-MDPV 
(see Methods Section for full names) under EI-MS conditions, but Hasegawa et al. [21] and Fornal 
[16] report the presence of both ions under ESI-MS/MS conditions. 
The analysis of synthetic cathinones with ESI-MS/MS reveals the tropylium ion (m/z 91) or 
methylenedioxy analog (m/z 135) as one of the most abundant ions in the protonated tandem mass 
spectra of many synthetic cathinones [22-25]. Despite the importance of the tropylium ion or 
methylenedioxy-analog ion in the product ion spectra of synthetic cathinones, previous attempts 
to explain the mechanistic origin of these important diagnostic ions have been inadequate. As 
examples, in the first report on the fragmentation of protonated PV8, Swortwood et al. do not 
address the mechanism of formation of the tropylium ion [26]. In a previous work, Ibanez et al. 
propose an unsupported ‘shift’ of the carbonyl group to explain the equivalent ion at m/z 135 for 
3,4-MDPV [27]. Similarly, Pozo et al., Fabregat-Safont et al., and Qian et al. propose mechanisms 
that involve the loss of CO directly from the aliphatic chain during the fragmentation of synthetic 
cathinones without the use of isotopic labeling to support these conclusions [28-30]. Our work 





In all the above cases, the mechanism(s) are either absent, ambiguous or unsupported with 
experimental data. A similar problem with the existing knowledge of synthetic cathinone 
fragmentation is exemplified by accurate mass studies involving methcathinone and ethcathinone 
fragmentation [31, 32]. Bijlsma et al. showed an unexpected product ion at m/z 105.0740, which 
must have the elemental composition C8H9
+ [31]. The ion is unexpected because its occurrence 
requires multiple rearrangements. However, the article did not describe the use of isotope labeling 
or MSn experiments, so the mechanism of formation of the C8H9
+ fragment remains unclear. The 
observation of both m/z 105.0334 and m/z 105.0697 from ethcathinone also indicates extensive 
covalent rearrangements that remain unexplained [32].  
These articles demonstrate that there is a significant lack of understanding in the fragmentation 
behavior of synthetic cathinones with ESI-MS/MS. To better defend the observations of existing 
casework, to better understand the current observations, and to better predict the fragmentation 
patterns of future synthetic cathinones, this project examines the fragmentation behavior of 
synthetic cathinones generated via ESI and analyzed with both ion trap (IT) and quadrupole time-
of-flight (Q-TOF) mass spectrometers. IT mass spectrometers are typically nominal mass 
instruments, but they have the capability to perform multiple stages of mass spectrometry. In 
contrast, Q-TOF mass spectrometers are high-resolution instruments that provide accurate mass 
measurements. The combination of multi-stage mass spectrometry (MSn), accurate mass 
measurements with high-resolution mass spectrometry (HRMS), isotopic labeling and infrared ion 
spectroscopy allows for the confirmation of intermediate product ions along the proposed 
fragmentation pathways and provides support for our proposed mechanisms. The identification of 





analog ion provides a more coherent framework of understanding for the identification of future 
synthetic cathinone analogs. 
1.2 Methods 
 Sample Preparation 
This study involved the analysis of 11 synthetic cathinones that were purchased through 
Cayman Chemical (Ann Arbor, MI, USA) and 11 isotopically labeled or non-commercially 
available synthetic cathinones synthesized in-house at Auburn University. The synthetic 
cathinones purchased through Cayman Chemical were: α-pyrrolidinopropiophenone (α-PPP), α-
pyrrolidinobutiophenone (α-PBP), α-pyrrolidinovalerophenone (α-PVP), α-
pyrrolidinoheptanophenone (PV8), 4-methoxy-α-pyrrolidinopentiophenone (4-MeO-α-PVP), 
3',4'-trimethylene-α-pyrrolidinovalerophenone, 3,4-methylenedioxy-α-pyrrolidinopropiophenone 
(3,4-MDPPP), 3,4-methylenedioxy-α-pyrrolidinobutiophenone (3,4-MDPBP), 3,4-
methylenedioxypyrovalerone (3,4-MDPV), 3,4-methylenedioxypyrovalerone-d8 on the 
pyrrolidine ring (3,4-MDPV-d8), and 2,3-methylenedioxypyrovalerone (2,3-MDPV). The 
synthetic cathinone samples synthesized at Auburn University were: 13C-α-
pyrrolidinovalerophenone labeled on the carbonyl carbon (13C-carbonyl carbon-α-PVP), 13C-α-
pyrrolidinovalerophenone labeled on the α-carbon (13C-α-carbon-α-PVP), 18O-α-
pyrrolidinovalerophenone (18O-α-PVP), α-pyrrolidinovalerophenone-d7 labeled on the alkyl chain 
(α-PVP-d7), α-pyrrolidinovalerophenone-d8 labeled on the pyrrolidine ring (α-PVP-d8), α-methyl-
pyrrolidinovalerophenone (α-PVP-methyl group), 13C-α-pyrrolidinoheptanophenone labeled on 
the carbonyl carbon (13C-PV8), 13C-α-pyrrolidinopropiophenone on the α-carbon (13C-α-PPP), 
13C-4'-methyl-α-pyrrolidinohexanophenone on the  carbonyl carbon (13C-MPHP), 13C-3,4-





carbonyl carbon. Before the synthetic samples were shipped to West Virginia University, a full 
characterization using NMR and GC-EI-MS was performed at Auburn University to confirm the 
correct labeling in acceptable purity. All samples were analyzed at a concentration of 
approximately 100 ppm. The non-deuterated samples were dissolved in a solution of 49% HPLC 
grade methanol, 49% distilled water and 2% acetic acid. Deuterated samples were dissolved in 
HPLC grade methanol only to prevent back exchange. The HPLC-grade methanol was supplied 
by Fisher Scientific (Palo Alto, CA, USA) and the acetic acid was supplied by Acros Organics 
(Palo Alto, CA, USA). 
 Instrumentation 
1.2.2.1 Velos Pro Linear Ion Trap 
A Thermo Scientific Velos Pro Linear Ion Trap (LIT) mass spectrometer was operated with 
heated-electrospray ionization (HESI). The HESI source was operated at 50 °C with a spray 
voltage of 4,000 V. The nitrogen sheath gas was operated at 8 arbitrary units with a nitrogen 
auxiliary gas flow of 5 arbitrary units. The mass spectrometer capillary temperature was 275 °C. 
The scan range and normalized collision energy (NCE) were different for each compound and are 
labeled with each mass spectrum. Ultra-pure helium was used as the bath gas purchased through 
Matheson TRIGAS (Fairmont, WV, USA).  
1.2.2.2 Agilent Technologies 6538 UHD Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) 
An Agilent Technologies 6538 UHD Accurate-Mass Quadrupole Time-of-flight (Q-TOF) 
mass spectrometer was operated with a dual ESI source at a spray voltage of 3,500 V. The nitrogen 
gas was set to 300 °C with a drying gas flow of 5 L/min and a nebulizer flow of 30 psig. The MS 
fragmentor and skimmer voltages were operated at 225 V and 65 V, respectively. The scan range 





isolation width of 1.3 Da was used for all samples. Ultra-pure nitrogen was used for the collision 
gas purchased through Matheson TRIGAS (Fairmont, WV, USA). 
1.2.2.3 Ion Spectroscopy 
Gas-phase infrared ion spectroscopy experiments were performed at the FELIX laboratory in 
Nijmegen, Netherlands using an electrospray ionization source on a Bruker Amazon ion trap mass 
spectrometer, modified to provide optical access to the trapped ions [33]. The flow rate of the α-
PVP sample to the source was 120 μL/hr with a spray voltage of −4500 V and N2 nebulizer gas 
was used. Precursor ions at m/z 119 and m/z 133 were generated through ESI-MS/MS of α-PVP 
(fragmentation of [M+H]+ at m/z 232), isolated in the ion trap and irradiated with 10 infrared laser 
pulses from the free electron laser (FEL) (repetition rate 10 Hz, pulse energies between 80 and 200 
mJ), which was tuned over the frequency range 1000-1850 cm-1. The recorded mass spectra were 
used to determine the infrared multiple photon dissociation (IRMPD) yield at each wavelength, 
which is defined as the ratio of the summed product ion intensities divided by the total ion intensity. 
After measuring the intensities of the precursor and fragment ions at a given wavelength of 
irradiation, the IR frequency was changed in steps of 3 cm−1. For each IR frequency, new packets 
of ions were loaded into the ion trap and irradiated. The intensities of the precursor and product 
ions were the average of five replicate mass spectra per IR step. The whole process continued 
across the fingerprint spectral region (1000- 1850 cm−1). IRMPD spectra were linearly corrected 
for variations in laser power as a function of IR frequency. The experimental gas-phase IRMPD 
spectra could then be compared to the density functional theory (DFT) calculated spectra. 
The lowest-energy geometry was calculated at the B3LYP/6-311+G(d,p) level of theory using 
Gaussian 09 [34] for several isomeric structures of each of the two intermediate product ions at 





isomeric structures for the product ions at m/z 119 and m/z 133 are presented in Table 1.1 and 
Table 1.2, respectively. The vibrational frequencies calculated at this level of theory provided 
thermodynamic corrections to the raw energies and the theoretical vibrational spectra of each of 
the species. Comparison of the calculated and the IRMPD spectra, along with the relative energies 
between isomers, provided justification for the assignment of the most probable isomer of each of 







Figure 1.1. Optimized geometries of seven possible isomeric structures of the fragment at m/z 
119. Relative energies and theoretical IR spectra are calculated at the B3LYP/6-311+G(d,p) level 
of theory. Energies are reported in kJ/mol relative to structure 119a. Calculated IR (blue) are 








Figure 1.2. Optimized geometries of nine possible isomeric structures of the fragment at m/z 
133. Relative energies and theoretical IR spectra are calculated at the B3LYP/6-311+G(d,p) level 
of theory. Energies are reported in kJ/mol relative to structure 133a. Calculated IR (blue) are 






Table 1.1. Cartesian coordinates of each of optimized structures at m/z 119 in Figure 1.1. 
 
119a 
C    0.00000000  0.00000000  0.00000000 
C   -0.39274900 -1.43647300  0.07716100 
C    0.34831200 -2.60329800  0.08739900 
C   -0.35442800 -3.81077100  0.17023800 
C   -1.76004500 -3.86539200  0.24151600 
C   -2.51185400 -2.70546000  0.23216000 
C   -1.80903300 -1.48756500  0.14892200 
C   -2.24802200 -0.15364200  0.11726100 
O   -1.29193200  0.70908500  0.03569000 
H   -3.25603800  0.24724000  0.15109300 
H   -3.59338900 -2.72958700  0.28633900 
H   -2.24998500 -4.82881900  0.30410000 
H    0.20345500 -4.74024600  0.18000400 
H    1.42989600 -2.59848800  0.03401500 
H    0.57579900  0.37180400  0.85039500 
H    0.48717900  0.29998200 -0.93042500 
119b 
C    0.00000000  0.00000000  0.00000000 
C    1.39007000  0.17760600  0.00935700 
C    1.96941200  1.45606500 -0.01054700 
C    1.16148400  2.57312000 -0.03995100 
C   -0.24988500  2.40119000 -0.04941200 
C   -0.82828000  1.10425400 -0.02944900 
H   -1.90609400  0.99161400 -0.03719200 
C   -1.08465200  3.51241900 -0.07860600 
 
O   -0.94244800  4.78377100 -0.10193900 
C   -2.35732600  4.17824500 -0.10335300 
H   -2.87325600  4.32252200 -1.04554200 
H   -2.89035300  4.35924800  0.82283500 
H    1.58488700  3.57050400 -0.05579100 
H    3.04684100  1.56217800 -0.00280100 
H    2.03454200 -0.69408400  0.03253600 
H   -0.41969800 -0.99773500  0.01581400 
119c 
C    0.00000000  0.00000000  0.00000000 
C    1.15734400 -0.85030900  0.03689900 
C    1.81511700 -2.07461900  0.06124700 
C    3.23577200 -2.11681000  0.10305200 
C    3.86633100 -3.34296300  0.12692800 
C    3.10160600 -4.52007600  0.10966700 
C    1.70117100 -4.48666700  0.06839200 
C    1.04859300 -3.27010100  0.04391500 
H   -0.03344900 -3.21953700  0.01186100 
H    1.13642700 -5.41012100  0.05583600 
H    3.60746600 -5.47895500  0.12873500 
H    4.94699900 -3.40005300  0.15886800 
H    3.80414000 -1.19426400  0.11554900 
O    1.48937000  0.38533100  0.04184600 
H   -0.46663200  0.23599000 -0.94936500 







C    0.00000000  0.00000000  0.00000000 
C    1.46806700  0.00257000 -0.17895900 
C    2.23730900 -1.12529000 -0.07830200 
C    1.56232000 -2.33727800  0.17979400 
C    0.16882600 -2.41151200  0.41007200 
C   -0.61332600 -1.28395400  0.33737200 
H   -1.69296100 -1.35351300  0.42270100 
H   -0.27584400 -3.37410000  0.63169500 
H    2.14543700 -3.24970800  0.26309700 
H    3.32049400 -1.08553300 -0.09857800 
C    1.61266300  1.43761400  0.31151900 
C    0.20294100  1.30241700  0.93641800 
H    0.25867000  1.06422100  1.99915000 
H   -0.51100200  2.10320800  0.74900800 
O    2.45086100  2.27278500  0.27118500 
H   -0.53096500  0.39796900 -0.88164400 
119e 
C    0.00000000  0.00000000  0.00000000 
C   -1.27451300 -0.44254100  0.00167300 
C   -1.27456000 -1.91789000  0.00153500 
C   -2.52162900 -2.62948600 -0.00415000 
C   -3.66833100 -1.90409200 -0.00158500 
C   -3.66832300 -0.45642300 -0.00154300 
C   -2.52163400  0.26900000 -0.00399600 
H   -2.53041300  1.35107300 -0.00828700 
H   -4.62359900  0.05438200 -0.00248700 
H   -4.62358800 -2.41494400 -0.00247800 
H   -2.53032400 -3.71156000 -0.00862300 
C   -0.00007700 -2.36030400 -0.00038500 
O    0.83360200 -1.18034000 -0.06566400 
H    1.69930600 -1.18072700  0.38564800 
H    0.53799100 -3.29150000 -0.03122400 
H    0.53833600  0.93091400 -0.03385500 
119f 
C    0.00000000  0.00000000  0.00000000 
C   -0.88712700 -0.96949900 -0.67571100 
C   -2.21480100 -0.73444300 -0.78389200 
C   -2.95428300  0.46967400 -0.47315700 
C   -2.54794000  1.78639000 -0.40246600 
C   -1.22706300  2.24655400 -0.61510200 
C   -0.13701600  1.42708000 -0.48258000 
C    1.21570700  1.36068100 -0.82034200 
O    1.43710900  0.10515000 -0.50254900 
H    2.00831900  2.00657100 -1.18370000 
H   -1.08048000  3.27387700 -0.93724400 
H   -3.32586000  2.53710000 -0.32398300 
H   -4.02843200  0.31911900 -0.41358600 
H   -2.82622000 -1.55414800 -1.14797800 
H   -0.46655300 -1.91440300 -1.00577800 






Table 1.2. Cartesian coordinates of each of optimized structures at m/z 133 in Figure 1.2. 
 
133a 
C    0.00000000  0.00000000  0.00000000 
C   -1.48676700 -0.02475900  0.17268700 
C   -1.93158700  1.30027100  0.40346300 
C   -3.28903600  1.61348700  0.60698100 
C   -4.18900800  0.56420400  0.57233400 
C   -3.74574800 -0.75222000  0.34275100 
C   -2.39695400 -1.06563100  0.14034500 
H   -2.09262200 -2.08993000 -0.03593300 
H   -4.47737900 -1.55194500  0.32254400 
H   -5.24500100  0.74963600  0.72275300 
H   -3.61245600  2.63230000  0.78256000 
C   -0.77942500  2.10720900  0.37954900 
O    0.30899600  1.45736000  0.16571600 
H   -0.68629200  3.18075200  0.51326500 
C    0.84098400 -0.79093200  0.98833700 
H    1.90090200 -0.59959600  0.81933400 
H    0.58271300 -0.53817100  2.01775100 
H    0.65490700 -1.85586700  0.83202800 
H    0.29934100 -0.20733900 -1.03180400 
133b 
C    0.00000000  0.00000000  0.00000000 
C    0.38282900 -1.40359100  0.16356600 
C   -0.53485400 -2.40542900  0.33112500 
C   -1.89015200 -2.03541300  0.44457600 
C   -2.32528400 -0.69254700  0.39329300 
 
C   -1.41640200  0.31908600  0.20042900 
H   -1.74136600  1.35114200  0.11261100 
H   -3.37934300 -0.47181300  0.50921900 
H   -2.63167800 -2.81185500  0.60740200 
H   -0.22224600 -3.43774000  0.44219300 
C    1.89194100 -1.49461400  0.26781200 
C    2.41592700 -0.06437700  0.35122700 
C    1.18379400  0.81860300  0.63759900 
H    1.25354400  1.81851100  0.21308700 
H    1.00579100  0.91119600  1.71032600 
H    2.87952800  0.18515500 -0.61035700 
H    3.19622700  0.01420100  1.10932900 
O    2.50176000 -2.52781800  0.30314500 
H    0.11237300  0.18513700 -1.09997700 
133c 
C    0.00000000  0.00000000  0.00000000 
C    0.84621700  0.55467600 -1.09505700 
C    2.19084600  1.03253000 -0.90432200 
C    3.56907200  0.84950400 -0.76875500 
C    4.10769700 -0.45784400 -0.87270000 
C    5.47194300 -0.63664100 -0.74450700 
C    6.29659900  0.47199500 -0.51493500 
C    5.77087400  1.76848200 -0.41125000 
C    4.41104900  1.96844100 -0.53645000 
H    3.98199000  2.96068800 -0.46127100 





H    7.36620500  0.32505500 -0.41563200 
H    5.90277000 -1.62679100 -0.82147100 
H    3.45218500 -1.30194600 -1.05237400 
O    1.39704200  2.02857500 -0.87207700 
H    0.50805500  0.45863700 -2.12247100 
H   -0.07634700 -1.08314000 -0.14527200 
H   -1.00920500  0.41250500 -0.05932500 
H    0.42000200  0.19290300  0.98717100 
133d 
C    0.00000000  0.00000000  0.00000000 
C   -0.84574900 -0.55428100 -1.09568300 
C   -2.19032800 -1.03252600 -0.90557400 
C   -3.56856900 -0.84958400 -0.76994300 
C   -4.10717300  0.45776900 -0.87401800 
C   -5.47137700  0.63666800 -0.74543500 
C   -6.29599300 -0.47188900 -0.51533500 
C   -5.77027800 -1.76838000 -0.41161800 
C   -4.41050000 -1.96844900 -0.53727700 
H   -3.98151300 -2.96072100 -0.46202400 
H   -6.43072100 -2.60775100 -0.23426900 
H   -7.36555400 -0.32490300 -0.41564800 
H   -5.90217800  1.62682100 -0.82247500 
H   -3.45167500  1.30179800 -1.05400900 
O   -1.39621100 -2.02831300 -0.87343300 
H   -0.50723500 -0.45751800 -2.12290700 
H    0.07660500  1.08316300 -0.14479200 
H    1.00918800 -0.41265200 -0.05911100 
H   -0.42032900 -0.19337900  0.98692100 
133e 
C    0.00000000  0.00000000  0.00000000 
C    0.95904000 -0.88195500 -0.75981200 
C    2.27696900 -0.62069600 -0.89207900 
C    2.98317100  0.55718400 -0.46206300 
C    2.51008500  1.84186800 -0.30193500 
C    1.18198800  2.25534300 -0.54061200 
C    0.07192500  1.43391400 -0.50574800 
C   -1.21605800  1.82098700 -0.86116400 
O   -2.11677800  0.90450900 -0.72825300 
C   -1.49081700 -0.34374000 -0.22792800 
H   -2.04129700 -0.61084900  0.67103400 
H   -1.66258700 -1.08912200 -1.00454900 
H   -1.56006000  2.78761600 -1.21437400 
H    1.02434900  3.30367700 -0.78204200 
H    3.24341200  2.62146800 -0.12933200 
H    4.05993500  0.43919000 -0.37785200 
H    2.89314200 -1.38635600 -1.35336900 
H    0.57053500 -1.80594400 -1.17828500 
H    0.24508100 -0.02606000  1.06837200 
133f 
C    0.00000000  0.00000000  0.00000000 
O    0.61035100 -1.24531400  0.05723800 
C    1.80245900 -1.37072900  0.67444400 
C    2.91941000 -1.70819700 -0.03723400 
C    4.11138700 -1.13832800  0.49853400 
C    4.63323900 -0.10471200 -0.29417300 





C    3.02884700  1.63449000 -0.14989300 
C    1.94426000  1.44347800  0.65986000 
C    0.56505000  1.20064300  0.19374100 
H   -0.07371200  2.05569800 -0.01099800 
H    2.12223500  1.34641100  1.72921000 
H    2.91040600  1.71768000 -1.22552600 
H    4.36381400  1.09517000  1.47317200 
H    4.53096600 -0.15325200 -1.37404200 
H    4.23543600 -1.09906500  1.57755300 
H    2.81955900 -1.86700300 -1.10629600 
H    1.81836500 -1.15172000  1.73891400 
H   -1.02384800 -0.11626100 -0.32549900 
133a’ 
C    0.00000000  0.00000000  0.00000000 
C   -1.16726200 -0.92768500  0.00084800 
C   -0.66255900 -2.24675300 -0.00841000 
C   -1.51397600 -3.36538100 -0.01193000 
C   -2.87708600 -3.12637500 -0.00230100 
C   -3.37477500 -1.81052700  0.00740300 
C   -2.53185800 -0.69566200  0.00886100 
H   -2.94303500  0.30622000  0.01540100 
H   -4.44784500 -1.65760400  0.01273100 
H   -3.57217700 -3.95648700 -0.00394300 
H   -1.12274200 -4.37530300 -0.02084500 
C    0.75604300 -2.14620800 -0.01235100 
O    1.15424700 -0.90906200 -0.01218400 
C    1.78360000 -3.20321700  0.01088400 
H    2.70836000 -2.85357500 -0.44847700 
H    2.00092700 -3.45251600  1.05783100 
H    1.42788500 -4.10897100 -0.48035200 
H    0.09136900  0.62856700 -0.88816700 
H    0.10085800  0.61680200  0.89548600 
133e’ 
C    0.00000000  0.00000000  0.00000000 
O   -1.02116500 -1.05471000  0.08380700 
C   -2.23440300 -0.53542600  0.08459900 
C   -3.32348500 -1.42583800  0.09250000 
C   -4.66300000 -1.09775200  0.08028900 
C   -5.27553700  0.17165100  0.05629900 
C   -4.67663900  1.41711600  0.04902300 
C   -3.30429900  1.73675400  0.06649600 
C   -2.22237800  0.88469300  0.08460300 
C   -0.77486700  1.32206400  0.13110500 
H   -0.56451900  1.82680900  1.07849600 
H   -0.53889600  2.02298200 -0.67219400 
H   -3.07308700  2.79813900  0.06672500 
H   -5.34958800  2.26820300  0.03157200 
H   -6.36029300  0.16473600  0.04376800 
H   -5.34585900 -1.94150000  0.08588300 
H   -3.05642800 -2.47738600  0.10556500 
H    0.70824800 -0.18870200  0.80344500 








C    0.00000000  0.00000000  0.00000000 
C   -1.48676700 -0.02475900  0.17268700 
C   -1.93158700  1.30027100  0.40346300 
C   -3.28903600  1.61348700  0.60698100 
C   -4.18900800  0.56420400  0.57233400 
C   -3.74574800 -0.75222000  0.34275100 
C   -2.39695400 -1.06563100  0.14034500 
H   -2.09262200 -2.08993000 -0.03593300 
H   -4.47737900 -1.55194500  0.32254400 
H   -5.24500100  0.74963600  0.72275300 
H   -3.61245600  2.63230000  0.78256000 
C   -0.77942500  2.10720900  0.37954900 
O    0.30899600  1.45736000  0.16571600 
H   -0.68629200  3.18075200  0.51326500 
C    0.84098400 -0.79093200  0.98833700 
H    1.90090200 -0.59959600  0.81933400 
H    0.58271300 -0.53817100  2.01775100 
H    0.65490700 -1.85586700  0.83202800 
H    0.29934100 -0.20733900 -1.03180400 
133b 
C    0.00000000  0.00000000  0.00000000 
C    0.38282900 -1.40359100  0.16356600 
C   -0.53485400 -2.40542900  0.33112500 
C   -1.89015200 -2.03541300  0.44457600 
C   -2.32528400 -0.69254700  0.39329300 
C   -1.41640200  0.31908600  0.20042900 
H   -1.74136600  1.35114200  0.11261100 
H   -3.37934300 -0.47181300  0.50921900 
H   -2.63167800 -2.81185500  0.60740200 
H   -0.22224600 -3.43774000  0.44219300 
C    1.89194100 -1.49461400  0.26781200 
C    2.41592700 -0.06437700  0.35122700 
C    1.18379400  0.81860300  0.63759900 
H    1.25354400  1.81851100  0.21308700 
H    1.00579100  0.91119600  1.71032600 
H    2.87952800  0.18515500 -0.61035700 
H    3.19622700  0.01420100  1.10932900 
O    2.50176000 -2.52781800  0.30314500 
H    0.11237300  0.18513700 -1.09997700 
133c 
C    0.00000000  0.00000000  0.00000000 
C    0.84621700  0.55467600 -1.09505700 
C    2.19084600  1.03253000 -0.90432200 
C    3.56907200  0.84950400 -0.76875500 
C    4.10769700 -0.45784400 -0.87270000 
C    5.47194300 -0.63664100 -0.74450700 
C    6.29659900  0.47199500 -0.51493500 
C    5.77087400  1.76848200 -0.41125000 
C    4.41104900  1.96844100 -0.53645000 
H    3.98199000  2.96068800 -0.46127100 
H    6.43134400  2.60791400 -0.23428800 
H    7.36620500  0.32505500 -0.41563200 
H    5.90277000 -1.62679100 -0.82147100 
H    3.45218500 -1.30194600 -1.05237400 





H    0.50805500  0.45863700 -2.12247100 
H   -0.07634700 -1.08314000 -0.14527200 
H   -1.00920500  0.41250500 -0.05932500 
H    0.42000200  0.19290300  0.98717100 
133d 
C    0.00000000  0.00000000  0.00000000 
C   -0.84574900 -0.55428100 -1.09568300 
C   -2.19032800 -1.03252600 -0.90557400 
C   -3.56856900 -0.84958400 -0.76994300 
C   -4.10717300  0.45776900 -0.87401800 
C   -5.47137700  0.63666800 -0.74543500 
C   -6.29599300 -0.47188900 -0.51533500 
C   -5.77027800 -1.76838000 -0.41161800 
C   -4.41050000 -1.96844900 -0.53727700 
H   -3.98151300 -2.96072100 -0.46202400 
H   -6.43072100 -2.60775100 -0.23426900 
H   -7.36555400 -0.32490300 -0.41564800 
H   -5.90217800  1.62682100 -0.82247500 
H   -3.45167500  1.30179800 -1.05400900 
O   -1.39621100 -2.02831300 -0.87343300 
H   -0.50723500 -0.45751800 -2.12290700 
H    0.07660500  1.08316300 -0.14479200 
H    1.00918800 -0.41265200 -0.05911100 
H   -0.42032900 -0.19337900  0.98692100 
133e 
C    0.00000000  0.00000000  0.00000000 
C    0.95904000 -0.88195500 -0.75981200 
C    2.27696900 -0.62069600 -0.89207900 
C    2.98317100  0.55718400 -0.46206300 
C    2.51008500  1.84186800 -0.30193500 
C    1.18198800  2.25534300 -0.54061200 
C    0.07192500  1.43391400 -0.50574800 
C   -1.21605800  1.82098700 -0.86116400 
O   -2.11677800  0.90450900 -0.72825300 
C   -1.49081700 -0.34374000 -0.22792800 
H   -2.04129700 -0.61084900  0.67103400 
H   -1.66258700 -1.08912200 -1.00454900 
H   -1.56006000  2.78761600 -1.21437400 
H    1.02434900  3.30367700 -0.78204200 
H    3.24341200  2.62146800 -0.12933200 
H    4.05993500  0.43919000 -0.37785200 
H    2.89314200 -1.38635600 -1.35336900 
H    0.57053500 -1.80594400 -1.17828500 
H    0.24508100 -0.02606000  1.06837200 
133f 
C    0.00000000  0.00000000  0.00000000 
O    0.61035100 -1.24531400  0.05723800 
C    1.80245900 -1.37072900  0.67444400 
C    2.91941000 -1.70819700 -0.03723400 
C    4.11138700 -1.13832800  0.49853400 
C    4.63323900 -0.10471200 -0.29417300 
C    4.21490300  1.03758400  0.39801000 
C    3.02884700  1.63449000 -0.14989300 
C    1.94426000  1.44347800  0.65986000 
C    0.56505000  1.20064300  0.19374100 





H    2.12223500  1.34641100  1.72921000 
H    2.91040600  1.71768000 -1.22552600 
H    4.36381400  1.09517000  1.47317200 
H    4.53096600 -0.15325200 -1.37404200 
H    4.23543600 -1.09906500  1.57755300 
H    2.81955900 -1.86700300 -1.10629600 
H    1.81836500 -1.15172000  1.73891400 
H   -1.02384800 -0.11626100 -0.32549900 
133a’ 
C    0.00000000  0.00000000  0.00000000 
C   -1.16726200 -0.92768500  0.00084800 
C   -0.66255900 -2.24675300 -0.00841000 
C   -1.51397600 -3.36538100 -0.01193000 
C   -2.87708600 -3.12637500 -0.00230100 
C   -3.37477500 -1.81052700  0.00740300 
C   -2.53185800 -0.69566200  0.00886100 
H   -2.94303500  0.30622000  0.01540100 
H   -4.44784500 -1.65760400  0.01273100 
H   -3.57217700 -3.95648700 -0.00394300 
H   -1.12274200 -4.37530300 -0.02084500 
C    0.75604300 -2.14620800 -0.01235100 
O    1.15424700 -0.90906200 -0.01218400 
C    1.78360000 -3.20321700  0.01088400 
H    2.70836000 -2.85357500 -0.44847700 
H    2.00092700 -3.45251600  1.05783100 
H    1.42788500 -4.10897100 -0.48035200 
H    0.09136900  0.62856700 -0.88816700 
H    0.10085800  0.61680200  0.89548600 
133e’ 
C    0.00000000  0.00000000  0.00000000 
O   -1.02116500 -1.05471000  0.08380700 
C   -2.23440300 -0.53542600  0.08459900 
C   -3.32348500 -1.42583800  0.09250000 
C   -4.66300000 -1.09775200  0.08028900 
C   -5.27553700  0.17165100  0.05629900 
C   -4.67663900  1.41711600  0.04902300 
C   -3.30429900  1.73675400  0.06649600 
C   -2.22237800  0.88469300  0.08460300 
C   -0.77486700  1.32206400  0.13110500 
H   -0.56451900  1.82680900  1.07849600 
H   -0.53889600  2.02298200 -0.67219400 
H   -3.07308700  2.79813900  0.06672500 
H   -5.34958800  2.26820300  0.03157200 
H   -6.36029300  0.16473600  0.04376800 
H   -5.34585900 -1.94150000  0.08588300 
H   -3.05642800 -2.47738600  0.10556500 
H    0.70824800 -0.18870200  0.80344500 









 Data Analysis 
Xcalibur 2.0.0.48 software was used for the data analysis on the Velos Pro and Mass Hunter 
Qualitative Analysis B.05.00 was used for the Agilent Q-TOF data analysis. Microsoft Excel 
version 14 (Microsoft, Redmond, WA, USA) and ChemDraw 16.0 (PerkinElmer, Waltham, MA, 
USA) were used for mass spectral plots and mass spectral fragmentation mechanisms, 
respectively. 
1.2.3.1 Mass Spectral Interpretation and Mechanisms 
The proposed fragmentation mechanisms in the following section are based on MSn analyses, 
rational electron pushing mechanisms and the expected lowest energy pathways [35]. Whereas the 
identification of the exact hydrogen(s) in a specific rearrangement is not always possible in this 
study, deuterium labeling was often able to exclude the involvement of certain hydrogen atoms. 
The use of MSn permits the structural determination of all the intermediates along a fragmentation 
pathway, so even when the exact structure of an intermediate is not known, it is still possible to 
generate a deeper understanding of the precursors and products of a certain intermediate than the 
present status. Odd-electron product ions formed from even-electron (i.e. protonated) precursor 
ions of synthetic cathinones have been reported before by Fornal [36, 37], but none of the α-
pyrrolidinophenone synthetic cathinones analyzed in this study provided a significant abundance 
of odd-electron product ions, which is consistent with previous literature [36].  
1.3 Results and Discussion 
 HESI-Velos Pro MSn 
Since the seminal publication by Rylander et al. in 1956 [38], the propensity of aromatic 
compounds to form energetically favored tropylium fragments has been studied extensively in EI-





rearrangement of the benzylium ion (C7H7
+, m/z 91) to the tropylium ion, which is a constitutional 
isomer. In the 1970s, McLafferty et al. focused on the formation of tropylium ions from a variety 
of alkyl-substituted benzenes under EI-MS conditions [39, 40] McLafferty and coworkers showed 
that whereas benzylium and tropylium ions are often equally favored at threshold fragmentation 
energies, the tropylium ion is favored by a factor of at least 2:1 at EI energies around 70 eV [39, 
40].  
Lifshitz et al. also demonstrated that the tropylium ion is more stable than several other isomers 
and noticeably lower in energy than the benzylium ion, which explains the preference for the ring 
expansion of benzylium ions to the tropylium ion structure [41]. More recently, Hayward et al. 
have described the formation of the tropylium ion with surface-induced dissociation (SID) [42]. 
Hayward et al. showed that the ring expansion from the benzylium ion to the tropylium ion was 
exothermic and often involves the incorporation of alkyl substituents. Specifically, the reaction of 
neutralized benzene with sputtered C3H5
+ followed by the loss of ethene was the most likely route 
for tropylium ion formation [42]. Using a variety of theoretical calculations, several groups have 
shown that the activation barrier from the benzylium ion to the tropylium ion is in the range of 1.4-
3.4 eV and that the tropylium ion is thermodynamically more stable than the benzylium ion by 
approximately 0.37 eV [43-49]. Although the mechanism(s) from the benzylium ion to tropylium 
ion is therefore very well documented, mechanisms to form the tropylium ion from aromatic 
ketones—like alkylphenones and cathinones—have not been adequately described. We therefore 
conducted various experiments to rationalize the significant rearrangements that are required to 
produce the tropylium ion from a variety of synthetic cathinones.  
Figure 1.3 shows the MSn fragmentation of α-PVP with the major structural fragments 





primary product ions at m/z 214, 189, 161, and 154 (Figure 1.3a). The base peak of this spectrum 
is observed at m/z 161, which is formed through the loss of the pyrrolidine ring from the precursor 
ion. Figure 1.3b shows the product ions produced from the isolation and fragmentation of the 




Figure 1.3. Tandem mass spectra of α-PVP: a) MS2 product ion spectrum of the [M+H]+ 
molecular ion (35% NCE); b) MS3 product ion spectrum of the product ion at m/z 161 (30% 
NCE) showing the formation of product ions at m/z 143, 133, 119, 105, and 91; c) MS4 product 
ion spectrum of the secondary product ion at m/z 119 (30% NCE) showing the formation of only 
the tropylium ion at m/z 91. Evidence for the phthalane structure shown in panel b) is provided 
by ion spectroscopy and DFT calculations in section 1.3.2.  
 
Based on the MSn analysis of m/z 161, the secondary product ions at m/z 143, 133, and 119 are 





















the isolation and fragmentation of the secondary product ion at m/z 119, which results in the 
exclusive formation of the tropylium ion at m/z 91, which can only occur through the loss of CO 
from the intermediate at m/z 119. 
Figure 1.4 shows the MSn fragmentation of α-PVP that has a 13C label on the carbonyl carbon. 
The structures of major fragments are also embedded in Figure 1.4. Evidence for the phthalane 
structure shown in Figure 1.4b is provided by ion spectroscopy and DFT calculations in section 
1.3.2. Isolation and fragmentation of the isotope-labeled precursor ion [M+H]+ at m/z 233 (Figure 
1.4a) results in a variety of ions, including m/z 162, 133, 120, 106, and 91. Following the same 
logic as Figure 1.3, the structure at m/z 162 corresponds to the loss of the pyrrolidine ring from 
the precursor. The product ions formed through the isolation and fragmentation of m/z 162 (Figure 
1.4b) include m/z 144, 134, 133, 120, 106, 105, and 91. Based on MSn analyses, the 13C-labeled 















Figure 1.4. Tandem mass spectra of 13C-carbonyl labeled α-PVP: a) MS2 product ion spectrum 
of the [M+H]+ molecular ion (35% NCE); b) MS3 spectrum of the intermediate ion at m/z 162 
(30% NCE); c) MS4 spectrum of the intermediate ion at m/z 120 (30% NCE) showing the 
formation of only the secondary product ion at m/z 91. Evidence for the phthalane structures in 
panels a) and b) are provided by ion spectroscopy and DFT calculations in section 1.3.2. 
 
The observation of the intermediate at m/z 133 in the MS2 and MS3 spectra of Figure 1.4a and 
Figure 1.4b, respectively, is particularly interesting. Although the loss of CO directly from the 
alkyl chain had been proposed by Pozo et al. [28], Fabregat-Safont et al. [29] and Qian et al. [30], 
this pathway had not been verified until the current use of isotopic labeling.  
The MSn fragmentation of the precursor ion [M+H]+ at m/z 234 for 18O-α-PVP results in the 
formation of primary product ions at m/z 214,  191, 163, and 156 (Figure 1.5a). The primary 





















ions for α-PVP, which appear at m/z 189, 161, and 154. This observed 2 Da shift indicates these 
fragments must include the 18O-labeled oxygen. In contrast, the primary product ion at m/z 214 
must not contain the 18O label. The product at m/z 214 can therefore only be explained by the loss 
of H2
18O from the precursor.  
 
 
Figure 1.5. Tandem mass spectra of 18O-α-PVP: a) MS2 product ion spectrum of the [M+H]+ 
molecular ion (35% NCE); b) MS3 spectrum of the product ion at m/z 163 (30% NCE) showing 
the formation of product ions at m/z 143, 135, 133, 121, 107 and 91; c) MS4 spectrum of the 
secondary product ion at m/z 121 (30% NCE) showing only the formation of tropylium ion at 
m/z 91. Evidence for the phthalane structures in panels a) and b) are provided by ion 
spectroscopy and DFT calculations in section 1.3.2. 
 
Figure 1.5b shows that the product ion spectrum from the isolation and fragmentation of the 
primary product ion at m/z 163 results in product ions at m/z 143, 135, 133, 121, 107, and 91. The 
ions at m/z 135, 121, and 107 must include the 18O oxygen, whereas the ions at m/z 143, 133, and 





















secondary product ions at m/z 135 and m/z 133, which highlights competing pathways through the 
loss of ethylene (C2H4) and C
18O for the loss of 28 or 30 Da, respectively, from the primary product 
ion at m/z 161 for α-PVP (Figure 1.3b). Isolation and fragmentation of the 18O-containing 
secondary product ion at m/z 121 results in only the tropylium ion at m/z 91, again consistent with 
the loss of CO from the precursor with the elemental composition C8H7
18O+ at m/z 121 (Figure 
1.5c). 
Figure 1.6 contains the MSn fragmentation of α-PVP that has a 13C label on the α-carbon. 
Fragmentation of the isotope-labeled precursor ion [M+H]+ at m/z 233 (Figure 1.6a) results in 
product ions at m/z 162, 144, 134, 127, 120, 105, and 92. These product ions are entirely consistent 
with the product ions observed in Figure 1.4a with the 13C label on the carbonyl carbon instead of 
the -carbon. Figure 1.6b shows the product ions formed through the isolation and fragmentation 
of the intermediate at m/z 162, which includes m/z 144, 134, 120, and 92. Fragmentation of the 
intermediate ion at m/z 120 is almost devoid of signal at m/z 91 for the all-12C-isomer (Figure 












Figure 1.6. Tandem mass spectra of 13C-α-carbon α-PVP: a) MS2 product ion spectrum of the 
[M+H]+ molecular ion (35% NCE); b) MS3 spectrum of the intermediate ion at m/z 162 (30% 
NCE); c) MS4 spectrum of the intermediate ion at m/z 120 (30% NCE) showing the formation 
of only the product ion at m/z 92. Evidence for the phthalane structures in panels a) and b) are 
provided by ion spectroscopy and DFT calculations in section 1.3.2. 
 
Based on the isotope labeling and MSn results, Figure 1.7 shows the proposed fragmentation 
mechanisms for the generation of the product ions at m/z 134, 133, and 120 from collisional 
activation of the protonated molecular ion of 13C-carbonyl-α-PVP at m/z 233. After the loss of the 
pyrrolidine moiety from the precursor, the ion at m/z 162 follows two primary pathways. The first 
is the loss of 13CO directly from the alkyl chain, which results in the formation of the intermediate 
at m/z 133 (green pathway). The other dominant pathway for the intermediate at m/z 162 is through 




















fragment through a variety of charge-remote mechanisms including a 4-center elimination of 
ethylene to give the product at m/z 134 (red pathway) and through a different 4-center elimination 
of propylene to give the product at m/z 120 (blue pathway). For the precursor labeled with 13C on 
the carbonyl carbon, the loss of 13CO (29 Da) and the loss of C2H4 (28 Da) are readily 
distinguished. In contrast, the unlabeled precursor provides losses of 12CO (28 Da) and C2H4 (28 
Da) have the same nominal mass and are indistinguishable on unit-mass-resolution instruments.  
 
Figure 1.7. Proposed mechanisms for the formation of m/z 134, 133, and 120 product ions from 
13C-carbonyl carbon-α-PVP. The phthalane structures at m/z 120 and m/z 134 were confirmed 
by ion spectroscopy and DFT calculations (see Figure 1.22 and Figure 1.23). 
 
According to DFT calculations, there is no energy barrier to form the epoxide at m/z 162 in the 





carbon distal to the ring can then undergo nucleophilic attack by π-electrons from the aromatic 
ring—after or during the loss of an ethylene or propylene neutral loss of 28 or 42 Da, 
respectively—to provide the phthalane core for the product ions at m/z 134 and m/z 120, 
respectively. DFT calculations show that the phthalane structure (bottom right structure in Figure 
1.7) is thermodynamically the most stable isomer compared to seven alternative isomeric 
structures. However, energy barriers associated with these isomer interconversions have not been 
studied. These mechanisms help explain both the presence of the secondary product ions at m/z 
134 and m/z 133, and they are consistent with the ion spectroscopy results for the most probable 
structures (see section 1.3.2). The competing pathways between the loss of the non-13C-labled 
ethylene neutral (28 Da) and the 13C-labled CO neutral (29 Da) explains the presence of both m/z 
134 and m/z 133 in the product ion spectrum of 13C-carbonyl carbon--PVP.  
Figure 1.8 shows two possible mechanisms for the formation of the product ions at m/z 91 and 
m/z 92 from the intermediate at m/z 120. The conversion energetics of the last few steps—from 
the benzylium ion to the tropylium ion—have been described in detail by Vala et al. [49]. These 
pathways are based on the 13C isotopic labeling of both the carbonyl carbon and α-carbon, and 
they help explain the observations that the α-carbon is incorporated into the tropylium ion through 
the loss of neutral CO containing the carbonyl carbon. According to the acquired spectra, the alkyl 
hydrogens must have a sufficiently high barrier for rearrangement to prevent the phthalane 
structures at the top of Figure 1.8 from interconverting. The two fragments shown at the top of 








Figure 1.8. Proposed mechanisms for the formation of product ions at m/z 91 and m/z 92 from 
the intermediate at m/z 120 for MS4 based on 13C isotopic labeling of the carbonyl carbon and 
the α-carbon for α-PVP. 
 
Figure 1.9a shows the MS3 product ion spectrum from the intermediate product ion at m/z 134 
for 13C-carbonyl carbon--PVP. This spectrum highlights the formation of product ions at m/z 
106, 105, and 92. The corresponding MS3 product ion spectrum for the intermediate product ion 
at m/z 133 for 13C-carbonyl carbon--PVP is shown in Figure 1.9b. Figure 1.9b demonstrates the 
formation of product ions at only m/z 105 and m/z 91. Figure 1.10 shows the proposed mechanisms 
for the formation of the m/z 106, 105, 92, and 91 product ions from the intermediate product ions 
at m/z 134 and m/z 133 for 13C-carbonyl carbon--PVP. Figure 1.11 shows the MS3 fragmentation 
of the intermediate product ion at m/z 134 from 13C-α-carbon-α-PVP and Figure 1.12 demonstrates 







Figure 1.9. MS3 product ion mass spectra of: a) the product ion at m/z 134 (30% NCE) showing 
the formation of product ions at m/z 106, 105, and 92 from 13C-carbonyl carbon-α-PVP and b) 
the product ion at m/z 133 (30% NCE) showing the presence of only the product ions at m/z 105 
















Figure 1.10. Proposed mechanisms for the formation of the product ions from the intermediate 
ions at m/z 134 and m/z 133 as observed from the MS3 analysis for 13C-carbonyl carbon-α-PVP. 
 
 
Figure 1.11. MS3 product ion mass spectra of the product ion at m/z 134 (30% NCE) showing 











Figure 1.12. Proposed mechanisms for the formation of the product ions at m/z 106, 105, 92, 
and 91 from the MS3 analysis of the intermediate ion at m/z 134 from 13C-α-carbon-α-PVP. 
 
The analysis of α-PVP-d7, which is perdeuterated along the alkyl chain, provides additional 
support for the proposed mechanisms shown in Figure 1.7 and Figure 1.8. When α-PVP is 
perdeuterated along the alkyl chain, the [M+H]+ precursor ion is observed at m/z 239, and 
fragmentation of the d7 precursor results in abundant fragments at m/z 168, 140, 120, 93 and 92, 
among others (Figure 1.13a). Isolation and fragmentation of the intermediate at m/z 168 (Figure 
1.13b) shows an interesting distribution of fragments around m/z 92 and m/z 120. The formation 
of the ion at m/z 92 must occur through the incorporation of a single deuterium into the tropylium 
ion, whereas the formation of ions at m/z 93 and m/z 94 must involve the incorporation of two and 
three deuteriums, respectively, into the tropylium ion. This same pattern of deuterium inclusion is 





and Figure 1.8 are consistent with the experimental observations regarding scrambling along the 
alkyl chain (m/z 93 and m/z 121) and the aromatic ring (m/z 94 and m/z 122).  
Based on the results for the fragmentation of α-PVP labeled with 18O, one would expect α-
PVP-d7 to lose either 
12CO (28 Da) or C2D4 (32 Da) from the intermediate at m/z 168 to provide 
product ions at m/z 140 and m/z 136, respectively. Although both are observed, only the 
intermediate product ion a m/z 140 is readily observed in the full-scale plot. These observations 
are consistent with both the C9H9O
+ and C10H13
+ intermediate product ions in unlabeled -PVP, 
which are discussed later in the high-resolution mass spectrometry section. 
 
 
Figure 1.13. Tandem mass spectra of α-PVP-d7: a) MS
2 product ion spectrum of the [M+H]+ 
molecular ion (35% NCE); b) MS3 product ion spectrum of the product ion at m/z 168 (30% 
NCE) showing the formation of secondary product ions at m/z 140, 122, 121, 120, 94, 93, and 
92; c) MS4 product ion spectrum of the intermediate at m/z 140 (30% NCE) showing the 





















ESI-MS/MS analysis of other cathinone structures showed that the alkyl chain length has a 
direct impact on the formation of the tropylium ion and associated intermediate product ions. As 
the alkyl chain length increases, additional intermediates are possible, and they also contribute to 
the formation of the tropylium ion. For example, PV8 has two additional methylene groups relative 
to α-PVP. The [M+H]+ precursor of PV8 is observed at m/z 260, and the major product ions appear 
at m/z 189, 147, 133, 119 and 91. Consistent with the other pyrrolidine-containing cathinones, the 
structure of the intermediate product ion at m/z 189 corresponds to the preferred loss of the 
pyrrolidine ring from the precursor. The structure of the intermediate product ion at m/z 119 is 
presumably the same as in Figure 1.3, which likely has the same phthalane structure as shown in 
Figure 1.7 and Figure 1.8. The mass of the intermediate product ion at m/z 147 suggests that it 
corresponds to the fragment at m/z 133 (described in Figure 1.4, Figure 1.5, Figure 1.7) with an 
additional methylene group (CH2). Secondary fragmentation of the intermediate at m/z 147 
provides secondary product ions at m/z 119 and m/z 91.  
Product ion spectra change more dramatically when the alkyl chain length is decreased relative 
to -PVP. For example, Figure 1.14 shows ESI-MS/MS spectra of cathinones with both shorter 
and branched alkyl chains and their ability to prevent the formation of the tropylium ion. Our 
results show that when the alkyl chain attached to the aromatic ring is at least four carbons long 
(including the carbonyl cabon), the tropylium ion is observed, which is consistent with previous 
results [18, 22, 37, 50]. However, as a general rule, when the alkyl chain is shorter than four carbon 
atoms, the formation of the tropylium ion is severely inhibited. These observations are explained 
by the need for a sufficient number of carbons on the alkyl appendage to enable both sterically 
favorable rearrangements and a good leaving group for the phthalane ring to form, as is the case 





carbon atoms, the incorporation of a methyl group on the α-carbon also quenches the mechanism 
for tropylium ion formation. Quenching of the tropylium ion formation is an expected outcome of 
the mechanism shown in Figure 1.7 because the additional methyl group on the α-carbon both 
stabilizes the charge on the α-carbon and provides steric hinderance to the nucleophilic attack by 




















Figure 1.14. Tandem mass spectra of: a) α-PBP (35% NCE), b) α-PPP (30% NCE), and c) α-PVP-
methyl at the α-carbon (35% NCE) demonstrating the presence of the tropylium ion at m/z 91 for 



















Figure 1.15 shows the ESI-MS/MS spectrum of protonated 3,4-MDPV-d8. The spectrum 
indicates that the deuterium atoms on the pyrrolidine ring are not incorporated into the benzene 
ring during the skeletal rearrangement and instead remain on the pyrrolidine moiety. The absence 
of deuterium scrambling is confirmed with the product ion at m/z 134, which is an 8 Da mass 
increase relative to the 1-butylidenepyrrolidin-1-ium product ion at m/z 126 observed for non-
deuterated 3,4-MDPV (Figure 1.15a). When the [M+H]+ precursor of 3,4-MDPV-d8 at m/z 284 is 
isolated and fragmented, the base peak is the secondary product ion at m/z 205 (Figure 1.15a). 
This ion is a 44 Da mass increase relative to the secondary product ion at m/z 161 of α-PVP, which 
corresponds to the additional mass of the methylenedioxy substituent, as expected.  
MS3 fragmentation of the base peak at m/z 205 for 3,4-MDPV-d8 produces secondary product 
ions at both m/z 177 and m/z 163, which both represent a 44 Da mass increase relative to the 
corresponding non-methylenedioxy substitutions observed for α-PVP (Figure 1.15b). These 
fragments also support the conserved nature of the proposed fragmentation mechanisms that are 
apparently unperturbed by modifications on the aromatic ring. The product ion at m/z 175 forms 
through the loss of formaldehyde (CH2O), which comes from the methylenedioxy substituent and 
explains why this equivalent fragment is not observed for α-PVP. Figure 1.15c shows the isolation 
and fragmentation of the intermediate product ion at m/z 177 for 3,4-MDPV-d8, which highlights 
the loss of both propylene (42 Da) and formaldehyde (30 Da). Again, the formaldehyde loss from 








Figure 1.15. Tandem mass spectra of 3,4-MDPV-d8: a) MS
2 product ion spectrum of the 
[M+H]+ molecular ion (35% NCE); b) MS3 product ion spectrum of the product ion at m/z 205 
(35% NCE) showing the formation of secondary product ions at m/z 177, 163 and 135; and c) 
MS4 product ion spectrum of the product ion at m/z 177 (35% NCE) showing the formation of 
the tropylium ion derivative at m/z 135. 
 
Figure 1.16 compares the tandem mass spectra of the [M+H]+ precursor ion for 3,4-MDPV 
and the [M+H]+ precursor ion for 2,3-MDPV, both of which are observed at m/z 276. In both cases, 
the major fragments leading to the formation of the substituted tropylium ions are observed at m/z 
205, 177, 163 and 135. However, the isomers have different fragment ion abundances at m/z 205 
and m/z 135. When the methylenedioxy substituent is in the 3,4-positon, the intermediate product 
ion at m/z 205 is the base peak of the tandem mass spectrum and the product ion at m/z 135 is 
present at ~10% abundance. In contrast, when the methylenedioxy substituent is in the 2,3-




















ion at m/z 135 is about 70% of the base peak. This behavior highlights two trends about the position 
of the methylenedioxy substituent: 1) the formation of the tropylium ion is favored for the 2,3-




Figure 1.16. Tandem mass spectra of positional isomers highlighting the impact of substituent 
location as demonstrated by a) 3,4-MDPV (35% NCE) and b) 2,3-MDPV (35% NCE) 
demonstrating the differences in fragmentation based on location of the methylenedioxy 
substituent. 
 
Figure 1.17 shows the pathways from the [M+H]+ precursor to the final tropylium product ion 
along each major pathway for α-PBP, α-PVP, and PV8. The flux is expressed as a percentage of 













additional intermediate product ions that feed into the tropylium ion pathway. Likewise, the 
conversion rate from precursor to intermediate changes as a function of possible pathways, where 
α-PBP contains only two intermediates and PV8 contains four intermediates along the tropylium 
ion pathways. The length of the alkyl chain has a direct effect on the conversion rates; the 
intermediate product ion at m/z 133 for α-PVP having a 79% conversion to the tropylium product 
ion at m/z 91, whereas the intermediate product ion at m/z 133 from PV8 has only a 1% conversion 
rate to the tropylium product ion at m/z 91. Figure 1.17 also shows that the conversion rate for the 
intermediate product ion at m/z 119 to the tropylium product ion at m/z 91 is ~100% for the three 
unsubstituted cathinones. 
 
Figure 1.17. Selected fragmentation pathways and corresponding flux for: a) α-PBP, b) α-PVP, 
and c) PV8. The percentages shown at each level of MSn provide the ion’s abundance relative 
to the summed ion abundance of the product ion spectrum at that level. For example, m/z 147 is 
the base peak (100% peak height) in the MS2 product ion spectrum of α-PBP and 55% of the 
summed product ion spectrum. 
 





 High-Resolution Mass Spectrometry (HRMS) Measurements using ESI-Q-TOF 
Whereas the IT mass spectrometer offered the capability to perform multiple stages of mass 
spectrometry (MSn), HRMS allowed for accurate mass measurements from the tandem mass 
spectra. Accurate mass measurements are useful because they provide unique elemental 
compositions, with our typical instrument uncertainty on the order of 10 ppm or about 3 mDa. The 
ability to identify the elemental composition of a fragment becomes particularly important when 
there are multiple ways to explain a neutral loss, such as CO and C2H4, which both have the 
nominal mass of 28 Da. Figure 1.18a shows the high resolution tandem mass spectra of α-PVP 
with the major structural fragments embedded.  
 
 
Figure 1.18. Tandem mass spectra of α-PVP showing: a) the fragmentation observed on the Q-
TOF mass spectrometer with a 25 eV collision energy and b) a zoomed-in view of product ions 











The HRMS tandem mass spectrum of α-PVP allows for the determination of the elemental 
formula of four important ions. The first is the tropylium ion with an accurate mass of m/z 91.0559, 
which is about 12 ppm from the exact mass of C7H7
+. The second important ion is the proposed 
phthalane structure with an accurate mass of m/z 119.0530, which deviates 28 ppm from the exact 
mass for C8H7O
+. Finally, the HRMS measurements of the two product ions with a nominal mass 
of m/z 133 in Figure 1.18a had elemental compositions of both C9H9O
+ (measured at m/z 
133.0670; expected at m/z 133.0653; 13 ppm error) and C10H13
+ (measured at m/z 133.1029; 
expected at m/z 133.1017; 9 ppm error). Although CID in the HRMS instrument tends to favor the 
formation of fragments at smaller m/z values than in the lower-energy IT instrument, the low-
abundance C10H13
+ product ion was slightly less abundant than the C9H9O
+ product ion under 35 
eV CID conditions (Figure 1.18b). The combination of the 18O-α-PVP IT results (Figure 1.5) and 
the HRMS results provide unequivocal evidence for the competing pathways between the loss of 
CO and ethylene for the formation of the product ion with a nominal mass of m/z 133.  
Figure 1.19 shows the tandem mass spectra of PV8 with the major structural fragments 
embedded. Although the alkyl chain is two carbons longer for PV8 than -PVP, the same core 
tropylium ion fragmentation ions are observed for both α-PVP and PV8. Based on the HRMS 
accurate mass measurements, the error between the accurate mass measurements and exact masses 
is on the order of those discussed in Figure 1.18. The additional intermediate at m/z 147.0838 is 
hardly above the noise level at the conditions used for this experiment; however, the accurate mass 








Figure 1.19. Tandem mass spectra of PV8 (25 eV) showing the conserved nature of the loss of 
the pyrrolidine moiety with the Q-TOF mass spectrometer and the propensity to form the 
tropylium ion. 
 
Figure 1.20 contains an additional example of the tandem mass spectra generated with the Q-
TOF mass spectrometer for 3,4-MDPV.  
 
Figure 1.20. Tandem mass spectrum of 3,4-MDPV (25 eV collision energy) showing the 
propensity to form the substituted tropylium ion is conserved in a wide variety of substituted 
cathinones. 
 
Based on the accurate mass measurements from the Q-TOF mass spectrometer and the MSn 











the fragmentation behavior of α-pyrrolidinophenone synthetic cathinones along the tropylium ion 
or substituted-tropylium ion pathways. The loss of the pyrrolidine moiety always forms the first 
intermediate ion along this pathway, as shown by the product ion at m/z 189 for PV8. From this 
intermediate, there are competing pathways for the loss of CO and ethylene with the loss of CO 
favored for all compounds, observed at m/z 161 (more visible on the IT instrument than the Q-
TOF instrument). Additionally, any compound with a chain length of at least four carbons can 
form intermediates through the loss of 28 Da (i.e. product ion at m/z 133 for PV8) and 42 Da with 
the loss of 42 Da always corresponding with the loss of propylene (i.e. product ion at m/z 147 for 
PV8). The intermediate formed through the loss of propylene feeds directly into the tropylium ion 
pathway through the loss of 28 Da (ethylene) in all cases studied, as shown by the product ion at 
m/z 119 for all cathinones. Finally, the intermediate ion formed through the loss of propylene forms 
the tropylium ion at m/z 91 through the loss of CO for all cathinones.  
The differences in the mass spectra generated with IT and Q-TOF mass spectrometers are 
beyond the focus of the current project. However, in brief, the IT mass spectrometer favors the 
formation of lower energy and higher mass intermediate ions relative to the Q-TOF mass 
spectrometer, which included some higher-energy pathways like the loss of alkyl radicals to form 
odd-electron product ions. These spectral differences stem from the well-known differences in the 
collision energy, number of collisions, and activation time scales between the IT and Q-TOF mass 
spectrometers. The IT fragmentation process involves trapping CID (very slow activation, i.e. 10-
100 ms) through hundreds of collisions with the bath gas, whereas the Q-TOF fragmentation 
occurs through low-energy (slow activation, i.e. 0.5-1 ms) beam-type  collisions (i.e. 10-100) as 





In general, the mass spectra collected with both the IT and Q-TOF mass spectrometers were 
sufficiently similar that they are cross-comparable and the fragmentation pathways were conserved 
across all synthetic cathinones analyzed with one notable exception. The fragmentation behavior 
of 13C-carbonyl carbon-4'-methyl-α-PHP (MPHP) was somewhat unique. The MS2 spectrum of 
13C-MPHP is different than the fragmentation described above, even though the chemical structure 
meets all the requirements for the rearrangements involved in the formation of the tropylium ion. 
Figure 1.21 shows the tandem mass spectrum of 13C-MPHP, which is dominated by the product 
ion at m/z 105.0727. This fragment must have the elemental composition C8H9
+ and must form 
after the loss of 13CO directly from the alkyl chain. The reason for this deviation in fragmentation 
behavior is probably that the methyl substitution on the aromatic ring favors the formation of the 
product ion at m/z 105.0727 rather than the tropylium product ion at m/z 91.0565. The impact of 
this information is that it allows for a quick and easy manner for the detection of a methyl-
substitution to the aromatic ring for substituted synthetic cathinones, which will be dominated by 
the product ion at m/z 105 instead of the product ion at m/z 91. The ratio of m/z 105 to m/z 91 is 







Figure 1.21. Tandem mass spectra of 13C-MPHP (25 eV collision energy) showing the dominant 
abundance of m/z 105.0727 for the C8H9
+ ion relative to m/z 91.0565 for the C7H7
+ tropylium 
ion. The structure of the ion at m/z 105 could equally take the form of a methyl-substituted 
tropylium ion. 
 
 Infrared Ion Spectroscopy 
The combination of the MSn and accurate mass measurement results determined the 
relationship between each intermediate product ion of interest and the tropylium ion, but also the 
elemental formula of those intermediates. However, neither of these techniques allow for the 
determination of the exact arrangement of the atoms present in each intermediate. To help answer 
the question of constitutional arrangement, infrared ion spectroscopy was employed to characterize 
the intermediates at m/z 119 and m/z 133 for -PVP.  
Figure 1.22 shows a comparison between the experimentally observed gas-phase IR spectra 
and the theoretically calculated DFT spectra for two proposed structures for the intermediate 
product ion at m/z 119. Based on being the lowest-energy isomer from eight isomeric structures 
evaluated (Table 1.1), and the similarity in wavenumber between the experimental and theoretical 








intermediate product ion at m/z 119. We note here that the IR-induced dissociation was 
energetically demanding, requiring 10 FEL pulses at high IR laser pulse energy, probably as a 
consequence of the compact nature of the interrogated structures. We suspect these high thresholds 
in combination with non-linearities in the multiple-photon excitation process lead to a skewed 
frequency dependence of the fragment yield, reducing the observed intensities in the IRMPD 
spectra towards lower photon energies. 
The structure 119d is an example of a poor fit both in terms of relative energy of formation 
(208 kJ/mol relative to structure 119a) and alignment of the experimental and theoretical spectra. 
The principal feature of the calculated spectra of 119d at ~1850 cm-1 can be assigned to the 
stretching of the carbonyl bond. The highly coupled stretch of the Cα–Cβ bonds is responsible for 
both the peaks at ~1600 cm-1 and 1400 cm-1. Based on the experimental spectra, we know that the 
intermediate product ion at m/z 119 cannot contain a carbonyl because of the absence of the 
characteristic feature at 1850 cm-1, which is well beyond the experimentally observed peak at 1600 
cm-1. The additional peaks in the measured spectrum between ~1100-1500 cm-1 derive from C-H 
wagging of CH2 hydrogens. The absence of the feature at the carboxylic absorption wavelength 
and the good match of the peak at ~1600 cm-1, assigned to a highly-coupled C-C stretching of 
aromatic carbon bonds, along with the most favorable thermodynamics, make isomer 119a the 







Figure 1.22. Comparison of experimental gas-phase IR ion spectroscopy and DFT theoretical 
IR spectra for fragments of protonated -PVP: a) proposed 119a structure demonstrating a good 
alignment between experimental and predicted spectra and b) proposed 119d structure 
demonstrating a poor alignment between the experimental and predicted spectra. 
 
Figure 1.23 shows the analogous comparison for the intermediate product ion at m/z 133. The 
133a’ structure was identified as the most likely structure for the intermediate product ion at m/z 
133 based on the relative energy (35 kJ/mol more stable than the next isomer Table 1.2) and 
similarity between the experimental and theoretical spectra. The experimental band at ~1600 cm-1 
matches well with the theoretical absorption frequency for a highly-coupled C-C stretching mode 
involving all aromatic carbons and C(aromatic)–Cα bonds. The experimental absorption at ~1500 
cm-1 is matched by Cα–Cβ and Cα–O stretching coupled to aromatic C-H wagging. The absorption 
at ~1400 cm-1 is where CH2 and CH3 scissoring motions are predicted to absorb. In comparison, 
structure 133c gives a poorer fit because of the high relative energy (123 kJ/mol) and the significant 
differences between the experimental and theoretical spectra. For instance, the main predicted 
band, the C=O stretch coupled to adjacent C-C stretching modes, should appear near 1700 cm-1, 
but is absent in the experimental IRMPD spectrum. Thus, the IR spectra indicate that neither an 






The gas-phase IR spectra in Figure 1.23 indicates the presence of two structures in the IR 
spectra. The structure 133a’ has both the best spectral match and the lowest energy configuration 
and is likely the dominant structure. However, the structure 133g, which lacks an oxygen, cannot 
be ruled out and is also likely to be present. The MSn and accurate mass data indicate the loss of 
the CO is favored over the loss of ethylene (C2H4) for -PVP. However, the accurate mass data 
indicates that both pathways co-exist, so both structures are likely to be present in the gas-phase 
ion spectroscopy analysis. Due to the isobaric nature of these compounds, the isolation step before 
IR irradiation of the ions is unable to separate the intermediates C9H9O
+ and C10H13
+ that are both 
observed at nominal m/z 133. 
 
Figure 1.23. Comparison of experimental gas-phase IR ion spectroscopy and DFT calculated 
IR spectra for fragments of protonated -PVP: a) proposed 133a’ structure demonstrating a good 
alignment between experimental and predicted spectra and b) proposed 133c structure 
demonstrating a poor alignment between the experimental and predicted spectra. 
 
The various experiments described above enable the generation of a general set of rules to 
describe the fragmentation patterns and the formation of substituted tropylium ions in the tandem 
mass spectra of substituted cathinones. For example, the base peak in the tandem mass spectra of 






The only exception in our studies was 2,3-MDPV. The second common feature in the 
fragmentation behavior is the competition between the loss of CO and ethylene (C2H4) from this 
base peak, which both have a nominal mass of 28 Da. Of the two losses, the loss of CO is typically 
dominant.  
Another experimentally observed aspect of the fragmentation behavior is that competing 
fragmentation pathways lead to the formation of the tropylium ion via various neutral losses from 
the alkyl chain. As far as we have established, the fragmentation pathways seem to go through one 
of two phthalane structures shown in Figure 1.7; the only difference between the two is whether 
or not there is a methyl substitution on the saturated phthalane ring. The use of 13C isotopic labeling 
on both the carbonyl carbon and α-carbon demonstrate that the α-carbon from the m/z 120 
intermediate ion is almost exclusively incorporated into the tropylium ion and the carbonyl carbon 
is quantitatively lost as neutral CO, which, to our knowledge, has not been demonstrated in 
literature before.  
There are several requirements for the proposed tropylium ion rearrangements to occur. First, 
the alkyl chain must be at least four carbon atoms long (including the carbonyl carbon) to enable 
the necessary rearrangements to occur. Second, there must be a reasonable leaving group available 
prior to ring expansion. Third, the -carbon must not be substituted; in the case of methyl 
substitution on the -carbon, for example, the methyl group poses a barrier to nucleophilic attack 
and the bicyclic phthalane intermediate cannot form. A final trend in tropylium ion behavior is that 
the abundance of the tropylium ion tends to increase with increasing alkyl chain lengths. 
Presumably, longer alkyl chains provide additional pathways towards the tropylium ion and larger 





Regarding other trends in fragmentation behavior, the mechanisms described in Figure 1.7 
remain conserved even with additional substituents. For example, the intermediate products ions 
of 3,4-MDPV show a similar distribution to α-PVP, but shifted by the expected 44 Da of the 
methylenedioxy substituent. Similarly, when a methyl group is present on the aromatic ring, such 
as with MPHP, the substituted tropylium ion at m/z 105 (C8H9
+) is more abundant than the 
native/unsubstituted tropylium ion at m/z 91. However, for cathinones with different substituents 
on the aromatic ring, the favorability of a specific pathway can be influenced by the position of 
the substituent, as demonstrated for 3,4-MDPV versus 2,3-MDPV. Finally, whereas the proposed 
mechanisms in Figure 1.7 do not pinpoint the exact hydrogens involved in the hydride shifts, the 
product ions at m/z 134 and m/z 92 of deuterated 3,4-MDPV-d8 specifically exclude the hydrogens 
on the pyrrolidine ring. In this class of cathinones, the pyrrolidine neutral is lost before any 
hydrogen rearrangements occur. 
1.4 Conclusions 
This manuscript describes the use of MSn on an IT mass spectrometer, accurate mass 
measurements with HRMS, stable isotope labeling, and gas-phase infrared ion spectroscopy to 
elucidate the mechanism of formation of the tropylium ion in the tandem mass spectra of various 
α-pyrrolidinophenone synthetic cathinones. The identification of the proposed carbon backbone 
rearrangements for the generation of the tropylium ion or substituted tropylium ion analogs with 
ESI-MS/MS provides the forensic science community with new information about the 
fragmentation behavior of protonated synthetic cathinones. The conserved nature of the proposed 
mechanisms offers an additional tool for the identification of emerging synthetic cathinones using 
tandem mass spectra. Finally, the ability to defend the observations of existing casework and better 





confidence in their interpretations and provides a stronger scientific foundation for their opinions 
























Chapter 2: Fragmentation pathways of α-pyrrolidinophenone synthetic cathinones and their 
application to the identification of emerging synthetic cathinone derivatives 
Reproduced in part with permission from J.T. Davidson, Z.J. Sasiene, Y. Abiedalla, J. DeRuiter, 
C.R. Clark, G.P. Jackson, International Journal of Mass Spectrometry, DOI: 
10.1016/j.ijms.2020.116343. 
2.1 Introduction  
Synthetic cathinones are phenylalkylamine derivatives designed to mimic the effects of the 
natural chemical cathinone, the psychoactive component of the Catha edulis plant, commonly 
referred to as khat. [1]. Because of their stimulant-like pharmacological effects, cathinones belong 
to a larger class of drugs known as novel psychoactive substances (NPS). Synthetic cathinones are 
often marketed as “not for human consumption” or “bath salts” to avoid legislative restrictions that 
have been imposed to decrease the sale and distribution of these compounds [2, 3]. Unfortunately, 
these labels also deceive users into believing the substances are safe, which has resulted in 
numerous intoxication-related deaths [53]. Reported symptoms of synthetic cathinone abuse 
include euphoria, hallucinations, psychosis, paranoia, agitation, violent behavior, tachycardia, 
acidosis, seizures and even death [53, 54]. In 2011, the Drug Enforcement Administration (DEA) 
recognized a growing trend in synthetic cathinone abuse and provisionally scheduled mephedrone, 
methylone, and 3,4-methylenedioxypyrovalerone (3,4-MDPV) as Schedule I controlled 
substances [55]. However, regulation of synthetic cathinones is difficult because the synthesis of 
new analogs only requires minor modifications to the generic chemical structure. The structural 
modifications allow the new analogs to avoid legal regulations, but potentially lead to more 





Whereas synthetic cathinones have become widely distributed designer drugs, the α-
pyrrolidinophenone derivatives stand out as one of the most abused designer drugs [7]. This class 
of compounds includes α-pyrrolidinopentiophenone (α-PVP), 3,4-methylenedioxypyrovalerone 
(3,4-MDPV), α-pyrrolidinoheptanophenone (PV8), α-pyrrolidinopropiophenone (α-PPP), among 
others [56]. The first reported seizure of these α-pyrrolidinophenone derivatives was in Germany 
in 1996 [57]. The key structural element of α-pyrrolidinophenone derivatives is the pyrrolidine 
ring substitution to the generic synthetic cathinone structure [56]. The main types of α-
pyrrolidinophenone derivatives are side chain extensions and substitution on the aromatic ring 
(methoxy and methylenedioxy are the most common) [56].  
Synthetic cathinones are inhibitors of monoamine transporters such as the dopamine 
transporter (DAT) and the noradrenaline transporter (NAT), which is consistent with other 
stimulant compounds such as amphetamines. However, α-pyrrolidinophenone derivatives are 
stronger inhibitors of these systems in comparison to non-pyrrolidinophenone synthetic cathinone 
derivatives increasing the effectiveness of these compounds [58]. In comparison to amphetamines, 
synthetic cathinones generally struggle to cross the blood-brain barrier, but the increased 
lipophilicity of the pyrrolidine substituent allows α-pyrrolidinophenone derivatives to more easily 
cross the blood-brain barrier than other cathinones [56, 59]. 
Due to the widespread analysis of α-pyrrolidinophenone synthetic cathinones, there is a need 
to understand the fragmentation behavior under different ionization and fragmentation conditions. 
The analysis of seized drugs typically employs gas chromatography-electron ionization-mass 
spectrometry (GC-EI-MS) to identify unknowns, whereas the toxicological community often 
employs liquid chromatography with electrospray ionization and tandem mass spectrometry (LC-





in real time (DART). Whereas DART produces both odd-electron and even-electron ions based on 
the experimental conditions, the fragment ion spectra from EI (odd-electron) and ESI (even-
electron) are known to differ, which has been documented for a variety of synthetic cathinones 
[13-17, 19-21, 60]. 
The fragmentation behavior of α-pyrrolidinophenone synthetic cathinones has been reported 
throughout literature; however, rarely are the underlying fragmentation mechanisms that lead to 
the observed fragment ions discussed or understood [14, 16, 20, 26-29]. Instead, the mechanism(s) 
are either absent, vague, or improbable. For example, when valid mechanisms have been proposed, 
the lack of isotopic labeling and lack of multi-stage mass spectrometry (MSn) limit the certainty 
associated with the proposed mechanisms [30]. Recently, we demonstrated the first use of isotopic 
labeling, multi-stage mass spectrometry (MSn), accurate mass measurements with high-resolution 
mass spectrometry (HRMS) and ion spectroscopy to explain the formation of the tropylium ion 
(m/z 91) and its substituted derivatives for α-pyrrolidinophenone synthetic cathinones analyzed 
with ESI-MS/MS [61]. Here, we extend the study to a wider variety of α-pyrrolidinophenone 
synthetic cathinone structures and include fragmentation pathways accessed through radical and 
even-electron pathways. The generation of synthetic cathinone fragmentation pathways will assist 
with the mass spectral interpretation and identification of future synthetic cathinone derivatives. 
2.2 Methods  
 Sample Preparation 
This study involved the analysis of 22 α-pyrrolidinophenone synthetic cathinones that were 
either purchased through Cayman Chemical (Ann Arbor, MI, USA) or synthesized in-house at 
Auburn University. The 11 α-pyrrolidinophenone synthetic cathinones that were purchased 





pyrrolidinobutiophenone (α-PBP), α-pyrrolidinovalerophenone (α-PVP), α-
pyrrolidinoheptanophenone (PV8), 4-methoxy-α-pyrrolidinopentiophenone (4-MeO-α-PVP), 
3',4'-trimethylene-α-pyrrolidinovalerophenone, 3,4-methylenedioxy-α-pyrrolidinopropiophenone 
(3,4-MDPPP), 3,4-methylenedioxy-α-pyrrolidinobutiophenone (3,4-MDPBP), 3,4-
methylenedioxypyrovalerone (3,4-MDPV), 3,4-methylenedioxypyrovalerone-d8 on the 
pyrrolidine ring (3,4-MDPV-d8), and 2,3-methylenedioxypyrovalerone (2,3-MDPV). The 11 
synthetic cathinone samples synthesized at Auburn University were: 13C-α-
pyrrolidinovalerophenone labeled on the carbonyl carbon (13C-carbonyl carbon-α-PVP), 13C-α-
pyrrolidinovalerophenone labeled on the α-carbon (13C-α-carbon-α-PVP), 18O-α-
pyrrolidinovalerophenone (18O-α-PVP), α-pyrrolidinovalerophenone-d7 labeled on the alkyl chain 
(α-PVP-d7), α-pyrrolidinovalerophenone-d8 labeled on the pyrrolidine ring (α-PVP-d8), α-methyl-
pyrrolidinovalerophenone (α-PVP-methyl group), 13C-α-pyrrolidinoheptanophenone labeled on 
the carbonyl carbon (13C-carbonyl carbon-PV8), 13C-α-pyrrolidinopropiophenone on the α-carbon 
(13C-α-carbon-α-PPP), 13C-4'-methyl-α-pyrrolidinohexanophenone on the  carbonyl carbon (13C-
carbonyl carbon-MPHP), 13C-3,4-methylenedioxypyrovalerone on the carbonyl carbon (13C- 
carbonyl carbon-3,4-MDPV), and 13C-Naphyrone on the carbonyl carbon. A full characterization 
of the synthetic samples was performed with GC-EI-MS and nuclear magnetic resonance 
spectroscopy (NMR) at Auburn University to confirm the correct labeling and acceptable purity 
prior to shipment to West Virginia University. All samples were analyzed at a concentration of 
approximately 100 ppm. The samples analyzed by GC-EI-MS were dissolved in HPLC grade 
methanol from Fisher Scientific (Palo Alto, CA, USA). All non-deuterated tandem MS samples 
analyzed on the Velos Pro linear ion trap (LIT) and the Accurate-Mass quadrupole time-of-flight 





distilled water and 2% acetic acid. The acetic acid was supplied by Acros Organics (Palo Alto, 
CA, USA). The deuterated α-pyrrolidinophenone synthetic cathinones were dissolved in HPLC 
grade methanol to minimize H/D exchange.  
 Instrumentation 
2.2.2.1 Linear Ion Trap 
The Thermo Scientific Velos Pro linear ion trap (LIT) mass spectrometer was mounted with a 
heated-electrospray ionization (HESI) source. The HESI source was operated at 50 °C with a spray 
voltage of 4,000 V. The nitrogen sheath gas was operated at 8 arbitrary units with a nitrogen 
auxiliary gas flow of 5 arbitrary units. The mass spectrometer capillary temperature was 275 °C. 
The scan range and normalized collision energies (NCE), which were optimized for each 
compound are labeled with each mass spectrum. The % NCEs are sequential in that the provided 
% NCE at the MS2 level is used to reach the MS3 level prior to the % NCE used for fragmentation 
at the MS3 level.Ultra-high purity helium was used as the bath gas purchased through Matheson 
TRIGAS (Fairmont, WV, USA).  
2.2.2.2 Quadrupole Time-of-Flight 
An Agilent Technologies 6538 UHD Accurate-Mass quadrupole time-of-flight (Q-TOF) mass 
spectrometer was operated with both dual ESI and DART ionization sources. The DART-100 
source was mounted with a Vapur® interface (IonSense, Saugus, MA, USA). The DART ion 
source was operated with helium reagent gas at 300 °C with a flow rate of 3.0 L/min, a grid voltage 
of 400 V and a needle voltage of 3,500 V. The ESI source was operated with a spray voltage of 
3,500 V, nitrogen drying gas at a 300 °C and a flow rate of 5 L/min. The nebulizer flow was 30 
psig. All ESI samples were collected with direct injection at a flow rate of 10 µL/min. The MS 





collection and 150 V and 25 V, respectively for the DART data collection. The DART data 
collection used lower fragmentor and skimmer voltages per the recommendations of IonSense for 
optimum performance. For both ion sources, the fragmentor voltage and skimmer voltage 
relationship was optimized to maximize the [M+H]+ protonated precursor, with disregard to in-
source fragmentation due to the isolation of the protonated precursor prior to collisional activation.  
The scan range and collision energies were optimized for each compound of interest and are 
labeled with each mass spectrum. An isolation width of 1.3 Da was used for all samples. The ultra-
high purity nitrogen used for the collision gas and the ultra-high purity helium used for the DART 
gas were purchased through Matheson TRIGAS (Fairmont, WV, USA).  
The DART samples were prepared through the deposition of 5 µL of drug standard onto the 
closed end of 1.5 mm x 1.8 mm x 90 mm Pyrex® glass capillaries purchased from Corning Life 
Sciences (Corning, New York, USA) and allowed to completely dry before analysis. DART 
acquisition consisted of approximately 30 s of background collection, about 5 s of sample 
introduction, and then the analysis of a blank capillary to account for capillary-specific 
background. The total length of analysis was less than 90 s per sample.  
2.2.2.3 Single Quadrupole GC-EI-MS 
An Agilent Technologies 7890 GC-5977 MS with an HP-5 [(5% phenyl)-methylpolysiloxane] 
30 m x 250 µm x 0.25 µm column by Agilent J&W Columns was used for the GC-EI-MS analyses. 
The GC-EI-MS parameters were as follows: injection volume was 1 µL; injection temperature was 
250 °C; split ratio was 20:1. The initial oven temperature was 80 °C (1 min hold), which was 
ramped to 280 °C at 15 °C/min, then held for 2 min. The carrier gas (helium) flow rate was set to 
1 mL/min and the transfer line temperature was set to 280 °C. The ultra-high purity helium gas 





scanned from m/z 50-500 at a scan rate of 1,500 Da/sec after a solvent delay of 2 min. The source 
and quadrupole temperatures were 250 °C and 200 °C, respectively. 
 Data Analysis 
Xcalibur 2.0.0.48 software was used for the data analysis on the Velos Pro. ChemStation 
version C.01.01 was used for the Agilent GC-EI-MS data analysis and MassHunter Qualitative 
Analysis B.05.00 was used for the Agilent Q-TOF data analysis. Microsoft Excel version 14 
(Microsoft, Redmond, WA, USA) and ChemDraw 16.0 (PerkinElmer, Waltham, MA, USA) were 
used for mass spectral plots and mass spectral fragmentation mechanisms. 
2.2.3.1 Mass Spectral Interpretation and Mechanisms 
The proposed fragmentation pathways follow the expected lowest energy structures and are 
based on rational electron pushing mechanisms commonly used for the interpretation of protonated 
tandem MS and EI-MS data [35]. The use of isotopic labels, MSn and HRMS allows for the 
structural determination of all intermediates along the proposed fragmentation pathways. 
Deuterium labeling is not always able to identify the specific deuterium atoms and hydrogen atoms 
involved in tandem MS rearrangements, but such labeling usually offers some insight into the 
general fragmentation behavior. Finally, the observation of protonated precursor ions (even-
electron) forming odd-electron product ions was observed along minor abundance pathways, 
which is consistent with previous reports from Fornal [36, 37]. 
2.3 Results/Discussion 
 HESI-Velos Pro MSn 
Our previous work with α-pyrrolidinophenone synthetic cathinones involved the identification 
that the tropylium ion (m/z 91) or substituted derivative ions form through different oxygen-





carbonyl carbon as neutral CO [61]. Through this project we also discovered several fragmentation 
behaviors of the α-pyrrolidinophenone class of synthetic cathinones. First, we identified 
competitive pathways for the loss of CO and ethylene (C2H4) from the base peak of the tandem 
mass spectrum. Second, we determined that the base peak in the tandem mass spectrum is primarily 
formed through the loss of the neutral pyrrolidine molecule. Third, we identified that the alkyl 
chain length has a direct impact on not only the tropylium ion formation, but also the associated 
intermediate product ions. Finally, we demonstrated that the α-pyrrolidinophenone synthetic 
cathinone fragmentation pathways remain conserved when accounting for additional substituents.  
Figure 2.1a shows the MS2 analysis of protonated α-PVP-d8, which is deuterated around the 
pyrrolidine ring. The product ion spectrum indicates that the deuterium labels remain on the 
cleaved 1-butylidenepyrrolidin-1-ium fragment observed at m/z 134 and that no H/D scrambling 
occurs prior to fragmentation. The lone exception to this observation is the presence of the primary 
product ion at m/z 221, which must arise through the loss of HDO instead of H2O, the latter of 
which occurs to a slightly lesser extent at m/z 222. As expected, the MS3 product ion spectrum for 
the pathway m/z 240→161→ (Figure 2.1b) is consistent with structures proposed for the analysis 
of α-PVP [61], with the m/z 161 intermediate product ion formed through the loss of the pyrrolidine 
moiety. Figure 2.1c shows the MS3 spectrum for the pathway m/z 240→134→, which results in 
secondary product ions at m/z 106, 105 and 92. The intermediate at m/z 134 likely has the structure 
of 1-butylidenepyrrolidin-1-ium and fragments through the loss of ethylene, an ethyl radical 










Figure 2.1. Tandem mass spectra of α-PVP-d8: a) MS
2 product ion spectrum of the [M+H]+ 
molecular ion at m/z 240 (35% NCE); b) MS3 product ion spectrum for the pathway m/z 
240→161→ at 30% NCE showing the formation of secondary product ions at m/z 143, 133, 
119, 105 and 91; c) MS3 product ion spectrum for the pathway m/z 240→134→ at 30% NCE 
showing the formation of product ions at m/z 106, 105 and 92. 
 
 DART/ESI-Q-TOF 
Figure 2.2 compares MS2 analysis of 4-MeO-α-PVP collected using the ESI and DART 
ionization sources on the same HRMS instrument. The main benefit of the HRMS instrument is 
the ability to determine the elemental formula of the different fragment ions. The ESI and DART 
mass spectra are very similar in the position and abundance of fragments, and ESI shows primary 
product ions at m/z 219.1282 (expected at m/z 219.1259 for C13H17O2N
+˙; 10 ppm error), m/z 
191.1102 (expected at m/z 191.1072 for C12H15O2
+; 16 ppm error) and m/z 154.1249 (expected at 
m/z 154.1231 for C9H16ON
+; 12 ppm error). Secondary product ions at m/z 135.0471 (expected at 
m/z 135.0446 C8H7O2



















16 ppm error) are observed for ESI, and they are formed via the stepwise loss of C4H8 and CO 
from their primary product ions at m/z 191.1102 (C12H15O2
+) and m/z 154.1249 (C9H16ON
+), 
respectively. The tertiary product ion at m/z 121.0677 (expected at m/z 121.0653 for C8H9O
+; 20 
ppm error) is the base peak in the ESI-generated mass spectrum. The fragment at m/z 121.0677 
(C8H9O
+) in the ESI-generated mass spectrum arises from the loss of CO from the secondary 
product ion at m/z 149.0632 (expected at m/z 149.0602 for C9H9O2
+; 20 ppm error) and the loss of 
propylene from the secondary product ion at m/z 163.1168 (expected at m/z 163.1122 for 
C11H15O
+; 28 ppm error). In all cases, the mass accuracy of both the ESI and DART mass spectra 
are on the order of 10 ppm from the exact masses for the proposed elemental formulas, which 













Figure 2.2. Tandem mass spectra of 4-MeO-α-PVP collected on the same Q-TOF HRMS 
instrument using a) ESI with a 25 eV collision energy and b) DART ionization with a 25 eV 
collision energy. 
 
Figure 2.3 highlights the similarities between the MS2 spectra from ESI and DART ionization 
of protonated 3,4-MDPV at m/z 276.1607 (expected at m/z 276.1599 for C16H22NO3
+; 3 ppm error) 
for the ESI-generated mass spectrum. The most abundant ions appear at m/z 126.1305 (expected 
at m/z 126.1282 for C8H16N
+; 18 ppm error) and m/z 135.0476 (expected at m/z 135.0446 for 
C8H7O2
+; 22 ppm error) for the ESI-generated mass spectrum, which correspond to the 1-
butylidenepyrrolidin-1-ium ion and methylenedioxy-substituted tropylium ion, respectively. Due 
to the methylenedioxy substituent on the aromatic ring moiety, an additional dominant pathway is 













group. Ions corresponding to the loss of formaldehyde are observed at m/z 175.0812 (expected at 
m/z 175.0759 for C11H11O2
+; 30 ppm error) and m/z 147.0821 (expected at m/z 147.0809 for 
C10H11O
+; 8 ppm error) for the ESI-generated mass spectrum, which are both 30 Da less than their 
predecessor ions at m/z 205.0922 (expected at m/z 205.0864 for C12H13O3
+; 28 ppm error) 
and m/z 177.0955 (expected at m/z 177.0915 for C11H13O2
+; 23 ppm error), respectively. 
Generally, the accurate mass measurements were on the same order of magnitude from the exact 
masses of the proposed elemental formula as those in Figure 2.2; however, there was less 
agreement in the accurate mass measurements between the ESI and DART data likely due to 















Figure 2.3. Tandem mass spectra of 3,4-MDPV collected on the same Q-TOF HRMS 
instrument using a) ESI with a 25 eV collision energy and b) DART ionization with a 25 eV 
collision energy. 
 
Figure 2.4 compares the MS2 spectra of protonated adducts of 13C-MPHP formed by ESI and 
DART ionization. The labeled 13C is on the carbonyl carbon in both cases. The spectra have the 
major structural fragments embedded. These spectra demonstrate that both ion sources produce 
similar mass spectra with the base peak observed at m/z 105.0727 (expected at m/z 105.0704 for 
C8H9
+; 22 ppm error) for the ESI-generated mass spectrum. The formation of this ion is unexpected 
in that the isotopically labeled carbonyl adjacent to the aromatic ring moiety must be lost prior to 
ring expansion, which has been previously demonstrated as a possible fragmentation mechanism 













at m/z 204.1355 (expected at m/z 204.1338 for C12
13CH17ON
+˙; 8 ppm error), m/z 
190.1315 (expected at m/z 190.1307 for C12
13CH17O
+; 4 ppm error), and m/z 140.14535 (expected 
at m/z 140.1439 for C9H18N
+; 10 ppm error) for the ESI-generated mass spectrum originate through 
the loss of a butyl radical (˙C4H9), loss of the pyrrolidine molecule, and the generation of the 1-
pentylidenepyrrolidin-1-ium ion, respectively. The tertiary product ions at m/z 134.0725 (expected 
at m/z 134.0681 for C8
13CH9O
+; 33 ppm error) and m/z 120.0540 (expected at m/z 120.0524 for 
C7
13CH7O
+; 13 ppm error) for the ESI -generated mass spectrum form through the loss of butylene 
and stepwise loss of C5H10 from the primary product ion at m/z 190.1315 (C12
13CH17O
+). All 
accurate mass measurements are on the order of 10 ppm different than the exact masses for the 














Figure 2.4. Tandem mass spectra of 13C-MPHP collected on the same Q-TOF HRMS instrument 
using a) ESI with a 25 eV collision energy and b) DART ionization with a 25 eV collision 
energy. 
 
Figure 2.5 demonstrates the proposed general pathways for the fragmentation of α-
pyrrolidinophenone synthetic cathinones under protonated tandem MS conditions, where X 
represents substitution to the aromatic ring moiety and CnH2n+1 represents varying alkyl chain 
lengths. The 13C, 18O, and deuterated labeling are not shown in these general pathways but were 
used to support the proposed pathways. The proposed fragmentation pathways are based on data 
collected with both the IT and Q-TOF mass spectrometers, which are known to have differences 













spectrometer is considered very slow activation that occurs through 100s of collisions with the 
bath gas. In comparison, the Q-TOF fragmentation arises through low-energy, beam-type 
activation, involving 10s of collisions as the analyte passes through the collision cell [51, 52]. 
However, in general, the mass spectra collected with both the IT and Q-TOF mass spectrometers 
behaved as described below in Figure 2.5 with the favorability of each fragmentation pathway 







Figure 2.5. Proposed general fragmentation pathways for protonated α-pyrrolidinophenone 
synthetic cathinones undergoing tandem MS. The model compound is α-PVP where X = H 
and the m/z values that are specific to α-PVP indicated with an asterisk (*). 
 
Based on the analysis of 21 α-pyrrolidinophenone synthetic cathinones using isotope labeling, 
MSn and HRMS, the following general trends are observed. Isolation and fragmentation of the 
[M+H]+ precursor ion typically results in primary product ions through the loss of CH2CnH2n, H2O, 
˙C2H4CnHn2+1, C6H6, and NC4H9. Of these primary product ions, the loss of NC4H9 (pyrrolidine 





pathways. The two primary product ions that produce abundant consecutive product ions are the 
ions at m/z 161, from the loss of the pyrrolidine, and m/z 154, from the loss of the aromatic ring, 
in Figure 2.5. The fragmentation pathway through the intermediate at m/z 154 results in secondary 
product ions through the loss of CO (i.e. m/z 126) and propylene (i.e. m/z 112), which can then 
form tertiary and quaternary product ions. The fragmentation pathway through the intermediate at 
m/z 161 in Figure 2.5 continues through three abundant secondary product ions at m/z 143, 133, 
and 119. The secondary product ions at m/z 143 and m/z 119 form through the loss of H2O and 
propylene, respectively. However, secondary product ions at m/z 133 form via competing 
pathways through the loss of CO (28 Da) and ethylene (28 Da), as demonstrated previously [61]. 
The secondary product ions at m/z 133 in Figure 2.5 fragment into tertiary product ions at m/z 105 
and m/z 91. The secondary product ion at m/z 119 also fragment into the characteristic tropylium 
ion at m/z 91, which helps explain the significant presence of the tropylium ion in α-
pyrrolidinophenone synthetic cathinones that contain at least four carbon atoms in the alkyl chain 
[61]. Figure 2.6 demonstrates the formation of the tropylium ion from α-PBP, α-PVP, and PV8 
and the effect of alkyl chain lengths on the distribution of product ions observed in the protonated 
















Figure 2.6. Tandem mass spectra of: a) α-PBP (35% NCE), b) α-PVP (35% NCE), and c) PV8 
(35% NCE) demonstrating the effect of the alkyl chain length on the distribution of product ions. 
 
The biggest impact of the identification of the conserved fragmentation pathways described in 

















cathinones. If a questioned seized drug provides a tandem mass spectrum with an abundant neutral 
loss of 71 Da from the [M+H]+ precursor, as well as additional peaks consistent with neutral losses 
of C6H6, ˙C2H4CnHn2+1, H2O and CH2CnH2n, then the spectrum is consistent will all of the α-
pyrrolidinophenone synthetic cathinones in this study. The presence of secondary fragmentation 
from any of the aforementioned peaks provides additional confidence in the identification of an α-
pyrrolidinophenone synthetic cathinone. 
Additionally, the ability to identify substitution to the core α-pyrrolidinophenone synthetic 
cathinone structure through shifts in the mass axis provides an additional tool for the identification 
of α-pyrrolidinophenone synthetic cathinones. Specifically, the location of the substitution can be 
identified based on which peaks diverge from the proposed fragmentation pathways in Figure 2.5. 
Table 2.1 shows the [M+H]+ protonated precursor and the five most abundant product ions for 
13 α-pyrrolidinophenone synthetic cathinones from this study. The five most abundant fragments 
are listed in order of decreasing abundance with all comparisons made at a set collision energy 
within the LIT and Q-TOF data due to the dependence of product ion abundances on the applied 
collision energy. These 13 standards include 11 non-isotopically labeled and two deuterated α-
pyrrolidinophenone synthetic cathinones. The product ions in Table 2.1 highlight both the 
frequency of occurrence for the product ions described in Figure 2.5, and the similarity in fragment 
ion abundances between the IT and Q-TOF instruments. With the exception of the loss of 
formaldehyde from methylenedioxy-containing compounds, and the additional methyl group for 
α-PVP-methyl, the only product ion in Table 2.1 that is not described by Figure 2.5 is m/z 107 for 
PV8 (Figure 2.6c). The proposed elemental formula for the product ion at nominal m/z 107 is 
C7H7O
+, which has a theoretical exact mass of m/z 107.0496, about 5 ppm from the measured 





Table 2.1. Protonated precursor and the five most abundant product ions in decreasing order of 
abundance for 13 of the synthetic cathinones used in this study. Fragment ions are reported for 
both the LIT and Q-TOF instruments.  
Compound [M+H]+ LIT product ions (m/z) 
@30% NCE 
Q-TOF product ions 
(m/z) @25 eV 
α-PPP m/z 204 133, 105, 70, 186, 98 
105.07, 98.09, 133.06, 
70.06, 77.03 
α-PBP m/z 218 147, 91, 119, 70, 112 
91.05, 112.11, 105.07, 
70.06, 161.09 
α-PVP m/z 232 161, 91, 70, 119, 126 
91.05, 126.12, 105.03, 
70.06, 161.09 
α-PVP-methyl m/z 246 175, 105, 140, 72, 228 
105.07, 72.08, 77.04, 
140.14, 98.09 
PV8 m/z 260 189, 91, 119, 107, 154 
91.05, 154.16, 105.03, 
70.06, 119.04 
4-MeO-α-PVP m/z 262 191, 126, 121, 163, 135 
121.06, 126.12, 135.04, 
191.10, 84.08 
3',4'-trimethylene-α-PVP m/z 272 201, 131, 126, 145, 173 
131.08, 201.12, 126.12, 
145.06, 84.08 
3,4-MDPPP m/z 248 177, 147, 98, 149, 230 
98.09, 147.04, 149.06, 
177.05, 119.05 
3,4-MDPBP m/z 262 191, 161, 112, 163, 149 
112.11, 161.06, 149.02, 
191.07, 163.07 
3,4-MDPV m/z 276 205, 175, 126, 135, 177 
126.12, 135.04, 175.07, 
149.02, 205.08 
2,3-MDPV m/z 276 175, 135, 205, 177, 126 
135.04, 175.07, 126.12, 
149.02, 70.06 
3,4-MDPV-d8 m/z 284 205, 175, 134, 135, 177 
134.17, 135.04, 149.02, 
175.07, 92.13 
α-PVP-d8 m/z 240 161, 91, 77, 119, 134 




Thermal degradation was observed as shouldering or a split peak consistent with previous 
literature [62-64]; however, the formation of the 2,3-enamine degradation product was always 
insignificant relative to the abundance of the non-degraded parent compound. The GC-EI-MS data 
demonstrates that the proposed carbon backbone rearrangements observed for the protonated 
tandem MS data are insignificant for all compounds analyzed by EI. EI is a hard ionization source, 





cleavage to form the benzoylium ion at m/z 105. The mechanisms of fragmentation of EI-MS are 
both radical-directed and charge-directed, in contrast to the charge-remote 4-center eliminations 
that dominate the tandem mass spectra of protonated precursor ions. For example, Figure 2.7a 
shows the GC-EI-MS spectrum of 13C-α-PPP isotopically labeled with a 13C on the α-carbon. The 
major structural fragments are embedded. The spectrum has been truncated due to the lack of high 
mass ions, such as the molecular ion, which is often missing with EI-MS of synthetic cathinones 
[15]. The presence of the benzoylium ion at m/z 105, phenylium ion at m/z 77 and the dominant 1-
ethylidenepyrrolidin-1-ium ion at m/z 99 (accounting for 13C) are all consistent with previous 
literature on the EI-MS fragmentation of α-pyrrolidinophenone synthetic cathinones [12, 13, 15, 
30, 32, 65]. 
Figure 2.7b shows the truncated GC-EI-MS results for the analysis of 13C-3,4-MDPV labeled 
with a 13C on the carbonyl carbon. The major structural fragments are embedded. Even with the 
additional methylenedioxy substitution, the 1-butylidenepyrrolidin-1-ium ion at m/z 126 is the base 
peak of this spectrum. However, the methylenedioxy substitution does shift the phenylium and 
benzoylium ions by 44 Da to the observed peaks at m/z 121 and m/z 150, respectively. The product 












Figure 2.7. Full scan mass spectra of a) 13C-α-PPP and b) 13C-3,4-MDPV collected with GC-EI-
MS. 
 
The truncated GC-EI-MS results for the analysis of 13C-PV8 labeled with a 13C on the carbonyl 
carbon are shown in Figure 2.8 with the major structural fragments embedded. The base peak of 
this spectrum is the 1-hexylidenepyrrolidin-1-ium ion at m/z 154, which, as expected, does not 
contain the 13C from the carbonyl carbon. Other peaks of significant abundance are the benzoylium 







pathways through the acylium and iminium ions hold true across the series of substitutions 
analyzed during this study.  
 
Figure 2.8. Full scan mass spectra of 13C-PV8 collected with GC-EI-MS. 
 
Figure 2.9 demonstrates the proposed general fragmentation mechanisms for α-
pyrrolidinophenone synthetic cathinones under EI-MS conditions, where X represents substitution 
to the aromatic ring moiety and CnH2n+1 represents varying alkyl chain lengths. The 
13C, 18O, and 
deuterated labeling are not shown in these proposed general mechanisms, but were used to generate 






Figure 2.9. Proposed general mechanisms for the fragmentation of α-pyrrolidinophenone 
synthetic cathinones with EI-MS (adapted from references [30, 60, 65]). The model compound 
is α-PVP.  
 
The two most abundant fragmentation pathways of α-pyrrolidinophenone synthetic cathinones 
are acylium and iminium ions, with iminium ions being the most dominant pathway. Acylium ions 
form through α-cleavage initiated by a radical electron on the oxygen, which produces 
characteristic ions at m/z 105, 77, and 51 for all the α-pyrrolidinophenone synthetic cathinones 
studied here. However, the presence of iminium ions are far more useful for the differentiation of 
synthetic cathinone isomers because of the secondary and tertiary fragmentation described by Zuba 





and α-cleavage of the bond between the carbonyl carbon and the α-carbon adjacent to the 
pyrrolidine ring. Secondary iminium ion fragmentation forms characteristic ions, such as those 
demonstrated for α-PVP in Figure 2.9 at m/z 97, 84, and 69 through the loss of an ethyl radical 
(˙C2H5), propylene, and a butyl radical (˙C4H9), respectively. The secondary iminium ion at m/z 
97 further fragments into the tertiary iminium ion at m/z 55 through the loss of cyclopropane. 
2.4 Conclusions 
The combination of isotope-labeling, MSn, and HRMS was used to study the fragmentation 
behavior of α-pyrrolidinophenone synthetic cathinones to gain a deeper understanding about the 
characteristic fragmentation pathways of this class of synthetic cathinone analogs. Three 
instruments that are common in toxicology laboratories and crime laboratories were used to 
develop characteristic fragmentation pathways to assist practitioners with the identification of α-
pyrrolidinophenone synthetic cathinones. Through the analysis of 22 α-pyrrolidinophenone 
synthetic cathinones, ESI and DART ionization sources on the same Q-TOF mass spectrometer 
produced even-electron protonated molecular ions and almost indistinguishable tandem mass 
spectra. The fragmentation pathways are highly conserved between the LIT and Q-TOF mass 
spectrometers, although the multi-collisional environment of the ion trap occasionally tends to 
limit the extent of consecutive fragmentations relative to the Q-TOF instrument [35]. The Q-TOF 
therefore favored the abundant production of lower mass ions relative to the LIT instrument. 
The identification of conserved tandem mass spectrometry fragmentation pathways through 
the loss of CH2CnH2n, H2O, ˙C2H4CnHn2+1, C6H6, and NC4H9 from protonated molecular ions 
provides a series of diagnostic ions that can be used for the tandem mass spectrometry 
identification of α-pyrrolidinophenone synthetic cathinones. Particularly, the dominant pathways 





provides a technique for structural elucidation through mass axis shifts due to additional 
substitutions to the core synthetic cathinone structure. The presence of diagnostic ions such as the 
tropylium ion at m/z 91, substituted iminium ions (i.e. m/z 126 vs m/z 112), and the phenylethyl 
derivative at m/z 105 provide key information about the length of the alkyl chain and substitutions 
to the aromatic ring moiety.  
When GC-EI-MS is used to analyze α-pyrrolidinophenone synthetic cathinones, the 
fragmentation pathways are dominated by the formation of iminium and acylium ions as 
previously reported in literature [12, 13, 15, 30, 32, 65]. This is expected due to the large energy 
deposition through 70 eV electron fragmentation resulting in direct α-cleavage fragmentation 
rather than the low-energy rearrangements observed with collisional activation. However, the 
observed fragmentation mechanisms remain unaffected by substitutions to the core synthetic 
cathinone structure, which provides a rapid method for the identification of novel α-
pyrrolidinophenone synthetic cathinones through known fragmentation pathway shifts along the 
mass axis. For example, the product ions observed at m/z 149 and m/z 121 for the GC-EI-MS 
fragmentation of 3,4-MDPV are 44 Da larger than the product ions at m/z 105 and m/z 77 for non-
methylenedioxy substituted synthetic cathinones. This study highlights the differences between 
high energy radical-driven fragmentation in EI and lower energy collisional activation of 
protonated precursor ions. However, knowledge about the systematic tendencies of both 








Chapter 3: Fragmentation pathways of odd- and even-electron N-alkylated synthetic 
cathinones 
Reproduced in part with permission from J.T. Davidson, Z.J. Sasiene, G.P. Jackson, 
International Journal of Mass Spectrometry, DOI: 10.1016/j.ijms.2020.116354. 
3.1 Introduction 
N-alkylated synthetic cathinones are analogs of the natural product cathinone, which is derived 
from the leaves of the Catha edulis plant, commonly referred to as khat. Khat is a native plant to 
the Horn of Africa and the Southwest Arabian Peninsula that, when chewed, produces stimulant-
like effects [1, 66]. The stimulant properties of cathinones are typically stronger than over-the-
counter stimulants like caffeine and nicotine, and similar to the effects of amphetamines, which 
are structurally similar to cathinones [7]. N-alkylated synthetic cathinones are characterized by 
alkyl side chains on the amine moiety of the generic benzoylethanamine structure. Additional 
analogs within this class include those with aliphatic substitutions to the alkyl chain and with 
substitutions to the benzene ring. The N-alkylated class of compounds was the first class of 
synthetic cathinone derivatives that became available on the drug market [1].  
In the 1930s, methcathinone was marketed under the name ephedrone as an antidepressant in 
the USSR. Methcathinone was also developed as a central nervous system stimulant by the Parke 
Davis pharmaceutical company in the United States [7]. In the 1950s, the N-alkylated synthetic 
cathinone diethylpropion was marketed under the name amfepramone as an appetite suppressant 
[67]. Whereas N-alkylated synthetic cathinones were originally developed for therapeutic 
purposes, the 1970s brought reports of methcathinone abuse in the Soviet Union. By the 1990s, 
the United States also documented methcathinone abuse [63]. Due to the low cost and 





methylenedioxymethcathinone, better known as methylone were sold in head shops and the 
internet by the early 2000s [68]. The main reason for abuse of synthetic cathinones was for their 
recreational use at dance clubs and parties [1].  
Currently, synthetic cathinones are marketed as “not for human consumption” or “bath salts” 
to avoid legislative restrictions imposed to decrease the sale and distribution of these compounds 
[2, 3]. The reported symptoms of synthetic cathinone abuse include euphoria, hallucinations, 
psychosis, paranoia, agitation, violent behavior, tachycardia, acidosis, seizures, and even death 
[53, 54]. The first N-alkylated synthetic cathinone to be classified as a schedule I substance by the 
Drug Enforcement Administration (DEA) was methcathinone in 1993 [69], but the rapid 
modifications to the generic synthetic cathinone structure make it difficult to regulate. The 
clandestine synthesis of analogs with only minor modifications to the generic structure provides a 
way around the imposed regulations while also introducing potentially more harmful substances 
onto the illicit drug market [1, 70]. 
This project describes the fragmentation pathways of N-alkylated synthetic cathinones using 
three common analytical techniques available in crime laboratories and national laboratories, 
including gas chromatography-electron ionization-mass spectrometry (GC-EI-MS), electrospray 
ionization and tandem mass spectrometry (ESI-MS/MS), and direct analysis in real time (DART) 
with high-resolution mass spectrometry (DART-HRMS). The DART source was mounted on a 
quadrupole time-of-flight (Q-TOF) mass spectrometer, which also enables high-resolution MS/MS 
acquisition. These setups are representative of the instrumentation commonly employed in seized 
drug laboratories, toxicological laboratories, and national laboratories, respectively. The 
comparison of the fragmentation mechanisms of odd-electron ions (EI) and even-electron ions 





The fragmentation behavior of N-alkylated synthetic cathinones has been reported throughout 
literature; however, the underlying fragmentation mechanisms that lead to the observed fragment 
ions are rarely discussed or understood [13, 32, 37, 71]. Examples of the confusion about the 
formation of the tropylium ion from protonated synthetic cathinones have been highlighted 
previously by our group [61]. Even when mechanisms have been proposed, the lack of isotopic 
labeling and multi-stage mass spectrometry limits the certainty associated the proposed 
mechanisms [28]. Specific examples of reported N-alkylated fragmentation behavior without 
mechanistic understanding including the works of Jankovics et al. [17], Martinez-Clemente et al. 
[72], and Fornal [16]. These articles provide useful fragmentation pathways but highlight that the 
mechanistic explanation for the fragmentation behavior of N-alkylated synthetic cathinones remain 
unclear. By gaining a better understanding of the fragmentation mechanisms, analysist would be 
better positioned to both defend the data of known scheduled drugs and to perform structural 
characterization to identify novel psychoactive substances (NPS) entering the market [13].  
The goal of this project is to better understand the fragmentation pathways of N-alkylated 
synthetic cathinones. The developed fragmentation pathways and mechanistic explanations will 
help advance the current understanding of the behavior of N-alkylated synthetic cathinones under 
different ionization and fragmentation conditions. Specifically, the comparison between the 
fragmentation behavior of odd-electron (via EI) and even-electron (via ESI and DART) ions of 
different N-alkylated synthetic cathinones provides a more comprehensive understanding of these 
compounds. This project combines isotopic labeling, MSn, and accurate mass measurements with 
HRMS to confirm the mechanisms of odd-electron and even-electron fragmentation of N-alkylated 






 Sample Preparation 
The ten standards purchased through Cayman Chemical (Ann Arbor, MI, USA) were 
methcathinone, ethcathinone, pentedrone, buphedrone, α-propylaminopentiophenone, N-
ethylbuphedrone, 3,4-dimethyl-α-ethylaminovalerophenone, methylone, butylone, and pentylone. 
The nine standards purchased through Cerilliant (Round Rock, TX, USA) were methcathinone-d3 
(N-alkyl deuterated), diethylpropion, diethylpropion-d10 (N-alkyl deuterated), 
13C-benzedrone (13C 
on carbonyl carbon), 13C-ethylone (13C on carbonyl carbon), 13C-butylone (13C on carbonyl 
carbon), pentylone-d3 (N-alkyl deuterated), dibutylone-d3 (alkyl deuterated), and eutylone-d5 (N-
alkyl deuterated). The non-deuterated samples were prepared in a solution of 49% HPLC grade 
methanol, 49% distilled water, and 2% acetic acid. The HPLC grade methanol was supplied by 
Fisher Scientific (Palo Alto, CA) and the acetic acid was supplied by Acros Organics (Palo Alto, 
CA). The deuterated samples were left in the original methanol solvent. All samples were prepared 
to a final concentration of approximately 100 ppm. 
 Instrumentation 
3.2.2.1 Linear Ion Trap 
A Thermo Scientific Velos Pro Linear Ion Trap (LIT) mass spectrometer was operated with 
heated-electrospray ionization (HESI) operated at 50 °C. The spray voltage was 4,000 V with the 
nitrogen sheath gas flow set to 8 arbitrary units and the nitrogen auxiliary flow set to 5 arbitrary 
units. The mass spectrometer capillary temperature was set to 275 °C. The scan range and 
normalized collision energy (NCE) were specific for each compound and are labeled with each 






3.2.2.2 Quadrupole Time-of-Flight 
An Agilent Technologies 6538 UHD Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) 
mass spectrometer was operated with both a dual ESI source and a direct analysis in real time 
(DART) source. The DART-100 source was mounted to the Q-TOF with a Vapur® interface 
(IonSense, Saugus, MA, USA). The DART ion source was operated with helium gas at 300 °C, 
with a flow rate of 3.0 L/min, a grid voltage of 400 V and a needle voltage of 3,500 V. The ESI 
source was operated with a spray voltage of 3,500 V with a 300 °C nitrogen drying gas flow rate 
of 5 L/min and a nebulizer flow of 30 psig. The MS fragmentor and skimmer voltages, the scan 
range and collision energy were specific for each compound and are labeled with each mass 
spectrum. An isolation width of 1.3 Da was used for all samples. The ultra-high purity nitrogen 
used for the collision gas and the ultra-high purity helium used for the DART gas were purchased 
through Matheson TRIGAS (Fairmont, WV, USA).  
The DART samples were prepared through the deposition of 5 µL of drug standard onto the 
closed end of a 1.5 x 1.8 x 90 mm Pyrex® glass capillary purchased through Corning Life Sciences 
(Corning, New York, USA). Once the samples were dry, the DART analysis consisted of 
approximately 30 s of background collection, about 5 s of sample introduction, and then the 
analysis of a blank capillary to account for capillary specific background. The total length of 
analysis was less than 90 s per sample.  
3.2.2.3 Single Quadrupole GC-EI-MS 
An Agilent Technologies 7890 GC-5977 MS with a HP-5 ((5% phenyl)-methylpolysiloxane) 
30 m x 250 µm x 0.25 µm column manufactured by Agilent J&W Columns was used for these 
analyses. The GC-EI-MS parameters were as follows: injection volume was 1 µL; injection 





which was ramped to 280 °C at 15 °C/min, then held for 2 min. The carrier gas (helium) flow rate 
was set to 1 mL/min and the transfer line temperature was set to 280 °C. The ultra-high purity 
helium gas was purchased through Matheson TRIGAS (Fairmont, WV, USA). The mass 
spectrometer was scanned from m/z 50-500 after a solvent delay of 2 min. The scan rate was 1,500 
Da/sec. The source and quadrupole temperatures were 250 °C and 200 °C, respectively. 
 Data Analysis 
Xcalibur 2.0.0.48 software was used for the data analysis on the Velos Pro instrument. 
MassHunter Qualitative Analysis B.05.00 was used for the Agilent Q-TOF data analysis, and 
ChemStation version C.01.01 was used for the Agilent GC-EI-MS data analysis. Microsoft Excel 
version 14 (Microsoft, Redmond, WA, USA) and ChemDraw 16.0 (PerkinElmer, Waltham, MA, 
USA) were used for mass spectral plots and mass spectral fragmentation mechanisms. 
3.2.3.1 Mass Spectral Interpretation and Mechanisms 
The mass spectral fragmentation mechanisms proposed are based on the combination of 
isotopic labeling, MSn and accurate mass measurements with HRMS. The mechanisms follow the 
expected lowest energy pathways [35], which often involve charge-remote 4-center eliminations 
consistent with previous literature [73, 74]. The isotopic labeling consisted of per-deuteration on 
both the alkyl chains and the N-alkyl chains and 13C on the carbonyl carbons. These isotopic labels 
provide useful information through the loss of isotopically shifted neutrals. Even though it is not 
always possible to know the exact location of hydrogen or deuterium atoms in certain 
rearrangements, the use of MSn and HRMS helps identify the structure of intermediates along the 
proposed pathways and the elemental composition, respectively. The N-alkylated class of synthetic 
cathinones has been shown to form odd-electron product ions from even-electron (e.g. protonated) 






 HESI-Velos Pro MSn 
Figure 3.1 shows the MSn fragmentation of pentedrone with the major structural fragments 
embedded. Isolation and fragmentation of the precursor ion [M+H]+ at m/z 192 results in the 
production of two dominant product ions at m/z 174 and m/z 161 (Figure 3.1a). The product ion 
at m/z 174 forms through the loss of H2O, whereas the product ion at m/z 161 forms through the 
loss of the N-alkylated moiety. Figure 3.1b shows the MS3 spectrum from the isolation and 
fragmentation of the primary product ion at m/z 174. The major secondary fragments of m/z 174 
appear at m/z 159, 145, 132, and 131. These losses are consistent with the loss of a methyl radical 
(˙CH3), ethyl radical (˙C2H5), propylene (C3H6), and propyl radical (˙C3H7), respectively, with the 
propylene pathway being the dominant pathway. Figure 3.1c shows the resulting spectrum from 
the isolation and fragmentation of the primary product ion at m/z 161. The secondary product ions 
observed from the primary fragment at m/z 161 are consistent with the valerophenone ion 
fragmentation pathways previously demonstrated by our group [75] including the dominant 
tropylium ion. As described previously for α-pyrrolidinophenone synthetic cathinones, the 
tropylium fragment almost certainly contains the α-carbon and not the carbonyl carbon and forms 








Figure 3.1. Product ion mass spectra of pentedrone on the LIT: a) product ion spectrum of the 
[M+H]+ molecular ion (30% NCE); b) product ion spectrum of the product ion at m/z 174 (30% 
NCE) showing the formation of secondary product ions at m/z 159, 145, 132, and 131; c) product 
ion spectrum of the primary product ion at m/z 161 (30% NCE) showing the characteristic 
valerophenone ion fragmentation. 
 
Figure 3.2 contains the MSn fragmentation of pentylone with the major structural fragments 
embedded. Pentylone is the methylenedioxy substituted equivalent of pentedrone and has a 
protonated precursor ion at m/z 236, which is 44 Da larger than pentedrone. The product ion 
spectrum of pentylone obtained on the LIT shows product ions at m/z 218, 205, 188, 175, and 86. 
The primary product ions at m/z 218 and m/z 205 are consistent with the methylenedioxy 
derivatives of the primary product ions observed for pentedrone at m/z 174 and m/z 161, 


















pathways not available or prominent for pentedrone; they are the loss of formaldehyde (CH2O) 
from the substituted valerophenone-like intermediate and the formation of an iminium ion, as seen 
by the product ions at m/z 175 and m/z 86, respectively.   
Figure 3.2b shows the MS3 spectrum following isolation and fragmentation of the primary 
product ion at m/z 218, which results in the formation of secondary product ions at m/z 188, 176, 
and 175. The secondary product ions are consistent with the loss of formaldehyde (CH2O), 
propylene (C3H6), and a propyl radical (˙C3H7) from the vinyl intermediate at m/z 218, with the 
loss of formaldehyde from the methylenedioxy group being the dominant pathway. Figure 3.2c 
shows the resulting mass spectrum from the isolation and fragmentation of the primary product 
ion at m/z 205, which again is dominated by the loss of formaldehyde at m/z 175 and the formation 















Figure 3.2. Product ion mass spectra of pentylone: a) product ion spectrum of the [M+H]+ 
molecular ion (30% NCE); b) product ion spectrum of the product ion at m/z 218 (30% NCE) 
showing the formation of secondary product ions at m/z 176, 175, 160, and 146; c) product ion 
spectrum of the primary product ion at m/z 205 (30% NCE) showing the characteristic 
methylenedioxy valerophenone ion fragmentation. 
 
Figure 3.3 shows the MSn fragmentation of dibutylone-d3, which is deuterated on the end of 
the alkyl chain. The major structural fragments are embedded. Isolation and fragmentation of the 
protonated precursor ion [M+H]+ at m/z 239 results in the formation of major product ions at m/z 
194, 149, and 89. The primary product ion at m/z 194 forms through the loss of N-alkylated moiety 
whereas the product ions at m/z 149 and m/z 89 are the methylenedioxy substituted benzoylium 
ion and a deuterated iminium ion, respectively. The significance of the tandem mass spectrum in 
Figure 3.3 is that, in contrast to pentedrone in Figure 3.1, the loss of water from dibutylone-d3 is 



















oxygen and makes a more labile leaving group, both of which make the loss of the N-alkyl moiety 
the base peak for dibutylone-d3. Of the 15 unique N-alkylated structures studied, the only other 
compound to lose the N-alkylated moiety in preference to water was diethylpropion, which is also 
a tertiary amine.  
Isolation and fragmentation of the primary product ion of dibutylone-d3 at m/z 194 results in 
the formation of secondary product ions at m/z 166 and m/z 164, which form through the neutral 
losses of CO and formaldehyde (CH2O), respectively (Figure 3.3b). Based on MS
n analysis (not 
shown), the tertiary product ion at m/z 136 forms through the loss of CO from the intermediate 
product ion at m/z 164 and the loss of formaldehyde from the intermediate at m/z 166. Figure 3.3c 
shows the MS3 mass spectrum that results from the isolation and fragmentation of the primary 
product ion at m/z 89. Interestingly, Figure 3.3c  shows the presence of product ions at both m/z 
74 and m/z 71 for the losses of ˙CH3 or ˙CD3 radicals, respectively, with a clear preference to lose 












Figure 3.3. Product ion mass spectra of dibutylone-d3 on the LIT: a) product ion spectrum of 
the [M+H]+ molecular ion (30% NCE); b) product ion spectrum of the primary product ion at 
m/z 194 (30% NCE) showing the formation of product ions at m/z 166, 164, and 136; c) product 
ion spectrum of the primary product ion at m/z 89 (30% NCE) showing the loss of both a methyl 
radical and a deuterated methyl radical. 
 
 DART/ESI-Q-TOF  
Figure 3.4 compares ESI and DART MS/MS spectra of methcathinone-d3 with the major 
structural fragments embedded. The fragment ion m/z values and abundances for DART-MS/MS 
and ESI-MS/MS are generally similar throughout the spectra. One notable difference between the 
DART- and ESI-generated mass spectra is the presence of [M+H]+ precursor ion at m/z 167.1322 
(C10H11D3NO
+ expected at m/z 167.1260; 37 ppm error) in the DART mass spectra. The collision 


















fragmentor voltage setting to assist the in-source declustering of ions from the ion source. 
Apparently, the additional 25 V fragmentor potential for ESI imparts more internal energy to the 
ions and causes them to enter the collision cell with an elevated internal energy relative to the same 
ions entering from the DART source.  
The main structural fragments of interest are observed in the ESI-generated product ion 
spectrum at m/z 149.1160 (C10H9D3N
+ expected at m/z 149.1154; 6 ppm error), 134.0960 
(˙C9H6D3N
+ expected at m/z 134.0920; 30 ppm error), 133.0730 (C9H9O
+ expected at m/z 
133.0653; 58 ppm error), and 131.0744 (˙C9H9N
+ expected at m/z 131.0734; 8 ppm error), which 
are formed through the loss of H2O, a methyl radical (˙CH3), the N-alkylated moiety and a 
deuterated methyl radical (˙CD3), respectively. The high-resolution of the Q-TOF instrument 
allows for the determination of elemental formulas for diagnostic ions through their measured 
accurate masses. The accurate mass measurements of the product ions at m/z 149.1160 
(C10H9D3N
+) and m/z 131.0744 (˙C9H9N
+) are less than 10 ppm from the exact masses for the 
proposed structures, whereas the accurate mass measurements for the product ions at m/z 134.0960 
(˙C9H6D3N
+) and m/z 133.0730 (C9H9O
+) were approximately 3-5 times further from the exact 
masses for the proposed structures. Even with the expanded error, these sub-60 ppm differences 
between measured accurate masses and theoretical exact masses provides sufficient confidence to 
rely on the proposed elemental compositions. Likewise, the mass-dependence of ppm values 
inflates these reported errors relative to larger molecular weight compounds. If the mass errors 
discussed above were reported in mDa as suggested by others [76] our values range from less than 
1 mD to 8 mDa. 
Based on the MSn analysis on the LIT, the product ions in the ESI-generated product ion 
spectrum at m/z 105.0713 (C8H9






expected at m/z 103.0547; 27 ppm error), m/z 79.0556 (C6H7
+ expected at m/z 79.0547; 11 ppm 
error), and m/z 77.0397 (C6H5
+ expected at m/z 77.0391; 8 ppm error) originate from the 
intermediate product ion at m/z 133.0730 (C9H9O
+), whereas the product ions at m/z 132.0817 
(C9H6D2N
+ expected at m/z 132.0780; 28 ppm error) and m/z 130.0670 (C9H8N
+ expected at m/z 
130.0656; 11 ppm error) originate from the intermediate product ions atm/z 134.0960 (˙C9H6D3N
+) 
and m/z 131.0744 (˙C9H9N
+), respectively. Of all the cathinones studied, the only notable 
differences between MS/MS data from the DART and ESI ion sources were the abundances of the 
precursor ion; some residual precursor was always observed for the DART-generated precursors. 
Likewise, small, but insignificant differences in the accurate mass measurements were observed 
between the ESI- and DART-generated mass spectra, likely due to recency in mass spectrometer 
tuning prior to analysis. If needed, the mass accuracy could be improved by the inclusion of 
internal mass calibrants. However, the internal calibration solution is known to provide several 
low-mass fragments, such as m/z 121 and m/z 149, which are also expected in methylenedioxy-
containing synthetic cathinones. To prevent possible interference, we deactivated the internal mass 












Figure 3.4. Tandem mass spectra of methcathinone-d3 collected on the Q-TOF with both a) ESI 
and b) DART ionization with a collision energy of 25 eV and skimmer voltage of 65 V. The ESI 
spectrum was collected with a fragmentor voltage of 175 V, whereas the DART spectrum was 
collected with a fragmentor voltage of 150 V. 
 
The comparison between the ESI- and DART-generated mass spectra for diethylpropion-d10 
(perdeuterated on the diethylpropion moiety) in Figure 3.5 provides further support for the 
similarity between ESI and DART mass spectra. The accurate mass of the ESI-generated mass 
spectrum at m/z 105.0713 is closer to the exact mass for C8H9
+ at m/z 105.0704 (9 ppm error) rather 
than for C7H5O
+ at m/z 105.0340 (355 ppm error; 37 mDa). The accurate mass data indicates the 
primary product ion at m/z 133.0690 (C9H9O
+ expected at m/z 133.0653; 28 ppm error) loses CO 
instead of C2H4 to yield m/z 105.0713 (C8H9














expected at m/z 110.1743; 39 ppm error) is the iminium-d10 ion, whereas the product ion at m/z 
84.1616 (C4H2D10N
+ expected at m/z 84.1587; 38 ppm error) is the diethylamine-d10 ion. As 
mentioned earlier, diethylpropion-d10 is one of the two 3° amines analyzed during this study, and 
the elevated abundance of the product ion at m/z 105.0713 (C8H9
+) shows that the loss of the N-
alkylated moiety is favored over the loss of H2O for 3° amines.  This hypothesis is supported by 
previous research highlighting the dominant pathway through the loss of water and secondary 
fragmentation for 2° amine synthetic cathinones [36].  
 
 
Figure 3.5. Tandem mass spectra of diethylpropion-d10 collected on the Q-TOF with both a) 
ESI and b) DART ionization with a collision energy of 25 eV. The ESI spectrum was collected 
with a fragmentor voltage of 225 V, whereas the DART spectrum was collected with a 














Figure 3.6 is a comparison between the ESI and DART spectra of eutylone-d5 with the major 
structural fragments embedded. The ESI-generated product ion spectrum shows the presence of 
primary product ions at m/z 223.1516 (C13H11D5O2N
+ expected at m/z 223.1489; 12 ppm error), 
m/z 191.0738 (C11H11O3
+ expected at m/z 191.0708; 16 ppm error), m/z 149.0262 (C8H5O3
+ 
expected at m/z 149.0238; 16 ppm error), and m/z 91.1324 (C5H7D5N
+ expected at m/z 91.1278; 
51 ppm error) as well as secondary product ions at m/z 194.1161 (˙C11H6D5O2N
+ expected at m/z 
194.1098; 32 ppm error), m/z 193.1442 (C12H9D5ON
+ expected at m/z 193.1384; 30 ppm error), 
and m/z 161.0666 (C10H9O2
+ expected at m/z 161.0602; 40 ppm error). The tertiary product ions 
at m/z 135.0479 (C8H7O2
+ expected at m/z 135.0446; 24 ppm error) and m/z 133.0701 (C9H9O
+ 
expected at m/z 133.0653; 36 ppm error) originate from the secondary product ion at m/z 191.0738 
(C11H11O3
+). The primary product ions at m/z 223.1516 (C13H11D5O2N
+) and m/z 191.0738 
(C11H11O3
+) form through the loss of H2O and the loss of the N-alkylated moiety, respectively, 
whereas the primary product ions at m/z 149.0262 (C8H5O3
+) and m/z 91.1324 (C5H7D5N
+) 
correspond to the methylenedioxy-substituted benzoylium ion and the imminium-d5 ion, 
respectively. The secondary product ions at m/z 194.1161 (˙C11H7D5O2N
+) and m/z 193.1442 
(C12H9D5ON
+) form, respectively, through the loss of an ethyl radical (˙C2H5) and formaldehyde 
(CH2O) from the intermediate ion at m/z 223.1516 (C13H11D5O2N
+), whereas the secondary 
product ion at m/z 161.0666 (C10H9O2
+) forms through the loss of formaldehyde (CH2O) from the 
intermediate ion at m/z 191.0738 (C11H11O3
+). The error between the accurate mass measurements 
and the exact masses of the elemental compositions shown were the smallest errors of all possible 
elemental compositions and within approximately 50 ppm, which once again corresponds to <7 
mDa error. The HRMS accuracy is sufficient to provide unambiguous elemental compositions and 







Figure 3.6. Tandem mass spectra of eutylone-d5 collected with both a) ESI and b) DART 
ionization with a collision energy of 25 eV. The ESI spectrum was collected with a fragmentor 
voltage of 225 V, whereas the DART spectrum was collected with a fragmentor voltage of 150 
V, which were both collected with a skimmer voltage of 65 V. 
 
Figure 3.7 shows the proposed fragmentation mechanisms for the N-alkylated class of 
synthetic cathinones, where X represents substitution to the benzyl moiety and CnH2n+1 represents 
varying alkyl chain lengths. The 13C and deuterium labels are not shown in the proposed 
fragmentation mechanisms, but standards containing these isotopic labels were used to support the 















Figure 3.7. Proposed mechanisms for fragmentation pathways of N-alkylated synthetic 
cathinones. The model compound is pentedrone (aliphatic group=CH3, N-alkyl group=CH3, 
X=H) with ions specific pentedrone indicated with an asterisk (*); different functional groups, 
X, will shift the product ion m/z values accordingly. 
 
The primary fragmentation pathways for the N-alkylated class of synthetic cathinones are 
through the loss of H2O (blue pathway), CnH2n+3N (black pathway), and C7H6O (red pathway), 
which is consistent with previous work by others on this class of compounds [15, 17, 28, 37, 77, 
78]. The dominant pathway for 2° amines within this class is through the loss of H2O via two 
hydrogen transfers to the oxygen. Deuterium labeling on the N-alkyl group (e.g. methcathinone-
d3 in Figure 3.4 and eutylone-d5 in Figure 3.6) showed that hydrogens from the N-alkyl group do 
not contribute to the neutral loss of H2O. Similarly, CID of dibutylone-d3 (alkyl deuterated) 
provided evidence that the terminal hydrogens do not participate in the water loss. Therefore, the 





as proposed in the 4-center elimination in Figure 3.7, which forms a double bond between the α 
and β carbons to the amine.  
Several structures have been proposed for the loss of H2O from synthetic cathinones; however, 
the previous studies did not use of isotopic labeling or HRMS [15, 17, 28, 37, 77, 78]. Our data 
supports the mechanism proposed in Figure 3.7 based on the loss of a methyl radical (˙CH3) from 
the pentedrone intermediate at m/z 174 (Figure 3.1b) and the loss of a deuterated methyl radical 
(˙CD3) from the methcathinone-d3 intermediate at m/z 149.1160 (Figure 3.4). In both cases the 
radical loss would be impossible with an iminium intermediate containing a double bond between 
the N and the N-alkylated moiety.  
Secondary fragmentation also occurs through the loss of alkyl radicals from the aliphatic chain 
(gold pathway), alkyl radicals from the N-alkylated moiety (green pathways), and even-electron 
alkenes through 4- or 6-center eliminations along the aliphatic chain (blue pathways). The presence 
of distonic radicals (like the structures at m/z 131 and m/z 159), along with the loss of H2O, was 
observed for every 2° amine N-alkylated synthetic cathinone analyzed in this study. 
The second most abundant fragmentation pathway for 2° amine N-alkylated synthetic 
cathinones is the formation of the valerophenone-like ion at m/z 161 through the loss of CnH2n+3N 
(black pathway). The secondary and tertiary product ions deriving from the valerophenone-like 
intermediate have been described extensively for α-pyrrolidinophenone synthetic cathinones. They 
include fragments at m/z 133 and m/z 119, which have a phthalane-like structure and the tropylium 
ion at m/z 91 [61]. Similar to the α-pyrrolidinophenones studied previously [75], which have a 
facile leaving group in the form of pyrrolidine, fragmentation via the loss of a neutral 3° amines 
was the dominant fragmentation pathway for the 3° amines analyzed here. The other observed 





iminium ions similar to the one at m/z 86 for pentedrone in Figure 3.7. This pathway is readily 
explained via a McLafferty rearrangement and leads to secondary fragments through the loss of 
alkyl radicals from the N-alkyl chain (green pathway) and even-electron alkenes through 4-center 
eliminations from the aliphatic chain (blue pathway).  
 GC-EI-MS 
Previous literature on the analysis of phenethylamines with GC-EI-MS has documented the 
need to identify phenethylamines, their metabolites and their thermal degradation products, the 
latter of which can occur in the injection port or on-column and are often observed as a shoulder 
or split peak in the GC [62-64]. The 2,3-enamine degradation products observed from the N-
alkylated synthetic cathinones in this project were always minor relative to the abundance of the 
precursor compound. Figure 3.8 shows the GC-EI-MS spectrum of 13C-ethylone, which is 
isotopically labeled with on the carbonyl carbon. The extensive fragmentation caused by EI 
ionization occurs through well-established fragmentation mechanisms such as the formation of the 
benzoylium ion at m/z 105 or iminium ion (CnH2n+2N
+) at m/z 72 for ethylone [15]. The established 
fragmentation mechanisms for EI-MS are both radical-directed and charge-directed, in contrast to 
the charge-remote, 4-center eliminations commonly observed in protonated tandem mass spectra. 
The iminium ions are so dominant in EI that competing fragmentation pathways are of low 
abundance (<10% base peak) and provide minimally informative spectra [79]. Figure 3.8 contains 
the embedded major structural fragments. The spectrum has been truncated to m/z 40-200 because 
the molecular ion at m/z 221 was not observed. The most abundant structural fragments are the 
methylenedioxy-substituted benzoylium and phenylium ions at m/z 150 and 121, respectively, and 
the iminium ion observed at m/z 72. Note that the methylenedioxy-substituted tropylium ion at m/z 






Figure 3.8. Full scan mass spectra of 13C-ethylone (isotopically labeled with on the carbonyl 
carbon) collected with GC-EI-MS. 
 
The GC-EI-MS spectrum of α-propylaminopentiophenone (Figure 3.9) follows the same 
fragmentation behavior as 13C-ethylone, with the formation of the iminium, benzoylium and 
phenylium ions of significant abundance. The molecular ion at m/z 219 is not observed, and the 
fragmentation pattern is consistent with previous work [77]. However, α-
propylaminopentiophenone has a propyl amine and pentyl aliphatic chain, leading to the formation 
of the iminium ion at m/z 114 in Figure 3.9. This iminium ion can fragment further to form another 






Figure 3.9. Full scan mass spectra of α-propylaminopentiophenone collected with GC-EI-MS. 
 
Figure 3.10 shows the GC-EI-MS spectrum of 13C-benzedrone—isotopically labeled on the 
carbonyl carbon—with the major structural fragments embedded. This compound is unique in that 
the N-alkylated moiety contains an aromatic ring. The aromatic ring causes a notable shift in the 
fragmentation behavior of this compound. For example, the base peak of Figure 3.10 is the 
tropylium ion at m/z 91, which forms through charge-directed cleavage of the aromatic moiety. 
The aromatic substituted iminium ion (m/z 134), 13C-labled methyl substituted benzoylium ion 






Figure 3.10. Full scan mass spectra of 13C-benzedrone collected with GC-EI-MS. 
 
Figure 3.11 contains the proposed EI-MS fragmentation mechanisms for the N-alkylated class 
of synthetic cathinones, where X represents substitution to the benzyl moiety and CnH2n+1 
represents varying alkyl chain lengths. Pentedrone is the model compound for illustrative 
purposes. The isotopic labels are not shown in Figure 3.11 but were used to further support the 
proposed mechanisms. The acylium (red pathway) and iminium ions (blue pathway) are the 
dominant fragmentation behavior for N-alkylated synthetic cathinones. The acylium ion pathway 
is initiated by α-cleavage of the bond between the carbonyl carbon and the α-carbon adjacent to 
the amine. The subsequent loss of CO from the acylium ion produces the phenylium ion at m/z 77, 
which can then ring-contract to lose C2H2 to form the cyclobutadienyl cation at m/z 51. The 
iminium ion cascade is initiated by a radical electron on the nitrogen and α-cleavage of the bond 
between the carbonyl carbon and the α-carbon adjacent to the pyrrolidine ring. The iminium ion 
pathway forms secondary fragmentation through a 4-center elimination along the alkyl chain 





through α-cleavage of the bond between the carbonyl carbon and the α-carbon, which is initiated 
by a lone pair of electrons on the oxygen (green pathway). 
 
 
Figure 3.11. Proposed EI-MS fragmentation mechanisms for the N-alkylated class of synthetic 
cathinones (adapted from [60, 75]). The model compound is pentedrone (aliphatic group=CH3, 
N-alkyl group=CH3, X=H) with ions specific to pentedrone indicated with an asterisk (*). 
 
3.4 Conclusions 
The combination of isotopic labeling, MSn, and HRMS was used to further develop the current 
understanding of the fragmentation behavior of the N-alkylated class of synthetic cathinone 
derivatives. In addition, a comparison between three different ionization and fragmentation 





behavior of these compounds under different instrumental conditions. The most common mass 
spectrometer used for seized drug analysis is GC-EI-MS, whereas the toxicological community 
typically employs LC-ESI-MS/MS and more recently the community has expanded the use of 
ambient ionization, such as DART. The identification of characteristic fragmentation pathways 
provides practitioners with an additional tool for the identification of N-alkylated synthetic 
cathinones.  
The protonated tandem mass spectrometry fragmentation pathways and proposed 
fragmentation mechanisms were developed based on the analysis of a series of N-alkylated 
synthetic cathinone derivatives. The LIT instrument provided the capability to identify the direct 
relationship between each ion along the proposed fragmentation pathways using MSn analysis. In 
comparison, the Q-TOF mass spectrometer identified the elemental formulas by comparing the 
accurate mass measurements with the theoretical exact mass measurements. The identification of 
fragmentation pathways that are conserved between ion trap- and beam-type mass spectrometers 
provides additional confidence, although the multi-collisional environment of the ion trap tends to 
favor low-energy pathways and higher-mass ions [35]. Finally, both ESI and DART ion sources 
produced in-tact protonated molecular ions with very similar protonated tandem mass spectra for 
all the analogs studied.  
The diagnostic ions formed with protonated tandem mass spectrometry occur through the loss 
of H2O, CnH2n+3N, and C7H6O, as displayed in Figure 3.7. The loss of H2O appears to be the 
dominant pathway for 2° amines, which is in stark contrast to 3° amines, which favors the 
formation of alkylphenones via the loss of imine neutrals. The hydrogens lost as water do not 
originate from the N-alkyl groups or the terminal carbon of the alkyl chains, but instead originate 





characteristic secondary fragmentation for 2° amines occurs through the loss of alkenes (CnH2n) 
from the amine moiety and alkyl radicals (˙CnH2n+1) from both the amine and aliphatic chains. The 
same fragmentation behavior is observed for the iminium ion fragmentation pathway through the 
loss of alkyl radicals (˙CnH2n+1) and alkenes (CnH2n) from the amine moiety.  
In contrast to CID of protonated precursors, EI-MS spectra of N-alkylated synthetic cathinones 
are dominated by radical-directed cleavages that lead to acylium and iminium ions. One down-
side to the conserved iminium ions is when one observes, say, a 42-Da shift in the iminium ion 
from ethylone to α-propylaminopentiophenone one cannot readily confirm whether the three 
additional methylene groups are on the aliphatic chain, the N-alkyl chain or a combination of the 
two.  
The proposed fragmentation mechanisms for the protonated tandem mass spectrometry and 
EI-MS pathways provide rational explanations for the observed fragmentation behavior based on 
the combination of isotopic labeling, MSn, HRMS, and EI-MS. The significance of identifying 
fragmentation mechanisms is the application of this knowledge to novel compound identification. 
The interrogation of collected mass spectra against the proposed fragmentation pathways provides 
an additional tool for the identification of novel N-alkylated synthetic cathinones. Finally, 
providing fragmentation pathways and mechanistic explanations that are applicable across a range 
of ionization and fragmentation conditions provides useful multi-discipline mass spectral 










Chapter 4: The characterization of isobaric product ions of fentanyl using multi-stage mass 
spectrometry, high-resolution mass spectrometry and isotopic labeling 
Reproduced in part with permission from J.T. Davidson, Z.J. Sasiene, G.P. Jackson, Drug Testing 
and Analysis, DOI: 10.1002/dta.2758. 
4.1 Introduction 
Fentanyl and fentanyl analogs have emerged as some of the most deadly compounds from the 
growing opioid crisis in America [80]. Fentanyl is a synthetic opioid approved by the FDA as an 
analgesic and anesthetic, but licit and illicit fentanyl analogs end up on the drug market through 
theft, fraudulent prescriptions and illicit distribution by patients, doctors, and pharmacists [81]. 
Since 2013, fentanyl and fentanyl analogs have become increasingly common adulterants in heroin 
seizures, and their incredible efficacy for binding to opioid receptors in the body has caused 
accidental overdoses in almost every state [82]. According to the 2017 National Laboratory 
Forensic Information System (NFLIS), more than 56,000 fentanyl drug reports were filed the year 
before by local and state forensic laboratories [83].  
The Janssen and Siegfried methods are the two main synthetic routes for clandestine synthesis 
of fentanyl [84]. The Siegfried method is the easier of the two approaches, and it uses N-phenethyl-
4-piperidone (NPP) as the starting material and produces 4-anilino-N-phenethylpiperidine (4-
ANPP) as an intermediate to the fentanyl product. Investigators can benefit from knowing the 
synthetic route of a fentanyl seizure, and the synthetic pathway can be established by the 
identification of residual unreacted precursors in the seizure. The Siegfried method uses 4-ANPP 
and the Janssen method uses benzylfentanyl. According to the DEA, four of the five domestic 






Whereas fentanyl and its synthetic precursors are Schedule II narcotics, the impact on public 
health has led fentanyl analogs such as α-methylfentanyl, 3-methylfentanyl, acetylfentanyl, butyryl 
fentanyl, and β-hydroxythiofentanyl to be listed as Schedule I narcotics [82, 84, 85]. Figure 4.1 
shows the generic chemical structure of fentanyl analogs. This core structure is conserved in almost 
all analogs. Para-methylphenethylacetylfentanyl is an example of a fentanyl analog generated 
through modification at location R1. Thiofentanyl, α-methylfentanyl, and β-hydroxyfentanyl are 
examples of fentanyl analogs generated through modification at location R2. Carfentanil and 3-
methylfentanyl are examples of modifications at location R3. Sufentanil, alfentanil and 
remifentanil all contain modifications at locations R2 and R3, where R3 refers to a substitution at 
any position on the piperidine ring. Alteration in the length of the aliphatic chain at location R4 
differentiates butyrylfentanyl and acetylfenantyl analogs from fentanyl. Finally, substitutions such 
as a fluorine at location R5 generate fentanyl analogs such as para-fluorofentanyl [86]. 
 
The differentiation of fentanyl analogs with electron ionization (EI) mass spectrometry has 
proven to be difficult. Mallette et al. [88] noted that 2-methylfentanyl and 3-methylfentanyl can 
only be distinguished based on the subtle differences in the relative abundance of ions at m/z 202, 
203, 160 and 216. Similarly, cyclopropylfentanyl and crotonylfentanyl are only distinguishable by 
differences in the relative abundance of ions at m/z 69 and m/z 105 [89]. Kanamori et al. reported 
 






the conserved nature of fragmentation pathways with 3-methylfentanyl analogs with all spectra 
having a base peak due to the benzyl cleavage [90]. The relative ion abundances were similar 
between compounds, with cis-isomers having larger abundances than trans-isomers, such as m/z 
216, 203, 160, and 105 for cis-3-methylfentanyl relative to trans-3-methylfentanyl. However, some 
spectra, such as the diastereomers of β-hydroxy-cis-3-methylfentanyl, were too similar to 
differentiate. Ohta et al. have reported on the highly conserved nature of fentanyl analogs and 
called for forensic science laboratories to prepare for new designer drugs [91]. The conserved 
fragmentation pathways of these common structures has enabled the National Institute of 
Standards and Technology (NIST) to develop an EI-MS mass spectral database and algorithm 
specifically designed to assist with the identification of novel opioids including fentanyl analogs 
[92]. 
Whereas the use of tandem mass spectrometry is one of the most effective ways to identify 
fentanyl analogs, especially at trace levels in toxicological and seized drug samples [93, 94], 
certain analogs are extremely difficult to distinguish. For example, Feasel et al. observed largely 
analogous collision-induced dissociation (CID) spectra between carfentanil and remifentanil [95]. 
Caspar et al. discussed the value of having group-indicating ions that might help to identify novel 
compounds [96]. They recommended HRMS to help identify the elemental compositions of 
different fragment ions, including the fragment at m/z 188.1439 in the case of fentanyl analogs 
[96]. However, Wichitnithad et al. observed at least two isobaric product ions with the same exact 
mass at m/z 188.1439 [97]. They were only able to distinguish the constitutional isomers using 
MS3 and deuterium labeling [97]. Their observation further highlights the need for a better 





Two approaches that have demonstrated success in the identification of novel psychoactive 
substances (NPS) are the use of multi-stage mass spectrometry (MSn) [98, 99] and the use of 
accurate mass measurements with high-resolution mass spectrometry (HRMS) [100, 101]. The 
current work employs both of these tactics and isotopic labeling to elucidate additional 
fragmentation mechanisms of fentanyl and 4-ANPP. The discovery of three isobaric product ions 
at m/z 188 adds to the understanding of the fragmentation behavior of fentanyl analogs and helps 
to defend the use of transitions such as m/z 337→m/z 188 for the quantitation and identification of 
fentanyl in seized drugs and biological fluids [87, 102-104]. The mechanism of formation of the 
new intermediate can be extrapolated to other fentanyl analogs to help explain some previously 
unidentified product ions in the spectra of existing and future fentanyl analogs.   
4.2 Methods  
 Sample Preparation 
The 4-ANPP fentanyl precursor, fentanyl, and fentanyl-d5 (deuterated around the aniline) 
standards were purchased through Cayman Chemical (Ann Arbor, MI, USA). The 4-ANPP and 
fentanyl standards were dissolved in a solution of 49% HPLC grade methanol, 49% distilled water, 
and 2% acetic acid. The fentanyl-d5 certified reference material (CRM) was left in the original 
methanol solvent to reduce the risk of hydrogen back exchange. The HPLC grade methanol was 
supplied by Fisher Scientific (Palo Alto, CA, USA) and the acetic acid was supplied by Acros 






 Instrumentation  
4.2.2.1 Thermo Scientific Velos Pro Linear Ion Trap (LIT) 
A Thermo Scientific Velos Pro Linear Ion Trap (LIT) mass spectrometer was operated with a 
heated-electrospray ionization (HESI) source. The HESI source was operated at 50 °C with a spray 
voltage of 4,000 V. The nitrogen sheath gas was operated at 8 arbitrary units with a nitrogen 
auxiliary gas flow of 5 arbitrary units. The mass spectrometer capillary temperature was 275 °C. 
The scan range and normalized collision energies (NCEs) were compound specific and are labeled 
with each mass spectrum. An isolation width of 1 Da was used for all samples. Ultra-pure helium 
was used as the bath gas purchased through Matheson Tri-Gas (Fairmont, WV, USA).  
4.2.2.2 Agilent Technologies 6538 UHD Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) 
An Agilent Technologies 6538 UHD Accurate-Mass Quadrupole Time-of-flight (Q-TOF) 
mass spectrometer was operated with dual electrospray ionization (ESI) with a spray voltage of 
3,500 V. The nitrogen gas was set to 300 °C with a drying gas flow of 5 L/min and a nebulizer 
flow of 30 psig. The MS fragmentor and skimmer voltages were operated at 225 V and 65 V, 
respectively. The scan range and collisions energies were specific to each compound and are 
labeled in each mass spectrum. An isolation width of 1.3 Da was used for all samples. Ultra-pure 
nitrogen was used for the collision gas purchased through Matheson Tri-Gas (Fairmont, WV, 
USA). 
 Data Analysis  
Xcalibur 2.0.0.48 software was used for the Velos Pro LIT data analysis, whereas MassHunter 
Qualitative Analysis B.05.00 was used for the Agilent Q-TOF data analysis. Microsoft Excel 
version 14 (Microsoft, Redmond, WA, USA) and ChemDraw 16.0 (PerkinElmer, Waltham, MA, 





4.2.3.1  Mass Spectral Interpretation and Mechanisms 
The fragmentation mechanisms for each compound are based on MSn analyses, accurate mass 
measurements and prevailing electron pushing conventions. The proposed mechanisms follow the 
expected lowest energy pathways [35]. Whereas the identification of the exact hydrogen(s) 
involved in a specific rearrangement was not possible in this study, we could exclude certain 
hydrogen atoms by using perdeuterated analogs. Examples include MSn of fentanyl that was 
perdeuterated on the aniline ring. MSn resolved the relationships between primary, secondary and 
tertiary product ions in a variety of pathways, and even though the exact atoms could not always 
be resolved in a rearrangement, the results provided a deeper level of understanding than the 
present status. 
4.3 Results/Discussion 
Figure 4.2 shows an example of the product ion spectrum generated from the fragmentation 
of the [M+H]+ protonated precursor of fentanyl observed at m/z 337 with the major structural 
fragments embedded. The base peak in this spectrum is observed at m/z 188, which has been 
identified as a characteristic ion for the identification of fentanyl derivatives [96]. However, based 
on the competing mechanisms for the loss of the N-phenylpropanamide neutral, previous literature 
has demonstrated that this peak must contain at least two isobaric product ions with different 







Figure 4.2. Tandem mass spectrum of protonated fentanyl using CID in a linear ion trap mass 
spectrometer (35% NCE).  
 
Other ions of significant abundance are observed at m/z 281 and m/z 216, of which the ion at 
m/z 281 has been shown to fragment into m/z 188 [94, 98, 105]. Figure 4.3 shows the MS3 product 
ion spectrum from the isolation and fragmentation of the intermediate product ion at m/z 281 
(Figure 4.3a) and the MS4 product ion spectrum of the isolation and fragmentation of the 
intermediate product ion at m/z 188 from Figure 4.3a. These spectra contain the major structural 
fragments for each MS-level. The distribution of product ions in Figure 4.3b is in agreement with 












Figure 4.3. Product ion mass spectra of protonated fentanyl collected under different conditions: 
a) MS3 product ion spectrum for the transition m/z 337→281→ at 35% NCE, and b) MS4 product 
ion spectrum for the transition m/z 337→281→188→ at 33% NCE. 
 
As described by Wichitnithad et al. [97], the intermediate product ion at m/z 188 forms through 
a six-centered rearrangement resulting in the loss of N-phenylpropanamide. However, based on 
our MSn studies, we have identified the intermediate product ion at m/z 281 as an intermediate 
between the [M+H]+ precursor and the fragment at m/z 188. Our proposed mechanism involves a 
4-center-elimination of the methylketene from the N-phenylpropanamide moiety, as shown at the 
top of Figure 4.4. Figure 4.4 also shows the two proposed fragmentation pathways that explain 
the experimentally observed MS4 mass spectrum (Figure 4.3b). Pathway a) describes the 

















formation of the intermediate product ion at m/z 160 and ultimately, the product ion at m/z 120. 
Pathway b) describes the formation of the product ions at m/z 146, 132, and 105 from the second 
isobaric intermediate product ion at m/z 188.  
 
Figure 4.4. Proposed mechanisms for the formation of different product ions from two isobaric 
intermediates at m/z 188 [97]. Pathway a) leads to the formation of product ions at m/z 134, 160, 
and 120, whereas pathway b) leads to the formation of product ions at m/z 146, 132, and 105. 
 
In addition to the two isomers at m/z 188 that form from the intermediate at m/z 281, a third 
isobar at the nominal mass of m/z 188 forms via fragmentation of the intermediate product ion at 






forms a product ion at m/z 132 (Figure 4.5b). The product ion at m/z 188 formed through the 
intermediate at m/z 216 fragments differently than either of the two isomers at m/z 188 identified 
by Wichitnithad et al. [97].  
 
 
Figure 4.5. Product ion mass spectra of protonated fentanyl collected under different 
conditions: a) MS3 product ion spectrum for the transition m/z 337→216→ at 35% NCE, and 
b) MS4 product ion spectrum for the transition m/z 337→216→188→ at 25% NCE. 
 
 
Figure 4.6 shows product ion spectra collected in pseudo-MS3 mode on the Q-TOF instrument 
with proposed structures of the major fragments embedded. In these spectra, in-source CID of the 
protonated molecular ion generated pseudo-MS2 primary fragments, which were then isolated at 
the MS2 level and fragmented in the collision cell to generate pseudo-MS3 spectra. CID of the 

















m/z 188.1086. The accurate mass for the new product ion is consistent with an elemental 
composition of C12H14NO
+, which has an exact mass of 188.1075 Da (6 ppm error). In contrast, 
the isomers formed via the intermediate at m/z 281.2020 have an accurate mass of m/z 188.1465. 
This product is consistent with an elemental composition of C13H18N
+, which has an exact mass of 
188.1439 (14 ppm error). The measured masses are different by almost 200 ppm, so there can be 
no confusion between the different elemental compositions of the isobars formed via the two 
different pathways.  
 
 
Figure 4.6. Comparison of MS2 of: a) the in-source CID generated intermediate product ion at 
m/z 216.1300 (25 eV) and b) the in-source CID generated intermediate product ion at m/z 
















As shown in Figure 4.7, the intermediate product ion at m/z 216 most likely forms through the 
opening of the piperidine ring and charge stabilization on a tertiary carbocation as described by 
Thevis et al. [94]. From the structure at m/z 216, the intermediate product ion at m/z 188 can then 
form through a 4-center-elimination at the carbocation. The product ion at m/z 132 can be formed 
via two different pathways, one through the intermediate at m/z 188 and the other through the 
intermediate at m/z 160. Formation of m/z 132 from the intermediate at m/z 188 occurs through a 
4-center-elimination of methylketene. Formation of m/z 132 from m/z 160 can occur via the 4-
center-elimination of ethene. Either way, the resulting product at m/z 132 contains the original 
aniline moiety rather than the previously described phenyl moiety. This newly identified pathway 
provides a third alternative structure for the isobars at the nominal mass of m/z 188 in the tandem 
mass spectra of fentanyl.  
 
Figure 4.7. Proposed mechanisms for the formation of the novel product ion at m/z 188 from 





MSn-level analysis of protonated fentanyl also provided evidence for a fourth fragmentation 
pathway for a product with a nominal mass of m/z 188. This fourth pathway has a measured 
accurate mass of 188.1465, which is within 10 ppm of the exact mass of C13H18N
+. This minor 
pathway, which occurs at approximately 0.5% of the abundance of m/z 188 in Figure 4.2, involves 
an R-group transfer of the propionaldehyde moiety of the molecular ion to form the intermediate 
product ion at m/z 244. Figure 4.8a shows that although the formation of the product at m/z 190 
is the preferred product from the activation of the intermediate fragment at m/z 244, the product 
ion at m/z 188 is still observable at the MS4 level. Figure 4.8b shows that MS4-level fragmentation 
via the sequence m/z 337→244→188→ results in product ions at m/z 120 and m/z 134. Such 
fragmentation was not observed by Wichitnithad et al. [97], presumably because this pathway is 













Figure 4.8. Product ion mass spectra of protonated fentanyl collected under different conditions: 
a) MS3 product ion spectrum for the transition m/z 337→244→ at 25% NCE, and b) MS4 product 
ion spectrum for the transition m/z 337→244→188→ at 25% NCE. 
 
Figure 4.9 shows that the proposed R-group transfer to form the product ion at m/z 244 
involves transferring the propionaldehyde group from the aniline moiety to the piperidine nitrogen 
via nucleophilic attack of the carbonyl carbon by the lone pair on the piperidine nitrogen atom. 
Transfer to the nitrogen atom is more consistent with both MS4-level spectra of fentanyl and MS3-
level spectra of other fentanyl analogs. This mechanism is more easily visualized when the 
piperidine ring adopts a boat configuration. In the boat configuration, the propionaldehyde transfer 

















propionaldehyde group to the carbon atoms of the piperidine ring would involve sterically 
unfavorable rearrangements and weaker nucleophilic attack.   
 
Figure 4.9. Proposed mechanisms for the formation of the product ion at m/z 188 from the 
intermediate product ion at m/z 244. 
 
After transfer of the propionaldehyde group, the intermediate at m/z 244 forms via a 4-center-
elimination of aniline from the rearranged precursor. The intermediate product ion at m/z 188 
forms from a 4-center elimination of methylketene, which can then undergo a retro-Diels-Alder 
reaction to produce the product ion at m/z 134. Fragmentation at the MS3 level shows that the 
product ion observed at m/z 134 can also form through the intermediate product ion at m/z 190, 
which is formed through the loss of cyclobutene from the intermediate product ion at m/z 244. The 
intermediate at m/z 190 was identified through the conserved loss of 54 Da from a variety of 
fentanyl analogs [106] and the accurate mass measurements using the Q-TOF HRMS instrument 
(Figure 4.10). The measured accurate mass of m/z 190.1249 is less than 9 ppm different than the 







Figure 4.10. Tandem mass spectrum of fentanyl (25 eV) and showing the product ion at m/z 
190.1249, which supports the proposed C12H16ON
+ elemental formula. 
 
The analysis of the d5 version of fentanyl, which is deuterated around the aniline moiety, 
provides support for the three proposed mechanisms. Figure 4.11a shows the tandem mass 
spectrum of protonated fentanyl-d5 observed at m/z 342 with the structures of the major fragments 
embedded. The incorporation of 5 deuterium atoms instead of 5 hydrogen atoms onto the aniline 
ring allows this moiety to be traced down each fragmentation pathway. The observed product ions 
at m/z 286 and m/z 221 confirm that the deuterated aniline moiety is present, whereas the product 
ion at m/z 244 indicates the deuterated aniline moiety has been lost. The proposed R-group transfer 
in Figure 4.9 is further supported by the observation of the product ion at m/z 244 from both 
fentanyl and fentanyl-d5. The fragment at m/z 244 occurs through the loss of 93 Da from fentanyl 












Figure 4.11. Product ion mass spectra of protonated fentanyl-d5 collected under different 
conditions: a) MS2 product ion spectrum of the precursor at m/z 342 at 35% NCE, b) MS3 product 
ion spectrum for the transition m/z 337→286→ at 25% NCE, and c) MS3 product ion spectrum 




















Figure 4.11b shows the MS3-level fragmentation of the intermediate at m/z 286. The base peak 
at m/z 188 indicates that the deuterated aniline moiety is lost, which agrees with the proposed 
pathways in Figure 4.4. The most important discovery from the analysis of fentanyl-d5 is that the 
intermediate product at m/z 221 fragments into product ions at m/z 193, 165, and 137 (Figure 
4.11c). The product ion at m/z 193 is consistent with the deuterated version of the product ion at 
m/z 188, which is described in Figure 4.7.  
Deuterium labeling provides definitive proof that the aromatic ring that is ultimately 
incorporated into the product ion at m/z 188 from the intermediate product ion at m/z 216 pathway 
must be from the aniline moiety and not from the phenyl moiety. In contrast, the phenyl moiety is 
retained in the more-dominant pathways to m/z 188 that occur through intermediates at m/z 281 
and m/z 244. Also, observation of product ions at m/z 165 and m/z 137 in the deuterated fentanyl 
sample (Figure 4.11c) provides support for the mechanisms presented in Figure 4.7 through the 
incorporation of five deuterium into the proposed product ions at m/z 160 and m/z 132. Finally, 
Figure 4.12 contains the accurate mass measurements for the analysis of in-source CID generated 
m/z 221.1700 for fentanyl-d5 collected on the Q-TOF instrument. The incorporation of the 
deuterated aniline moiety is observed at every step along the proposed fragmentation pathway 







Figure 4.12. MS2 of the in-source CID generated intermediate product ion at m/z 221.1700 (25 
eV) for fentanyl-d5 highlighting the incorporation the deuterated aniline moiety in the product 
ions at m/z 221.1709, 193.1407, 165.1464, and 137.1147. 
 
MSn analysis of 4-ANPP enabled the identification of similar fragmentation pathways as 
fentanyl. For example, Figure 4.13a shows the tandem mass spectrum of the [M+H]+ precursor of 
4-ANPP at m/z 281. The MS2 product ion spectrum shows the characteristic base peak observed 
at m/z 188, which is present in most fentalogs. Product ions of other significance are observed at 
m/z 146, 134, and 105, which are all product ions of the dominant product ion at m/z 188 in Figure 
4. Figure 4.13b shows that MS3-level fragmentation of the intermediate at m/z 188. The product 
ion distribution is identical to that of fentanyl and is consistent with the proposed mechanisms in 
Figure 4.4. The two new pathways to the formation of isobars at m/z 188 for fentanyl are not 
possible for 4-ANPP. However, tandem mass spectrometry analysis of a variety of other fentalogs 
also show R-group transfers that are consistent with the mechanism shown in Figure 4.9, the 
results of which are the topic of ongoing work. 
337.22     









Figure 4.13. Product ion mass spectra of protonated 4-ANPP: a) MS2 product ion spectrum of 
protonated precursor ion at m/z 281 (35% NCE) and b) MS3 product ion spectrum for the 
transition m/z 281→188→ at 35% NCE. 
 
4.4 Conclusions  
 
This manuscript demonstrates the use of multi-stage mass spectrometry (MSn), accurate mass 
measurements with HRMS and isotopic labeling for the elucidation of the fragmentation 
mechanisms for fentanyl and 4-ANPP. Specifically, this manuscript establishes the identification 
of three isobaric fentanyl product ions at m/z 188 including a novel product ion formed through 
the intermediate product ion at m/z 216. This realization has a potential impact on product ion 
selection for quantitative analyses. The product ion at m/z 188 is commonly reported in literature 














However, there are at least three isobaric fentanyl product ions at m/z 188 which have different 
rates and energies of formation. These differences can lead to variation in ion abundances, which 
can affect the accuracy and precision of quantitative analyses [97], but recognition of these 
different pathways can also help identify similar mechanisms in emerging fentanyl analogs. As 
new fentanyl analogs enter the drug market our ability to identify characteristic fragmentation 
pathways and conserved fragmentation mechanisms can assist medical examiners, toxicologists 

















Chapter 5:  The influence of chemical modifications on the fragmentation behavior of 
fentanyl and fentanyl-related compounds in electrospray ionization tandem mass 
spectrometry 
Reproduced in part with permission from J.T. Davidson, Z.J. Sasiene, G.P. Jackson, Drug 
Testing and Analysis, DOI: 10.1002/dta.2794. 
5.1 Introduction 
Fentanyl is a synthetic opioid that was first synthesized in 1960 by Paul Janssen [85, 107]. Due 
to its rapid onset and potency, fentanyl became a popular general anesthetic and was approved by 
the FDA in 1972 under the brand name Sublimaze [108]. Fentanyl citrate (Sublimaze) was an 
intravenous anesthetic that was only available to clinicians and surgeons. However, in the 1990s 
the introduction of transdermal fentanyl patches resulted in reports of misuse [107, 109]. In 1994, 
the FDA issued a warning about the dangers associated with fentanyl patches and the over-
prescription of potent opioids [85, 107]. Unfortunately, fentanyl also began entering the drug 
market through clandestine laboratories and online suppliers who synthesized new analogs faster 
than could be controlled by the Drug Enforcement Administration (DEA) [107]. In response, the 
DEA temporarily scheduled all non-classified FRCs as Schedule I narcotics to alleviate 
administrative and regulatory issues with prosecution [110]. The two main routes of clandestine 
synthesis are the Janssen and Siegfried methods, with the Siegfried method—or a modified version 
thereof—being the most common method for clandestine synthesis [84].  
Very few fentanyl or FRC deaths were reported before 2013, and any reports were typically 
associated with heroin users. However, since 2013 an opioid epidemic has swept the United States 
and caused thousands of FRC deaths [107]. In the US, there was a 259% increase in fentanyl 





opioids, excluding methadone [85]. According to the 2017 and 2018 National Forensic Laboratory 
Information System (NFLIS) reports, there was an increase of more than 22,000 fentanyl cases 
between 2016 and 2017 and more than 27,000 cases between 2017 and 2018 [83, 111]. 
Fentanyl and its synthetic precursors, such as 4-anilino-N-phenethylpiperidine (4-ANPP), are 
classified as Schedule II narcotics due to the medicinal value of fentanyl [84, 107]. However, 
fentanyl analogs such as α-methylfentanyl, 3-methylfentanyl, acetylfentanyl, butyrylfentanyl, and 
β-hydroxythiofentanyl lack medicinal approval and are listed as Schedule I narcotics [85, 107, 
108]. Figure 5.1 shows a generic chemical structure for FRCs, which highlights regions of 
common substitution. Modification sites include substitution of the aniline ring (R1), loss or 
modification of the amide (R2), and substitution on the piperidine ring (R3), alkyl chain (R4) or the 
monocyclic substituent (R5), including phenyl, thiol and tetrazole derivatives.  
 
Because of its ubiquity, electron ionization-mass spectrometry (EI-MS) is frequently applied 
to the detection of FRCs, especially in combination with gas chromatography (GC). Ohta et al. 
analyzed 25 fentanyl derivatives and determined that 23 of the 25 compounds could be 
differentiated based on the combination of retention time on the GC and EI mass spectra, even in 
the absence of the molecular ion (M+.) [112]. Kanamori et al. analyzed a series of 3-methylfentanyl 
 





isomers and identified the conserved nature of the fragmentation pathways with the base peak of 
each spectrum corresponding with the cleavage of the benzyl moiety [113].  
The identification of novel FRCs has become so important that the National Institute of 
Standards and Technology (NIST) has developed an algorithm, known as the Hybrid Similarity 
Search (HSS) algorithm, that generates similarity scores based on both the fragment ions and 
neutral losses so that structural modifications can be identified [92]. However, the HSS algorithm 
still struggles with the differentiation of positional isomers, which, if not chromatographically 
separated, must be differentiated manually using precise comparisons of relative ion abundances. 
For example, Mallette et al. demonstrated the differentiation of 2-methylfentanyl and 3-
methylfentanyl using EI-MS, but differentiation was only possible based on the relative ion 
abundance of four fragment ions at m/z 216, 203, 202, and 160 [114]. The DEA has also conducted 
work with cyclopropylfentanyl and crotonylfentanyl wherein the relative ion abundance of m/z 69 
and m/z 105 was the criteria for differentiation [115]. Recently, a more novel application of EI was 
demonstrated through the use of a field portable nano-liquid chromatography (nLC)-EI-MS for the 
detection of fentanyl analogs [116]. 
Whereas EI-MS produces robust fragmentation that is conducive to mass spectral library 
searching, liquid chromatography (LC) introduction systems are also highly effective for the 
detection of FRCs in toxicology applications. LC introduction coupled to ESI or other ionization 
techniques can be used in conjunction with multiple reaction monitoring (MRM) for multiplex 
detection of a range of drugs and FRCs [87, 117]. LC introduction can also enable multiplex 
detection when combined with multi-stage mass spectrometry (MSn) [98, 99] or accurate mass 
measurements with high-resolution mass spectrometry (HRMS) [100, 101]. Another introduction 





samples, reducing the need for extraction and prior chromatographic separation prior to tandem 
mass spectrometric analysis [118]. Specifically, the application of direct analysis in real time 
(DART) ionization with HRMS has shown promising results for the identification of fentanyl and 
FRCs [119, 120]. Irrespective of sample introduction, tandem mass spectrometry benefits from the 
identification of both the molecular ion and the structural characterization through collision-
induced dissociation (CID).  
The conserved fragmentation behavior of FRCs can be very beneficial for the identification of 
novel FRCs, if the underlying fragmentation mechanisms can be understood. Examples of 
mechanistic interpretation for the generation of characteristic fentanyl fragmentation include 
Thevis et al. [94], Wichitnithad et al. [97] and our previous work on common intermediates in the 
tandem MS of FRCs [121]. However, these examples are focused on either fentanyl or specific 
FRCs, and as such do not provide a broad, generalized approach for the identification of the 
location of substitutions to the core fentanyl structure.  
This study investigates the effect of substitution on the fragmentation behavior of fentanyl and 
FRCs in ESI-MS/MS with the goal of developing a general approach for the identification of the 
location of substitutions to the core fentanyl structure. The 16 FRCs analyzed in this study 
represent a variety of permutations of substitution in Figure 1. The use of isotopic labeling, MSn, 
and accurate mass measurements with HRMS allows the determination of the direct relationship 
between each product ion (MSn) and the elemental formula (HRMS). The use of isotopic labeling 
allows the labeled functionality to be followed down each fragmentation pathway as well as the 
identification of gas-phase rearrangements during CID. The use of both trapping and beam-type 
mass spectrometers also increases the applicability of these fragmentation pathways because the 





of substitution to the core fentanyl structure provides an additional tool to practitioners in the 
identification of emerging FRCs.  
5.2 Methods 
 Sample Preparation 
Thirteen FRC standards were purchased through Cayman Chemical (Ann Arbor, MI, USA), 
and three FRC standards were purchased through Cerilliant (Round Rock, TX, USA). The FRC 
standards purchased through Cayman Chemical were: 4-anilino-N-phenethylpiperidine (4-ANPP), 
fentanyl, fentanyl-d5, ortho-methylfentanyl, meta-methylfentanyl, cyclopropylfentanyl, 
crotonylfentanyl, para-methoxybutyrylfentanyl, methoxyacetylfentanyl, α-methylfentanyl, β-
hydroxythiolfentanyl-d5 (perdeuterated on the amide), 
13C6-para-fluorofentanyl (labeled on the 
phenyl moiety) and 13C6-carfentanil (labeled on the phenyl moiety). The FRC standards purchased 
through Cerilliant were alfentanil, furanylfentanyl, and sufentanil-d5 (perdeuterated on the amide). 
Ortho-methylfentanyl, meta-methylfentanyl, and 13C6-para-fluorofentanyl (labeled on the phenyl 
moiety) are examples of FRCs with substitution at location R1 in Figure 1. Examples of FRCs with 
modification at location R2 of Figure 1 include: 4-ANPP (loss of propionaldehyde), 
cyclopropylfentanyl, crotonylfentanyl, methoxyacetylfentanyl and furanylfentanyl. 13C6-
carfentanil, labeled on the phenyl moiety, is an example of a modification to location R3 in Figure 
1, whereas α-methylfentanyl is an example of a modification to location R4. Para-
methoxybutyrylfentanyl, β-hydroxythiolfentanyl-d5, alfentanil, and sufentanil-d5 are examples of 
FRCs with a combination of modification locations, such as sufentanil-d5 at location R3 and R5 of 
Figure 1. All non-deuterated standards were prepared in a solution of 49% HPLC grade methanol 
(Fisher Scientific, Palo Alto, CA, USA), 49% distilled water and 2% acetic acid (Acros Organics, 





the risk of hydrogen back exchange. All solutions were prepared to a final concentration of 
approximately 100 ppm.  
 Instrumentation 
5.2.2.1 Thermo Scientific Velos Pro Linear Ion Trap (LIT) 
A heated-electrospray ionization source (HESI) was operated at 50 °C with a spray voltage of 
4,000 V. Nitrogen gas was used for the sheath and auxiliary gas with a flow of 8 and 5 arbitrary 
units, respectively. The mass spectrometer capillary temperature was 275 °C, and the scan range 
and normalized collision energy (NCE) were optimized for each compound and are provided with 
each mass spectrum. An isolation width of 1 Da was used for all samples. Ultra-pure helium from 
Matheson TRIGAS (Fairmont, WV, USA) was used as the bath gas.  
5.2.2.2 Agilent Technologies 6538 UHD Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) 
A dual ESI source was operated with a spray voltage of 3,500 V and a 300 °C nitrogen drying 
gas flow of 5 L/min and a nebulizer flow of 30 psig were used. The MS fragmentor and skimmer 
voltages, scan range, and collision energies were optimized for each compound and are labeled 
with each mass spectrum. An isolation width of 1.3 Da was used for all samples. Ultra-pure 
nitrogen was used for the collision gas purchased through Matheson TRIGAS (Fairmont, WV, 
USA). 
 Data Analysis 
Xcalibur 2.0.0.48 software and MassHunter Qualitative Analysis B.05.00 were used for the 
Velos Pro and Agilent data analysis, respectively. Microsoft Excel version 14 (Microsoft, 
Redmond, WA, USA) and ChemDraw 16.0 (PerkinElmer, Waltham, MA, USA) were used for 





5.2.3.1 Mass Spectral Interpretation and Mechanisms 
Results from isotopic labeling, MSn and accurate mass measurements with HRMS were 
combined to identify characteristic fragmentation pathways of FRCs. The complex nature of gas-
phase mass spectral rearrangements can make it difficult to identify the exact hydrogen(s) involved 
in specific structural rearrangements. However, the ability to monitor specific functional groups 
using isotopic labeling provides deeper insight into which groups are retained and lost in a given 
fragmentation pathway. 
5.3 Results and Discussion 
The first phase of this project established several fragmentation pathways for protonated 
fentanyl and its main synthetic precursor 4-ANPP using tandem MS on a Q-TOF and a LIT [121]. 
The previous study confirmed the identity of three isobaric structures for the base peak at m/z 188 
in MS2 spectra of fentanyl; two of the structures were previously recognized by Wichitnithad et 
al. [97], and the third structure has a unique elemental composition and structure but the same 
nominal mass of m/z 188. The previous study also provided compelling evidence for an R-group 
transfer of the amide moiety to the N-atom of the piperidine ring during fragmentation [121]. The 
current study provides additional support for this unusual mechanism and shows that the 
mechanism is conserved for a range of FRCs.  
The combination of the LIT and HRMS instruments permit the identification of the direct 
relationship between intermediate product ions. On the LIT, intermediates are identified via MSn 
through sequential isolation and fragmentation events. The HRMS instrument allows the 
resolution of ions that are nominal isobars but have different exact masses. Examples are the 
product ions at m/z 188.1439 for C13H18N
+ and m/z 188.1075 for C12H14NO
+ [97, 121], which 





are defined as product ions formed directly from the precursor ion without any intermediate ion 
between the precursor ion and primary product ion. Secondary and tertiary product ions are the 
result of subsequent fragmentation events from primary product ions. The relationships identified 
via the LIT instrument were then applied to the HRMS data collected on the Q-TOF instrument.  
 HESI-Velos Pro MSn 
Figure 5.2 shows the MSn fragmentation of ortho-methylfentanyl with the structures of the 
major fragments embedded. Isolation and fragmentation of the [M+H]+ precursor at m/z 351 results 
in product ions at m/z 295, 230, 188, 146 and 105 (Figure 5.2a). The base peak of the tandem mass 
spectrum is observed at m/z 188, which is consistent with the two isobaric product ions formed 
through competing mechanisms for the loss of the N-phenylpropanamide neutral previously 
demonstrated by Wichitnithad et al. [97]. The primary product ions at m/z 295 and m/z 230 are 
formed through the loss of methylketene (C3H4O) and phenethylamine (C8H11N), respectively, 
which are consistent with previous literature on the fragmentation of fentanyl [121].  
Figure 5.2b shows the MS4 product ion spectrum for the pathway m/z 351→295→188→. The 
product ions include m/z 160, 146, 132 and 105 are formed through the loss of ethylene (C2H4), 
cyclopropane (C3H6), cyclobutene (C4H8), and tetrahydropyridine (C5H9N). Isolation and 
fragmentation of the intermediate product ion at m/z 230 results in the formation of product ions 
at m/z 202 and m/z 146, which are consistent with the methyl-substituted equivalents for fentanyl 








Figure 5.2. Tandem mass spectra of ortho-methylfentanyl: a) MS2 product ion spectrum of the 
[M+H]+ molecular ion (30% NCE); b) MS4 product ion spectrum of the product ion at m/z 188 
(35% NCE) showing the formation of product ions at m/z 160, 146, 132 and 105, among others; 
c) MS3 product ion spectrum of the primary product ion at m/z 230 (30% NCE) showing the 
formation of m/z 202 and m/z 146. 
 
Figure 5.3 shows the MSn fragmentation of methoxyacetylfentanyl with the major structural 
fragments embedded. The MS2 spectrum is dominated by the intermediate product ion at m/z 188, 
which, like fentanyl, is comprised of at least two isobaric product ions (Figure 5.3a). The primary 
product ions observed at m/z 260 and m/z 232 correspond with the loss of aniline (C6H7N) and 
phenethylamine (C8H11N), which have been shown to be primary fragmentation pathways for 
fentanyl analogs [97, 121]. It is noteworthy that the primary product ion expected at m/z 281 is not 





















groups on the phenylalkylamide moiety eliminated the formation of this intermediate [122]. 
Figure 5.3b shows the isolation and fragmentation of the primary product ion at m/z 260, which 
results in a dominant product ion at m/z 206. The primary product ion at m/z 260 is formed through 
an R-group transfer from the aniline nitrogen to the piperidine nitrogen as previously demonstrated 
for fentanyl [121]. The fragment at m/z 206 is formed through the loss of cyclobutene, which is 
observed for other FRCs wherein the novel R-group transfer is present. Finally, isolation and 
fragmentation of the primary product ion at m/z 232 results in dominant product ions at m/z 204 
and m/z 176, which arise through the loss of ethylene (C2H4) and CO from the m/z 204 intermediate 















Figure 5.3. Tandem mass spectra of methoxyacetylfentanyl: a) MS2 product ion spectrum of the 
[M+H]+ molecular ion (30% NCE); b) MS3 product ion spectrum of the product ion at m/z 260 
(30% NCE) showing the formation of a dominant product ion at m/z 206; c) MS3 product ion 
spectrum of the primary product ion at m/z 232 (30% NCE) showing the formation of product 
ions at m/z 204, 176, 144, and 132. 
 
MSn fragmentation of sufentanil-d5 reveals an altered fragmentation pattern. Figure 5.4a 
demonstrates the dominance of two product ions at m/z 360 and m/z 238 in the MS2 spectrum. 
Formation of the product ion at m/z 360 occurs through the loss of methanol (CH4O) from the 
methoxymethylene substitution to the piperidine ring, which is analogous to the loss of methanol 
from the carboxymethylester functional group of carfentanil [95]. The base peak of the tandem 
mass spectrum of sufentanil-d5 is at m/z 238 and occurs through the loss of the deuterated N-
phenylpropanamide (C9H5D5NO) without the presence of any product ion through the loss of 





















Figure 5.4. Tandem mass spectra of sufentanil-d5: a) MS
2 product ion spectrum of the [M+H]+ 
molecular ion (30% NCE); b) MS3 product ion spectrum of the product ion at m/z 360 (30% 
NCE) showing the formation of product ions at m/z 332, 234, 225, 206, 137 and 111, among 
others; c) MS3 product ion spectrum of the primary product ion at m/z 238 (30% NCE) showing 
the formation of product ions at m/z 206, 140 and 111. 
 
As shown in Figure 5.4b, isolation and fragmentation of the primary product ion at m/z 360 
of sufentanil-d5 results in a large distribution of product ions including m/z 332, 225, 206, 137, and 
111. The base peak of the MS3 spectrum for the pathway m/z 392→360→ is observed at m/z 206 
(Figure 5.4b), which occurs through the loss of the deuterated N-phenylpropanamide 
(C9H5D5NO), similar to the generation of the intermediate product ion at m/z 238 from the [M+H]
+ 
precursor ion. Figure 5.4c is the MS3 spectrum for the pathway m/z 392→238→, which produces 


















Figure 5.5 shows MSn spectra of β-hydroxythiolfentanyl-d5 with the major structural 
fragments embedded. In the MS2 spectrum in Figure 5.5a, the primary product ion at m/z 346 
dominates the spectrum and must arise through the loss of H2O, which is facilitated by the presence 
of the hydroxyl group on the alkyl chain. The only other primary product ion observed in the MS2 
spectrum is observed at m/z 250, which forms through the loss of hydroxymethylthiol. This 
fragmentation behavior is different in that the loss of H2O is so dominant relative to the formation 
of any other primary product ions.  Figure 5.5b shows the MS3 spectrum for the pathway m/z 
364→346→, which results in product ions at m/z 286, 221, 207, 192, 158 and 147. The base peak 
at m/z 286 of the MS3 spectrum forms through the loss of deuterated methylketene. Figure 5.5c 
shows the MS3 spectrum for the pathway m/z 364→250→, which results in a variety of product 
ions, including m/z 207 and m/z 190, which form through piperidine ring enclosure and the loss of 











Figure 5.5. Tandem mass spectra of β-hydroxythiolfentanyl-d5: a) MS
2 product ion spectrum of 
the [M+H]+ molecular ion (30% NCE); b) MS3 product ion spectrum of the product ion at m/z 
346 (30% NCE) showing the formation of product ions at m/z 286, 221, 207, 192, 158 and 147, 
among others; c) MS3 product ion spectrum of the primary product ion at m/z 250 (30% NCE) 
showing the formation of product ions at m/z 207 and m/z 190, among others. 
 
 Accurate-Mass with HRMS Q-TOF 
Accurate mass measurements of the compounds in Figures 5.2-5.5 confirm the elemental 
formulas for the proposed structures. As an example of this capability, Figure 5.6 shows the high-
resolution tandem mass spectrum of para-methoxybutyrylfentanyl with the major structural 
fragments embedded. The primary product ions measured at m/z 311.2165 (expected at m/z 
311.2123 for C20H27N2O; 13 ppm error) and m/z 260.1663 (expected at m/z 260.1650 for 


















primary product ions at m/z 311.2165 and m/z 260.1663 occur through the loss of ethylketene 
(C4H6O) and phenethylamine (C8H11N), respectively. The accurate mass of the base peak of this 
spectrum at m/z 188.1455 (expected at m/z 188.1439 for C13H18N; 9 ppm error) is consistent with 
the structures shown in Figure 5.6. The conserved fragmentation pathways observed between the 
two instruments, and the consistency between the accurate mass measurements and theoretical 
exact masses, provides confidence that the proposed structures and pathways are typical 
observations in CID spectra of fentanyl analogs.  
 
Figure 5.6. Tandem mass spectrum of para-methoxybutyrylfentanyl collected a 25 eV collision 
energy, 250 V fragmentor voltage and 65 V skimmer voltage. 
 
The HRMS tandem mass spectrum of alfentanil (Figure 5.7) highlights obvious differences in 
the fragmentation pathways relative to para-methoxybutyrylfentanyl (Figure 5.6) through the 
generation of primary product ions at m/z 385.2381 (expected at m/z 385.2351 for C20H29N6O2; 7 
ppm error) and m/z 268.1831 (expected at m/z 268.1773 for C12H22N5O2; 21 ppm error). The 
primary product ions at m/z 385.2381 and m/z 268.1831 are formed through the loss of methanol 
(CH4O) and N-phenylpropanamide (C9H10NO). These observations are consistent with sufentanil-








product ion at m/z 314.1892 (expected at m/z 314.1868 for C18H24N3O2; 8 ppm error) forms 
through the loss of C2H5N3 from the tetrazole functional group. This same C2H5N3 loss from the 
tetrazole functional group also occurs from both the primary product ion at m/z 268.1831 and the 
secondary product ion at m/z 170.1061 (expected at m/z 170.1041 for C6H12N5O; 12 ppm error) to 
form product ions at m/z 197.1345 (expected at m/z 197.1290 for C10H17N2O2; 28 ppm error) and 
m/z 99.0572 (expected at m/z 99.0558 for C4H7N2O; 14 ppm error), respectively.  
 
Figure 5.7. Tandem mass spectrum of alfentanil collected with a 25 eV collision energy, 225 V 
fragmentor voltage and 65 V skimmer voltage.  
 
Figure 5.8 shows the HRMS tandem mass spectrum of α-methylfentanyl with proposed major 
structural fragments embedded. The base beak of this spectrum is observed at m/z 91.0580, 
consistent with the elemental formula C7H7
+, commonly referred to as the tropylium ion. The 
presence of the methyl group on the α-carbon leads to the formation of the intermediate ion at m/z 
119.0902 (expected at m/z 119.0860 for C9H11; 35 ppm error), which readily fragments into the 









Figure 5.8. Tandem mass spectrum of α-methylfentanyl collected with a 25 eV collision energy, 
250 V fragmentor voltage and 65 V skimmer voltage. 
 
The other dominant product ion at m/z 202.1653 (expected at m/z 202.1595 for C14H20N; 29 
ppm error) is consistent with the methyl-subsituted derivative of the m/z 188.1439 base peak for 
non-piperidine ring substituted fentanyl analogs. The primary product ions at m/z 295.2207 
(expected at m/z 295.2174 for C20H27N2; 11 ppm error) and m/z 216.1395 (expected at m/z 
216.1388 for C14H18NO; 3 ppm error) are formed through the loss of methylketene (C3H4O) and 
2-phenylpropylamine (C9H13N), respectively. The only other primary product ion of any 
meaningful abundance is observed at m/z 233.1658 (expected at m/z 233.1653 for C14H21N2O; 2 
ppm error), which forms through the loss of a phenylpropyl neutral that is facilitated by the 
presence of the methyl group on the α-carbon.  
Figure 5.9 contains the HRMS tandem mass spectrum of 13C6-carfentanil with the major 
strucutral fragments embedded. The [M+H]+ precursor at m/z 401.2495 (expected at m/z 401.2535 
for C18
13C6H31N2O3; 10 ppm error) fragments into primary product ions at m/z 369.2115 (expected 
at m/z 369.2273 for C17
13C6H27N2O2; 42 ppm error) and m/z 341.2345 (expected at m/z 341.2324 
for C16
13C6H27N2O; 6 ppm error). The secondary product ion at m/z 252.1754 (expected at m/z 
252.1695 for C9








phenylpropanamide (C9H10NO), which ultimately forms tertiary product ions at m/z 192.1504 
(expected at m/z 192.1484 for C7
13C6H16N; 10 ppm error), m/z 140.1201 (expected at m/z 140.1171 
for C3
13C6H16N; 21 ppm error) and m/z 113.0634 (expected at m/z 113.0602 for C6H9O2; 28 ppm). 
The secondary product ion at m/z 285.2077 (expected at m/z 285.2062 for C13
13C6H23N2; 5 ppm 
error) forms through the loss of methylketene and forms tertiary product ions at m/z 192.1504 
(expected at m/z 192.1484 for C7
13C6H16N; 10 ppm error) and m/z 146.1009 (expected at m/z 
146.0969 for C10H12N; 27 ppm error). 
 
Figure 5.9. Tandem mass spectrum of 13C6-carfentanil collected with a 25 eV collision energy, 
250 V fragmentor voltage and 65 V skimmer voltage.  
 
Figure 5.10 shows the observed primary product ions for FRCs with ESI-MS/MS based on 
the use of isotopic labeling, MSn, and HRMS. The eight fragmentation pathways highlight the 
effect of substitution to the core fentanyl structure on the observed primary product ions, with each 
location of substitution directing unique fragmentation pathways. Based on the FRCs analyzed, 
substitution to the aniline ring (R1) and amide moiety (R2) does not alter the fragmentation 
mechanisms relative to fentanyl with the lone exceptions being methoxyacetylfentanyl (Figure 
5.3) and furanylfentanyl, both of which show reduced abundance for pathway 5, likely due to the 








are still observed for methoxyacetylfentanyl and furanylfentanyl and in fact, the altered 
fragmentation mechanism seems to enhance to the formation of product ions through pathway 7. 
In general, pathways 5, 6 and 7 are more frequently observed for FRCs with substitution to the 
aniline ring (R1) and amide (R2) moieties, which is consistent with the fragmentation behavior of 
fentanyl. Pathway 5 occurs through the loss of a substituted-ketene from the protonated precursor 
and pathway 6 arises through the opening of the piperidine ring and charge stabilization on a 
tertiary carbocation. Whereas pathways 5 and 6 are the dominant primary product ions observed 
in the protonated tandem mass spectra for R1 and R2 substituted FRCs, the product ions of pathway 
7 are often observable at ~1% the abundance of the base peak.  
  
Figure 5.10. Observed primary product ions for FRCs with ESI-MS/MS. The color of an R 






The presence of a substituent on the piperidine ring (R3) favors pathways 3 and 4. Pathway 3 
occurs through the direct loss of the N-phenylpropanamide (C9H10NO), whereas pathway 4 arises 
through the loss of either a portion or the entire functional group on the piperidine ring (R3). The 
piperidine ring substituted FRCs analyzed in this study were all substituted in the 4-position of the 
piperidine ring and as such, the fragmentation behavior described for pathway 3 is only applicable 
to 4-position substitutions. A recent study by Nan et al. demonstrated that piperidine ring 
substitutions in the 3-position do not display the characteristic behavior of piperidine ring 
substitutions in the 4-positions [122]. Note that pathway 3 involves the direct cleavage of the N-
phenylpropanamide moiety—with the absence of any evidence of any intermediate—through the 
loss of methylketene, as observed for pathway 5. Examples for pathway 3 include nominal m/z 
238 for sufentanil-d5 (Figure 5.4), nominal m/z 268 for alfentanil (Figure 5.7), and nominal m/z 
252 for 13C6-carfentanil (Figure 5.9).  
The FRCs analyzed in this study were substituted in the 4-position of the piperidine ring with 
either methoxymethylene or carboxymethylester functional groups. The methoxymethylene 
substituted compounds favored pathway 4 through the loss of methanol as observed for product 
ions at nominal m/z 385 for alfentanil (Figure 5.7) and nominal m/z 360 for sufentanil-d5 (Figure 
5.4). In comparison, the carboxymethylester substituted compounds, such as 13C6-carfentanil 
(Figure 5.9) demonstrated both the loss of methanol (i.e. m/z 369) and the loss of methyl formate 
(i.e. m/z 341). This fragmentation behavior may be specific to carboxymethylester compounds, 
which would provide an additional method of the identification of carboxymethylester substituted 
novel FRCs. The position of the double bond in the piperidine ring of pathway 4 is specific to the 
compounds analyzed in this study, and the position is likely to change depending on the position 





The fragmentation pathways for FRCs with substitution to the alkyl chain (R4) are controlled 
by the composition of the substitution at R4. For example, pathway 1 in Figure 5.10 is the dominant 
fragmentation pathway for FRCs with a hydroxyl group at location R4, as seen by the peak at m/z 
346 for β-hydroxythiolfentanyl-d5 (Figure 5.5). In contrast, pathway 2 is favored with R4 as an 
aliphatic substitution on the α-carbon, as visualized by the product ion at m/z 233 for α-
methylfentanyl (Figure 5.8). Despite the presence of an R4 functional group to provide additional 
fragmentation products to the tandem mass spectrum of a FRC, certain product ions—such as those 
at m/z 119 and m/z 91, which form through secondary and tertiary fragmentation along pathway 
5—are far more dominant than any of the fragments of pathway 2, including the primary product 
ion at m/z 233 for α-methylfentanyl in Figure 5.8. The product ions at m/z 119 and m/z 91 for α-
methylfentanyl (Figure 5.8) were confirmed to derive mainly through pathway 5 using MS3 of the 
various primary product ions for α-methylfentanyl. In summary, the presence of aliphatic groups 
on the alpha carbon (R4) enable the observation of products through pathways 1 and 2, but these 
fragments are typically minor relative to the consecutive fragments of other pathways. 
As demonstrated in the last example for α-methylfentanyl, the abundance of a primary 
fragment ion of a pathway is not the only, or the most reliable, measure of the favorability of a 
fragmentation pathway. Instead, to determine the relative favorability of a pathway, we relied on 
MS3 spectra to determine the most abundant consecutive fragments of a pathway, and we used the 
sum of the product ion abundances of each spectrum to assess the relative favorability of each 
fragment. Therefore, although the abundance of a high mass primary product ion like m/z 233 for 
pathway 2 for α-methylfentanyl might not increase much when its formation is favored by the 
methyl group, the low mass consecutive fragments that derive from it, such as m/z 84, do show a 





Pathway 8 occurs through the loss of the substitution or a portion of the substitution to location 
R5. Examples of this pathway include m/z 250 for β-hydroxythiolfentanyl-d5 (Figure 5.5) wherein 
the whole R5 substitution is lost and m/z 314 for alfentanil (Figure 5.7), which demonstrates the 
loss of only a portion of the tetrazole substituent.  
Table 5.1 provides a summary of the five most abundant product ions in the MS2 spectra of 
the [M+H]+ protonated precursor for the 16 FRCs analyzed in this study. The table contains both 
LIT data and Q-TOF data, and the peaks are ordered according to their decreasing relative 
abundance. Whereas the five most abundant peaks contain a great deal of overlap between the two 
instruments, the Q-TOF product ion spectra often contain more abundant ions with lower m/z 
values relative to the LIT data. These abundances stem from the differences in activation 
timescales and energies between the two instruments, and the knowledge that beam-type CID in 
the Q-TOF instrument provides more rapid and higher energy activation, which ultimately 














Table 5.1. Protonated precursor ion mass-to-charge values and five most abundant product ions 
in decreasing order of relative abundance for each compound in this study with the LIT and Q-
TOF instruments. 
Compound [M+H]+ LIT product ions 
(m/z) @30% NCE 
Q-TOF product ions (m/z) 
@25 eV 
4-ANPP m/z 281 
1885#, 1345#, 1055#, 
1465#, 1205# 
105.075#, 188.145#, 134.095#, 
146.095#, 84.08 
Fentanyl m/z 337 




Fentanyl-d5 m/z 342 
1885#, 2865, 2216, 
1055#, 1465# 
188.145#, 105.075#, 221.166, 
134.095#, 146.095# 
Ortho-methylfentanyl m/z 351 
1885#, 2306, 1465/6#, 
2955, 1055# 
188.145#, 105.075#, 146.095/6#, 
230.156, 134.095# 
Meta-methylfentanyl m/z 351 
1885#, 2306, 2955, 
1055#, 1465/6# 
188.145#, 105.075#, 146.095/6#, 
134.095#, 230.156 
Cyclopropylfentanyl m/z 349 
1885#, 2815, 2286, 
1055#, 1465# 
188.145#, 105.075#, 69.03, 
134.095#, 228.136 
Crotonylfentanyl m/z 349 
1885#, 2815, 2286, 
1055#, 1465# 





1885#, 2606, 3115, 
1465#, 1345# 
188.145#, 105.075#, 134.095#, 
260.166, 162.096# 
Methoxyacetylfentanyl m/z 353 
1885, 1055#, 2067#, 
2326, 1465# 
188.145, 105.075#, 134.095#, 
146.095#, 84.08 
α-methylfentanyl m/z 351 
2025#, 2166, 1195#, 
2332, 2955 
202.155#, 91.055#, 119.085#, 
84.08, 216.136 
β-hydroxythiolfentanyl-d5 m/z 364 
3461, 2508, 2861#, 
1921#, 2071# 
192.081#, 97.01, 346.191, 
147.101#, 111.02 
13C6-para-fluorofentanyl m/z 361 
1945#, 2346, 3055, 
1115#, 1525# 
194.165#, 111.095#, 140.115#, 
234.126, 152.115# 
13C6-carfentanil m/z 401 
3694, 3414, 2525#, 
2205#, 2854# 
113.065#, 252.165#, 341.234, 
140.115#, 285.204# 
Alfentanil m/z 401 
2683, 3854, 1973#, 
1703#, 2363# 
197.123#, 314.184#, 268.173, 
165.103/4#, 170.103# 
Furanylfentanyl m/z 375 
1883, 1463#, 2546, 
2287#, 1343# 
188.143, 105.073#, 146.093#, 
134.093#, 84.08 
Sufentanil-d5 m/z 392 
2383, 3604, 1403#, 
2064#, 2948 
238.123, 111.023/4#, 360.214, 
140.103#, 206.094# 
*superscripts correspond with the primary product ion pathway from Scheme 1. 
# indicates secondary or tertiary fragmentation from the indicated primary product ion in 
Scheme 1. 
 
Table 5.1 emphasizes the following important FRC behaviors: 1) the five most abundant 
product ions in the tandem mass spectra are most often either the primary product ions identified 





are relatively conserved between the trapping (LIT) and beam-type (Q-TOF) mass spectrometers, 
and 3) If one takes into account the mass of the functional groups, the most abundant pathways 
and fragments are generally conserved between FRCs. For example, the base peak at m/z 188 for 
the first 9 compounds in the table follow pathway 5. The same pathway forms the base peak at m/z 
202 for α-methyl fentanyl and m/z 194 for 13C6-para-fluorofentanyl, for example. There are also 
several situations where product ions can be formed through two competing pathways, such as the 
product ion at m/z 111 for sufentanil-d5 through pathways 3 and 4. The real impact of this 
knowledge is that the product ions formed from ESI-MS/MS can be used to identify the mass and 
location of substitutions based on shifts in mass due to the additional substituent. However, we 
recognize that the use of this knowledge currently requires extensive manual interpretations, and 
that most practitioners will struggle to apply these general trends. The toxicology and seized drug 
communities could benefit from an automated spectral similarity search, similar to the HSS 
algorithm for EI spectra [92] that was applicable to tandem mass spectra of protonated FRCs. Until 
then, analysts will have to rely on manual interpretations following a generalized set of rules—
such as those proposed here—to identify emerging FRCs.  
5.4 Conclusions 
The combination of isotopic labeling, MSn, and accurate mass measurements with HRMS was 
used to develop general rules for the fragmentation of fentanyl analogs and the identification of 
substitutions to the core fentanyl structure. A series of 16 FRCs with substitutions at five common 
locations to the core fentanyl structure was used to identify general fragmentation pathways and 
their propensity to direct fragmentation down particular pathways. The identification of primary 
product ions for FRCs substituted at each of the five locations of substitution as well as the relative 





provides guidance to the forensic community about how to identify the location of substitution for 
FRCs that is applicable across different MS platforms. Finally, the identification of the conserved 
fragmentation pathways, when accounting for differences in the mass and location of the 
substituent for FRCs, provides an additional tool for the identification of novel FRCs to 





















Chapter 6: Comparison of in-source collision-induced dissociation and beam-type collision-
induced dissociation of synthetic cathinones and fentanyl analogs using a high-resolution 
quadrupole time-of-flight (Q-TOF) mass spectrometer 
6.1 Introduction 
Electron ionization mass spectrometry (EI-MS) is an invaluable tool for the structural 
identification of unknown organic compounds such as drugs and drug metabolites [128, 129]. In 
particular, the generation of mass spectral databases based on standardized ionization conditions 
with 70 eV electrons permits remarkable consistency and reproducibility in the spectra collected 
on different instruments and by different vendors [129]. However, the EI-MS spectra of many 
organic compounds, such as synthetic cathinones and fentanyl analogs, do not contain abundant 
molecular ions, which are incredibly helpful for determining the molecular weight of an unknown 
[15, 91]. An approach to solve this issue is the application of soft ionization sources, like 
electrospray ionization (ESI), which results in little to no fragmentation of the [M+H]+ pseudo-
molecular ions. When used in combination with tandem mass spectrometry (MS/MS), ESI-
MS/MS is capable of obtaining both the molecular weight information and structurally informative 
fragments to help identify compounds and distinguish isobaric and isomeric ions [125, 130].  
Tandem mass spectrometry has traditionally involved collisional activation of an isolated 
precursor ion with a neutral bath gas, commonly termed collision-induced dissociation (CID) 
[125]. The process of CID for beam-type instruments involves 10s-100s of collisions with a neutral 
gas like nitrogen or argon as the precursor ion passes through the collision cell. In contrast, CID 
in trapping-type instruments involves 100s of collisions between the stored precursor and the 
neutral bath gas, which is typically helium [51, 127]. Trapping-type CID therefore tends to 





include a collision cell or ion trap, so in-source CID has evolved as a way to accomplish CID in 
the absence of tandem-MS capabilities. In-source CID is achieved by manipulating the 
acceleration voltages as ions transition from the atmospheric pressure ionization source to the high 
vacuum of the mass analyzer. Manipulation of these voltages causes ions to undergo energetic 
collisions with residual background gases and, ultimately, fragment. Collision conditions for in-
source CID are usually at energies up to hundreds of eV and at pressures on the order of 1 mbar 
[127].  
In-source CID has proven to be successful with the fragmentation of a variety of 
macromolecules, including multiply charged peptides [131, 132], porphyrins [133] and 
cytochrome c [134] and smaller molecules such as opiates [135], synthetic cathinones [136] and 
fentanyl analogs [119]. In-source CID has many monikers, including nozzle/skimmer activation 
[131, 134], ESI-CID, up-front CID, and transport-region CID [129]. Such is the prominence and 
reliability of in-source CID that mass spectral libraries now exist to assist with the identification 
of unknowns [137]. The in-source CID libraries usually contain spectra at three different 
acceleration voltages or at an average of one high and one low acceleration voltage [137]. 
One widely used instrumental setup for in-source CID is the combination of direct analysis in 
real time (DART) with high-resolution mass spectrometry (HRMS), such as time-of-flight (TOF) 
mass spectrometers [138, 139]. DART is a rapid, non-contact, ambient ionization technique that 
produces ions through gas-phase reactions of hot gas effluent from an atmospheric corona-to-glow 
discharge with reagent molecules and polar or nonpolar analytes [140, 141]. The most common 
applications of DART-TOF with in-source CID are for the analysis of drugs, including synthetic 
cathinones [32, 136, 142, 143], opioids [144], cannabinoids [145], stimulants [146], and botanicals 





from the pseudo-molecular ion and structural information from the in-source CID [149, 150]. In-
source CID can also be employed on quadrupole time-of-flight (Q-TOF) instruments to enable 
product ion isolation and CID-TOF analysis to achieve pseudo-MS3 [37]. 
Whereas the use of in-source CID with HRMS has become widely accepted within the drug 
screening community, there is a void in the literature for the comparison between in-source CID 
and conventional beam-type CID. Power et al. examined the similarity between trapping-type CID 
spectra on an LTQ/Orbitrap instrument and in-source CID spectra collected with a single 
quadrupole [32]. However, their study isn’t an apples-to-apples comparison because the mass 
analyzers were drastically different and might have different mass biases. For example, when 
comparing the spectra of in-source CID of five compounds on six different instruments, Bristow 
et al. noted that the geometry of the ionization source has noticeable effects on the degree of 
fragmentation and product ion distributions [151]. For the purpose of the present study, we kept 
the ESI source geometry and conditions constant and the TOF detection settings constant. The 
only variable was whether the ions were fragmented using in-source CID or beam-type CID. 
Although we have made some comparisons between in-source CID of ESI- and DART-generated 
precursor ions, those results are beyond the scope of the current work.  
The goal of this study is to qualitatively analyze the product ion spectra generated with in-
source CID and beam-type CID for a series of fentanyl analogs and synthetic cathinones that have 
been previously well characterized [106, 152]. The Q-TOF mass spectrometer allows simultaneous 
collection of full scan (containing in-source CID product ions) and beam-type CID product ion 
spectra, thereby allowing the comparison of mass spectra generated under conditions as similar as 
possible [138]. Understanding the relationship between these two commonly employed 





beam-type CID studies to be applied to in-source CID spectra. Finally, this study provides insight 
into the benefits and drawbacks of in-source CID relative to beam-type CID and the implications 
for forensic practitioners.  
6.2 Methods 
 Sample Preparation 
Four N-alkylated synthetic cathinones and two fentanyl analog standards were purchased 
through Cerilliant (Round Rock, TX, USA) including: methcathinone-d3 (N-alkyl deuterated), 
diethylpropion-d10 (N-alkyl deuterated), pentylone-d3 (N-alkyl deuterated), dibutylone-d3 (alkyl 
deuterated), alfentanil, and furanylfentanyl. Two additional fentanyl analogs were purchased 
through Cayman Chemical (Ann Arbor, MI, USA) including: ortho-methylfentanyl, and β-
hydroxythiolfentanyl-d5 (perdeuterated on the amide). The synthetic cathinones were chosen based 
on the desire to have varying molecular weights and both 2° and 3° amines. The fentanyl analogs 
were chosen to represent analogs with substitutions on different positions of core fentanyl 
structure, consistent with our previous work on the influence of chemical modifications on the 
fragmentation behavior of fentanyl analogs [106]. All standards were prepared in a solution of 
49% HPLC grade methanol, 49% distilled water, and 2% acetic acid to a final concentration of 
approximately 100 ppm. The HPLC grade methanol was supplied by Fisher Scientific (Palo Alto, 
CA, USA) and the acetic acid was supplied by Acros Organics (Palo Alto, CA, USA). 
 Instrumentation 
6.2.2.1 Agilent Technologies 6538 UHD Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) 
A dual ESI source was operated with a spray voltage of 3,500 V and a 300 °C nitrogen drying 





skimmer setting of 65 V and fragmentor settings of varying from 95 V to 300 V to produce a range 
of in-source CID spectra. Likewise, the collision energy used for the beam-type CID portion of 
this study was varied from 15 to 35 eV to providing a range of beam-type CID spectra. All beam-
type CID spectra were collected with an isolation width of 1.3 Da and the scan range was from 
m/z 50 to a value that exceeded the molecular mass by ~50 Da. Ultra-pure nitrogen was used for 
the collision gas purchased through Matheson Tri-Gas (Fairmont, WV, USA).  
6.2.2.2 Thermo Scientific Velos Pro Linear Ion Trap (LIT) 
Supporting trapping-type CID experiments were also collected using a Thermo Scientific 
Velos Pro linear ion trap (LIT) mass spectrometer with a heated-electrospray ionization (HESI) 
source at 50 °C. The spray voltage was 4,000 V with the nitrogen sheath gas flow set to 8 arbitrary 
units and the nitrogen auxiliary flow set to 5 arbitrary units. The mass spectrometer capillary 
temperature was set to 275 °C. The scan range and normalized collision energy (NCE) were 
specific for each compound and are labeled with each mass spectrum. The bath gas was ultra-pure 
helium from Matheson TRIGAS (Fairmont, WV, USA). 
 Data Analysis 
MassHunter Qualitative Analysis B.05.00 was used for the Agilent Q-TOF data analysis. 
Microsoft Excel version 14 (Microsoft, Redmond, WA, USA) was used for the mass spectral plots 






6.3 Results and Discussiom 
 Fentanyl Analogs 
Figure 6.1 shows a comparison between beam-type CID and in-source CID spectra for ortho-
methylfentanyl. The beam-type CID spectrum (Figure 6.1a) was collected with a collision energy 
of 25 eV, a skimmer setting of 65 V and fragmentor setting of 250 V. In contrast, the in-source 
CID spectra were collected with a collision energy of 0 eV, a skimmer setting of 65 V and 
fragmentor settings of 175 V (Figure 6.1b) and 300 V (Figure 6.1c). The [M+H]+ protonated 
precursor for ortho-methylfentanyl, C23H31N2O
+, is observed at m/z 351.2437 (expected at m/z 
351.2436; <1 ppm error) in Figure 6.1a. A sodiated adduct ([M+Na]+, NaC23H30N2O
+) is also 
evident at m/z 373.2273 (expected at m/z 373.2255; 5 ppm error) in Figures 6.1b and 6.1c. Figure 
6.1a shows the beam-type CID spectrum with product ions at m/z 230.1590 (C15H20NO
+
 expected 
at m/z 230.1544; 20 ppm error), m/z 188.1483 (C13H18N
+ expected at m/z 188.1439; 23 ppm error), 
m/z 146.0990 (C10H12N
+ expected at m/z 146.0969; 14 ppm error), m/z 134.0983 (C9H12N
+ 
expected at m/z 134.0969; 10 ppm error) and m/z 105.0718 (C8H9
+ expected at m/z 105.0704; 13 
ppm error), which is consistent with our previous work [106]. For ortho-methylfentanyl, all of the 
product ions formed in beam-type CID are found in the in-source CID spectrum, but the reverse is 
not true. The in-source CID spectrum shows a phenylium peak at m/z 77.0417 that is negligible in 
the beam-type CID spectrum. The phenylium ion at m/z 77.0417 either derives from a higher 
energy direct cleavage of the precursor or from a simple neutral loss of C2H4 from the phenylethyl 
ion at m/z 105.0718.  
The fragmentor setting of 175 V in Figure 6.1b provided inefficient fragmentation and weak 
product ion signals. Low-abundance in-source CID product ions are observed at m/z 188.1483 for 
C13H18N
+ (expected at m/z 188.1439; 23 ppm error) and m/z 105.0718 for C8H9





105.0704; 13 ppm error). The phenethylpiperidine ion expected at m/z 188.1439 has been 
described extensively for fentanyl, including the presence of isobaric species formed through the 
loss of the N-phenylpropanamide moiety directly or through the loss of methylketene followed by 
the loss of aniline [97, 121].  
The presence of the phenethylpiperidine ion at m/z 188.1483 and the phenylethyl ion at m/z 
105.0718 are consistent with previous literature on in-source CID of fentanyl and fentanyl analogs 
[119]. The actual structure of the fragment at m/z 105.0718 could also be a methyl-tropylium or 
phenonium ion [153]. The ion at m/z 98.9782 in Figure 6.1b has a negative mass defect that is not 
consistent with any viable fragment of ortho-methylfentanyl and must therefore derive from an 
impurity or background contamination. The same ion was observed in other full-scan and low 
energy in-source CID spectra, and the most reasonable identity—based on the likelihood of 
occurrence and accurate mass—is H3SO4
+ (expected at m/z 98.9747; 35 ppm error). However, the 
chemical identity of the ion at m/z 98.9782 has not been confirmed. 
In contrast to the low energy in-source CID spectrum in Figure 6.1b, the higher energy in-
source CID spectrum in Figure 6.1c provides more abundant low mass ions, including the readily 
observed phenylium product ion, C6H5
+, at m/z 77.0417 (expected at m/z 77.0391; 34 ppm error). 
As expected, larger fragmentor voltages enhanced the fragmentation efficiencies and decreased 












Figure 6.1. Comparison of beam-type CID (top) and in-source CID (middle and bottom) for 
protonated ortho-methylfentanyl. For all spectra, the skimmer setting was held at 65 V. For 
beam-type CID, the fragmentor setting was 250 V with a collision energy of 25 eV. For in-
source CID, the fragmentor settings were 175 V and 300 V, for b) and c), respectively with the 
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The [M+H]+ protonated precursor of furanylfentanyl, C24H27N2O2
+, is observed at m/z 
375.2134, (expected at m/z 375.2072; 16 ppm error) in Figure 6.2. A sodiated adduct ([M+Na]+, 
NaC24H26N2O2
+) is also evident at m/z 397.1914 (expected at m/z 397.1891; 6 ppm error) in 
Figures 6.2b and 6.2c. Figure 6.2a is the beam-type CID spectrum collected with a collision 
energy of 25 eV, fragmentor setting of 250 V and skimmer setting of 65 V. In contrast to Figure 
6.1, the observed product ion distribution is noticeably absent of any intermediate of significant 
abundance between the precursor ion and the phenethylpiperidine ion at m/z 188.1471. At higher 
energies, the electron-withdrawing characteristics of the furyl group for furanylfentanyl tend to 
favor the direct loss of the N-phenylalkylamide moiety and drive facile secondary fragmentation 
[106]. The product ions at m/z 188.1471 (C13H18N
+, expected at m/z 188.1439; 17 ppm error), m/z 
146.1001 (C10H12N
+ expected at m/z 146.0969; 22 ppm error), m/z 134.1000 (C9H12N
+ expected 
at m/z 134.0969; 24 ppm error) and m/z 105.0713 (C8H9
+expected at m/z 105.0704; 9 ppm error) 
are consistent with the previous literature [94, 97, 105]. 
In contrast, Figures 6.2b and 6.2c show in-source CID generated mass spectra collected with 
a collision energy of 0 eV, a skimmer setting of 65 V and fragmentor setting of 165 V and 285 V, 
respectively. Figure 6.2b provides a low abundance of product ions because the fragmentor offset 
is too low to achieve efficient CID. The poor spectrum shows that it is difficult or impossible to 
obtain low-energy in-source CID spectra with acceptable CID efficiencies. The presence of the 
phenethylpiperidine ion, C13H18N
+, at m/z 188.1471 (expected at m/z 188.1439; 17 ppm error) and 
phenylethyl (or phenonium or methyl-tropylium ion [153]), C8H9
+, at m/z 105.0713 (expected at 
m/z 105.0704; 9 ppm error) has been reported previously in literature for furanylfentanyl [154]. 
As the fragmentor voltage is increased, the low-mass product ions increase in abundance relative 





One notable difference between the in-source CID spectrum and beam-type CID spectrum of 
furanylfentanyl is the abundance of the phenylium ion at m/z 77.0391 for beam-type CID, which, 
as discussed above, could be a higher energy direct cleavage product or a consecutive fragment. 
The accurate mass measurements indicate that the elemental composition at m/z 105.0713 is C8H9
+, 
which is consistent with a phenylethyl (or methyl-tropylium or phenonium ion [153]) structure 
from the N-phenylethyl group on the piperidine nitrogen. The expected pathway to the phenylethyl 
cation is through the charge-directed α-cleavage of the phenylethyl group from the 1-(2-


















Figure 6.2. Comparison of beam-type CID (top) and in-source CID (middle and bottom) for 
protonated furanylfentanyl. For all spectra, the skimmer setting was held at 65 V. For beam-type 
CID, the fragmentor setting was 225 V with a collision energy of 25 eV. For in-source CID, the 
fragmentor settings were 165 V and 285 V, for b) and c), respectively with the collision energy 
set to 0 eV.  
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Figure 6.3 shows a comparison between the beam-type CID spectra and in-source CID 
spectrum for alfentanil collected at different collision energies. Figures 6.3a and 6.3b were 
collected with collision energies of 15 eV and 25 eV, respectively. Given the product ion 
distribution and the pattern and extent of in-source CID fragmentation in Figure 6.3c, in-source 
CID collected with a collision energy of 0 eV, a skimmer setting of 65 V and a fragmentor setting 
of 285 V appears to produce similar product ion spectra to beam-type CID with collision energies 
between 15-25 eV (Figure 6.3a & 6.3b). Under the in-source CID conditions there is a wealth of 
product ion information in addition to the presence of the [M+H]+ protonated precursor, 
C21H33N6O3
+, at m/z 417.2628 (expected at m/z 417.2614; 3 ppm error) and the [M+Na]+ precursor, 
NaC21H32N6O3
+, at m/z 439.2480 (expected at m/z 439.2433; 11 ppm error). The major in-source 
CID generated product ions at m/z 385.2381 (C20H29N6O2
+ expected at m/z 385.2351; 8 ppm error), 
m/z 314.1892 (C18H24N3O2
+ expected at m/z 314.1868; 7 ppm error), m/z 268.1831 (C12H22N5O2
+ 
expected at m/z 268.1773; 22 ppm error), m/z 197.1296 (C10H17N2O2
+ expected at m/z 197.1290; 
3 ppm error) and m/z 165.1064 (C9H13N2O
+ expected at m/z 165.1027; 23 ppm error) are all in 
agreement with the beam-type CID spectra. The observed product ions are consistent with previous 
literature for substitution at the 4-position of the pipiderine ring, as seen by the neutral losses of 









Figure 6.3. Comparison of beam-type CID (top and middle) and in-source CID (bottom) for 
protonated alfentanil. For all spectra, the skimmer setting was held at 65 V. For beam-type CID, 
the fragmentor setting was 225 V with collision energies of 15 eV and 25 eV for panels a) and 
b), respectively. For in-source CID, the fragmentor setting was 285 V with a collision energy of 
0 eV.  
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Figure 6.4 compares spectra from beam-type CID and in-source CID of β-
hydroxythiolfentanyl-d5. The beam-type CID spectra in Figures 6.4a and 6.4b were collected with 
a skimmer setting of 65 V, a fragmentor setting of 225 V and collision energies of 15 eV and 25 
eV, respectively. As is typical for both beam-type and in-source CID, the product ion distribution 
shifts towards lower masses at higher collision energies (Figure 6.4b) relative to lower collision 
energies (Figure 6.4a) because of sequential neutral losses and access to pathways with higher 
dissociation energies. The base peak of Figure 6.4a is m/z 346.2021, which is consistent with the 
neutral loss of H2O from the [M+H]
+ protonated precursor. This intermediate ion at m/z 346.2021 
fragments into the products at m/z 286.1511 and m/z 192.0895, which have been described 
previously [106]. 
The in-source CID spectrum (Figure 6.4c) was collected with a collision energy of 0 eV, a 
skimmer setting of 65 V and a fragmentor setting of 285 V. Figure 6.4c contains both the [M+H]+ 
protonated precursor, C20H22D5N2O2S
+, at m/z 364.2114 (expected at m/z 364.2102; 3 ppm error) 
and the [M+Na]+ precursor, NaC20H21D5N2O2S
+, at m/z 386.1955 (expected at m/z 386.1921; 9 
ppm error). The fragmentor setting of 285 V provides sufficient collisional activation to generate 
multiple diagnostic product ions, including m/z 346.2021 for C20H20D5N2OS
+ (expected at m/z 
346.1996; 7 ppm error), m/z 286.1511 for C17H20DN2S
+ (expected at m/z 286.1487; 8 ppm error), 
m/z 210.0982 for C11H16NOS
+ (expected at m/z 210.0952; 14 ppm error), m/z 192.0895 for 
C11H14D5NS
+ (expected at m/z 192.0846; 26 ppm error), m/z 111.0295 for C6H7S
+ (expected at m/z 
111.0268; 23 ppm error) and m/z 97.0135 for C5H5S









      
  
Figure 6.4. Comparison of beam-type CID (top and middle) and in-source CID (bottom)for 
protonated β-hydroxythiolfentanyl-d5. For all spectra, the skimmer setting was held at 65 V. For 
beam-type CID, the fragmentor setting was 225 V with collision energies of 15 eV and 25 eV, 
for a) and b), respectively. For in-source CID, the fragmentor settings was 285 V with a collision 
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 Discussion of Fentanyl Analogs 
The comparison between in-source CID and beam-type CID for fentanyl analogs reveals a 
great deal of similarity between the observed product ion spectra. In general, the abundant product 
ions are conserved between the two activation techniques, and there is general agreement between 
the spectra. A careful assessment also reveals that the in-source CID spectra tend to be noisier 
relative to the beam-type CID spectra, and that there are usually distinguishable differences in the 
relative abundance of selected product ions, which is observed as both ion drop-in and ion drop-
out. For example, the in-source CID spectrum of ortho-methylfentanyl in Figure 6.1b shows the 
presence of a product ion at m/z 98.9782 that is not present in the beam-type CID spectrum in 
Figure 6.1a. We interpret this observation to imply that m/z 98.9782 must arise from an alternative 
precursor than ortho-methylfentanyl because there are no reported pathways to this fragment mass 
in the literature. Furthermore, the product ion at m/z 98.9782 is not present in the higher energy 
in-source CID spectrum (Figure 6.1c), which indicates that the ion has probably undergone 
collisional activation in Figure 6.1c. Such observations are significant because the fentanyl 
analogs in this study were standards and thus have minimal background interferences, unlike 
casework samples that would contain mixtures of drugs, cutting agents, adulterants or complex 
biological matrices.  
When comparing in-source CID and beam-type CID in Figures 6.1-6.3, subtle differences in 
the relative abundance of peaks with comparable m/z values indicate fundamental differences in 
internal energy deposition rates rather than mass bias or other effects if the peaks were spaced 
further apart. For example, the in-source CID spectrum of alfentanil (Figure 6.3c) shows a peak 
at m/z 170.1061 (expected at m/z 170.1042 for C6H12N5O
+; 12 ppm error) that is only ~20% the 
abundance of the fragment at m/z 165.1064 (expected at m/z 165.1027 for C9H13N2O
+; 22 ppm 





is ~80% the abundance of the peak at m/z 165.1064. In contrast, the lower energy spectrum in 
Figure 6.3a—with a collision energy of 15 eV—provides a peak at m/z 170.1061 that is 130% the 
abundance than the peak at m/z 165.1064. In the slow heating conditions of trapping-type CID, the 
same peak at m/z 170 was ~140% the abundance of the peak at m/z 165 [106]. The ratio of 
abundances at m/z 165:170 therefore varies from ~0.75:1 for in trapping-based CID and low-
energy beam-type CID to 1.25:1 at higher energy beam-type CID and ~5:1 for in-source CID. 
Based on MSn data collected on the LIT, the product ions at m/z 170 and m/z 165 form via 
consecutive neutral losses through several different fragmentation pathways, including the 
abundant intermediate ion at m/z 268, which is formed through the loss of neutral N-
phenylpropanamide from the protonated precursor. From the intermediate ion at m/z 268, the 
product ion at m/z 165 forms through the loss of C2H5N3 (i.e. m/z 197) followed by the loss of 
methanol, whereas the product ion at m/z 170 forms through the loss of C6H10O from a piperidine 
ring cleavage. The abundance of m/z 165 correlates with the abundance of its precursor at m/z 197, 
with both product ions (m/z 165 and m/z 197) gaining prominence at elevated CID energies in 
beam-type CID (Figure 6.3b) relative to trapping-type CID [106]. Based on the comparison 
between in-source CID (Figure 6.3c), beam-type CID (Figures 6.3a and 6.3b) and trapping-type 
CID [106], in-source CID provides the greatest relative abundance of peaks at m/z 165 and 197. 
Because the relative energies and activation barriers for these pathways are not known, we can 
only speculate that the product ion at m/z 170 has a lower activation barrier than m/z 165.  
In the slow heating conditions of trapping-type CID of β-hydroxythiolfentanyl-d5, the peak at 
m/z 207 was slightly more abundant than the peak at m/z 210 [106]. The beam-type CID spectra 
in Figures 6.4a and 6.4b provide an accurate mass of m/z 207.1540 (expected at m/z 207.1540 
for C13H11D5NO





loss of the hydroxymethylthiol to form the intermediate at m/z 250 followed by the loss of a 
C2NH5 neutral from the piperidine ring or through the loss of H2O, followed by the loss of the 
deuterated N-phenylpropanamide moiety. These pathways were confirmed in MS3 experiments 
with the ion trap [106]. In contrast to consecutive low-energy rearrangements leading to m/z 
207.1540, the product ion at m/z 210.0982 has an elemental composition C11H16NOS
+ (expected 
at m/z 210.0952; 14 ppm error), and forms via cleavage between the aniline nitrogen and the 
piperidine ring in a single step, so is probably kinetically favored. The beam-type CID spectra 
show similar abundances for the two product ions at m/z 207.1540 and m/z 210.0982, whereas 
the in-source CID spectrum in Figure 6.4a shows that the peak at m/z 210.0982 is considerably 
more abundant (by a factor of ~7x). Again, these findings show that the in-source CID spectrum 
in Figure 4a provides more rapid heating and kinetically-favored single-cleavage product ions 
relative to beam-type CID experiments or the trapping-type CID experiments of our previous 
work [33]. 
 Synthetic Cathinones 
Figure 6.5 shows the product ion spectra for methcathinone-d3 collected with beam-type CID 
and in-source CID. The perdeuterated methyl group is in the N-alkyl position. Methcathionone-d3 
is a 2° amine, N-alkylated, synthetic cathinone and has a relatively small molecular weight 
compared to other cathinones and fentanyl analogs. The beam-type CID in Figure 6.5a was 
collected with a collision energy of 25 eV, a skimmer setting of 65 V and a fragmentor setting of 
175 V. The in-source CID spectra were collected with a collision energy of 0 eV, a skimmer setting 
of 65 V and fragmentor settings of 175 V (Figure 6.5b) and 255 V (Figure 6.5c), respectively. 
Figure 6.5b shows the dominant loss of H2O observed at m/z 149.1160 (C10H9D3N
+ expected at 






expected at m/z 167.1260; 21 ppm error). This fragmentation behavior is consistent with previous 
literature for N-alkylated synthetic cathinones [15, 17, 28, 36, 77]. Note that, unlike the fentanyl 
analogs, neither methcathinone-d3, nor any of the other synthetic cathinones show sodiated adducts 
([M+Na]+) in the full scan mass spectra. The lack of sodiation likely is related to the relative 
sodium affinity of synthetic cathinones relative to fentanyl analogs, but could also be related to 
differences in the sodium impurities of the purchased standards.  
Figure 6.5c shows that, at higher acceleration potentials of in-source CID, the product ion 
distribution shifts towards lower masses, likely because the smaller ions are thermodynamically 
less stable than large ions and have higher dissociation thresholds. The ions at smaller m/z values 
could also derive from multiple neutral losses. The major product ions observed from beam-type 
CID are consistent with the major product ions observed for in-source CID, including product ions 
at m/z 149.1160 for C10H9D3N
+ (expected at m/z 149.1154; 4 ppm error), m/z 134.0960 for 
C9H6D3N
+ (expected at m/z 134.0920; 30 ppm error), m/z 131.0744 for C9H9N
+ (expected at m/z 
131.0734; 8 ppm error) and m/z 105.0713 for C8H9
+ (expected at m/z 105.0704; 9 ppm error). Two 
product ions of note are m/z 134.0920 and m/z 131.0744, which are formed through the loss of a 
radical methyl group (˙CH3) from the aliphatic chain and a radical deuterated methyl group (˙CD3) 
from the N-alkyl chain, respectively. The presence of even-electron intermediates fragmenting into 
odd-electron product ions has been reported before for N-alkylated synthetic cathinones [36, 37, 
152].  
Similar to the fentanyl analogs, the in-source CID spectra and beam-type CID spectra 
occasionally show significant differences in relative ion abundances for peaks that are close 
together and therefore these differences in abundance are not caused by mass bias. For example, 





~39% more abundant than the peak at m/z 130.0670. However, although the higher energy in-
source CID spectrum in Figure 6.5c shares overall spectral similarity with the beam-type CID 
spectrum, the relative abundance of the peak at m/z 131.0744 is only ~50% the abundance of the 
peak at m/z 130.0670. Previous work indicates that the product ion at m/z 131.0744 is a distonic 
radical cation formed via the loss of the methyl group from the N-alkyl position [31, 34, 41]. 
Without the benefit of isotope labeling Bijlsma et al. assumed that the methyl radical was lost from 
the aliphatic chain [31]. However, per-deuteration on the N-methyl group shows that the 
intermediate at m/z 149.1160 can evidently lose either •CH3 (15 Da) from the aliphatic chain to 
form the product at m/z 134.0960 or •CD3 (18 Da) from the N-methyl position to form the product 
at m/z 131.0744 with approximately equal preference [34]. The formation of an alkylphenone at 
m/z 133.0960 through the loss of the N-methyl moiety is generally unfavorable in all the spectra, 
whereas the additional radical loss of •H (1 Da) from the distonic radical intermediate at m/z 
131.0744 to give the even-electron product ion at m/z 130.0670 is kinetically favored at higher 
















Figure 6.5. Comparison of beam-type CID (top) and in-source CID (middle and bottom) for 
protonated methcathinone-d3. For all spectra, the skimmer setting was held at 65 V. For beam-
type CID, the fragmentor setting was 175 V with a collision energy of 25 eV. For in-source CID, 
the fragmentor settings were 175 V and 255 V, for b) and c), respectively with the collision 
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Like methcathinone-d3, diethylpropion also has a relatively small molecular weight, but 
diethylpropion is a 3° amine, N-alkylated, synthetic cathinone. Figure 6.6 provides a comparison 
between beam-type CID and in-source CID with the beam-type CID collected at a collision energy 
of 25 eV and the in-source CID collected at a collision energy of 0 eV, a skimmer setting of 65 V 
and fragmentor settings of 225 V (Figure 6.6b) and 285 V (Figure 6.6c), respectively. The in-
source CID spectra reveal the conversion of the [M+H]+ protonated molecular ion at m/z 206.1578 
for C13H20NO
+ (expected at m/z 206.1544; 16 ppm error) to product ions at m/z 160.1157 for 
C11H14N
+ (expected at m/z 160.1126; 19 ppm error), m/z 133.0690 for C9H9O
+ (expected at m/z 
133.0653; 28 ppm error), m/z 105.0713 for C8H9
+ (expected at m/z 105.0704; 9 ppm error), m/z 
100.1164 for C6H14N
+ (expected at m/z 100.1126; 38 ppm error) and m/z 77.0397 for C6H5
+ 
(expected at m/z 77.0391; 8 ppm error), and the most abundant product ions at m/z 105.0713 and 
m/z 100.1126 are consistent with previous literature [155].  
The product ions at m/z 133.0690 and m/z 100.1164 are of particular importance because these 
product ions correspond with the formation of an alkylphenone and iminium cation, respectively. 
Our previous work with N-alkylated synthetic cathinones demonstrated that, whereas 2° amines 
favor the loss of water, 3° amines favor the formation of alkylphenones and a corresponding 
iminium counter ion [152]. The common phenylethyl ion at m/z 105.0713 and phenylium ion at 
m/z 77.0397 were also identified [34]. In general, the in-source CID product ions are in agreement 
with the beam-type CID product ions at a collision energy of 25 eV (Figure 6.6a). One exception 
is the presence of the product ion at m/z 72.0845, C4H10N
+ (expected at m/z 72.0813; 44 ppm error) 
in the beam-type CID spectrum, which arises through consecutive fragmentation from the 
intermediate at m/z 100.1164. One explanation for the low abundance at m/z 72 in the in-source 





sequential neutral losses. Another reason for the absence of m/z 72 in the in-source CID spectra 
could be due to instrumental discrimination against low mass ions at elevated fragmentor settings. 
In our experience, m/z 77 was the lowest mass product ion of any significant abundance from 
dozens of in-source CID spectra, even though the scan range started at m/z 50 in all cases and the 









Figure 6.6. Comparison of beam-type CID (top) and in-source CID (middle and bottom) for 
protonated diethylpropion. For all spectra, the skimmer setting was held at 65 V. For beam-type 
CID, the fragmentor setting was 225 V with a collision energy of 25 eV. For in-source CID, the 
fragmentor settings were 225 V and 285 V, for b) and c), respectively with the collision energy 
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Figure 6.7 shows the beam-type CID and in-source CID mass spectra for pentylone-d3, which 
is a relatively large molecular weight, 2° amine, N-alkylated, synthetic cathinone. Figure 6.7c 
shows the in-source CID mass spectrum, which was collected with a collision energy of 0 eV, 
skimmer setting of 65 V and a fragmentor setting of 255 V. Under these conditions, a significant 
portion of the [M+H]+ protonated precursor ion at m/z 239.1530 for C13H15D3NO3
+ (expected at 
m/z 239.1471; 25 ppm error) is converted to product ions through collisional activation. The 
common product ions observed in Figure 6.7c include: m/z 221.1395 for C13H13D3NO2
+ (expected 
at m/z 221.1366; 13 ppm error) m/z 191.1275 for C12H11D3NO
+ (expected at m/z 191.1260; 8 ppm 
error), m/z 178.0843 for C10H6D3NO2
+ (expected at m/z 178.0818; 14 ppm error), m/z 135.0465 
for C8H7O2
+ (expected at m/z 135.0446; 14 ppm error) and m/z 89.1171 for C5H9D3N
+ (expected 
at m/z 89.1154; 19 ppm error), among others. 
The product ions at m/z 221.1395 and m/z 178.0843 are formed through the loss of H2O and a 
propyl radical (˙C3H7), respectively. As mentioned above, the radical losses from even-electron 
precursors are commonly observed in tandem mass spectra of N-alkylated synthetic cathinones 
[36, 37, 152]. Likewise, the product ion at m/z 191.1275 occurs through the loss of formaldehyde 
(CH2O), which is typical for methylenedioxy-containing synthetic cathinones [15, 61, 75]. Finally, 
the product ions at m/z 135.0465 and m/z 89.1171 are consistent with the methylenedioxy-
substituted tropylium ion and the deuterated iminium ion. As the collision energy is increased from 
15eV in Figure 6.7a to 25eV in Figure 6.7b, the corresponding product ion spectrum shifts to 
lower mass ions through higher energy fragmentation events which allows for the generation of 
additional product ions, such as those at m/z 105.0359 for C7H5O
+ (expected at m/z 105.0340; 8 
ppm error) and m/z 77.0397 for C6H5
+ (expected at m/z 77.0391; 48 ppm error). As with the 





cleavage or via consecutive cleavages. Whereas a potential pathway for the fentanyl analogs was 
via the loss of C2H2 from the phenylethyl ion at m/z 105.0713, a potential intermediate for the 























Figure 6.7. Comparison of beam-type CID (top and middle) and in-source CID (bottom) for 
protonated pentylone-d3. For all spectra, the skimmer setting was held at 65 V. For beam-type 
CID, the fragmentor setting was 175 V with collision energies of 15 eV and 25 eV, for a) and 
b), respectively. For in-source CID, the fragmentor setting was 255 V with a collision energy of 
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Dibutylone-d3 has the same molecular mass as pentylone-d3 (238 g/mol), but dibutylone-d3 is 
a 3° amine, N-alkylated, synthetic cathinone. The in-source CID spectrum (Figure 6.8c), which 
was collected with a collision energy of 0 eV, a skimmer setting of 65 V and a fragmentor setting 
of 285 V reveals efficient conversion of the [M+H]+ protonated precursor at m/z 239.1519 
(C13H15D3NO3
+ expected at m/z 239.1471; 20 ppm error) to product ions. The product ions in 
Figure 6.8 include: m/z 194.0920 for C11H8D3O3
+ (expected at m/z 194.0893; 14 ppm error), m/z 
166.0993 for C10H8D3O2
+ (expected at m/z 166.0944; 30 ppm error), m/z 164.0822 for C10H6D3O2
+ 
(expected at m/z 164.0787; 21 ppm error), m/z 149.0262 for C8H5O3
+ (expected at m/z 149.0238; 
16 ppm error), 136.0866 for C9H6D3O
+ (expected at m/z 136.0842; 17 ppm error) 108.0929 for 
C8H6D3
+ (expected at m/z 108.0889; 37 ppm error) and m/z 89.1169 for C5H9D3N
+ (expected at 
m/z 89.1154; 19 ppm error).  
The product ion at m/z 194.0920 is formed through cleavage of the N-alkyl group, which is 
common for 3° amine, N-alkylated synthetic cathinones [152]. The product ion at m/z 164.0822 
results from the cleavage of formaldehyde (CH2O) from the intermediate at m/z 194.0920, and the 
product ion at m/z 149.0262 is the methylenedioxy-substituted benzoylium ion. The loss of 
formaldehyde from methylenedioxy substituted cathinones has been reported previously for both 
N-alkylated synthetic cathinones and α-pyrrolidinophenone synthetic cathinones [15, 75].  
Using MSn on the LIT, the intermediates at m/z 164.0822 and 166.0944 can continue to lose 
small neutrals to form product ions at m/z 136.0842 and 108.0929, which are much more prominent 
in the higher energy beam-type CID spectrum and in-source CID than the lower energy beam-type 
CID spectrum. There are no mechanisms to form these lower mass fragments via direct cleavages, 
so their presence can only be explained by sequential neutral losses. The presence of the low-





further support for the presence of a synthetic cathinone. However, this low energy product ion is 
lowest in abundance in the in-source CID spectrum because other pathways and sequential neutral 
losses become more competitive. The in-source CID spectrum in Figure 6.8c contains greater 
differences in product ion abundances relative to the beam-type CID spectra at a collision energy 
of 15eV in Figure 6.8a and at 25eV in Figure 6.8b than the other spectral comparisons. Still, from 
the perspective of drug identification, the most abundant product ions in the beam-type CID spectra 









Figure 6.8. Comparison of beam-type CID (top and middle) and in-source CID (bottom) and) 
for protonated dibutylone-d3. For all spectra, the skimmer setting was held at 65 V. For beam-
type CID, the fragmentor setting was 225 V with collision energies of 15 eV and 25 eV, for a) 
and b), respectively. For in-source CID, the fragmentor settings was 285 V with a collision 
energy of 0 eV.  
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 Discussion of Synthetic Cathinones 
Through the analysis of a series of N-alkylated synthetic cathinones, we have identified the 
general consistency between product ion spectra of in-source CID and beam-type CID on the same 
instrument with the same ion source. The compounds analyzed had a range of molecular weights 
and various degrees of substitution, including the presence of 2° and 3° amines, which are known 
to favor different pathways during tandem mass spectrometry [152]. Whereas in-source CID and 
beam-type CID spectra are generally similar in the distribution and types of product ions formed, 
the spectra can be distinguished based on subtle differences in relative ion abundances and by the 
fact that the in-source CID spectra typically provide increased noise and additional adducts relative 
to beam-type CID spectra. Differences between in-source CID spectra and beam-type CID spectra 
can be ascribed to four major factors: 1) in-source CID spectra can include ions from different 
precursor molecules; 2) in-source CID spectra can contain product ions from different adducts of 
the same precursor molecules; 3) in-source CID spectra appear to access kinetically favored, 
higher-energy fragmentation pathways; and 4) in-source CID spectra seem to suffer from 
discrimination against low-mass product ions in the region m/z 50-77. 
As examples of factors 1 and 2 above, the high energy in-source CID spectrum of 
methcathinone-d3 (255V, Figure 6.5c) shows an abundant product ion (peak drop-in) at m/z 
98.9781, which is absent from the lower energy in-source CID spectrum (175 V, Figure 6.5b) and 
the beam-type CID spectrum (Figure 6.5a). We assume that this fragment derives from a sulfuric 
acid impurity or from a precursor with a higher activation energy than methcathinone-d3. 
Supporting this hypothesis, the same product ion at m/z 98.9781 was observed in other in-source 
CID spectra, such as ortho-methylfentanyl (Figure 6.1b). The impurity could derive from a 
contaminant within the solvent, the residual gases, the sample container or the ionization source 





ion at m/z 79.0556 for C6H7
+ (expected at m/z 79.0547; 11 ppm error) in Figure 6.5a. This product 
ion is only present in the beam-type CID. The occurence of ion drop-in/drop-out is particularly 
tricky when dealing with more complex samples or matrices than the drug standards used in this 
study.  
The nature of in-source CID implies that the product ions generated through in-source CID 
arise not only from the analyte of interest but also from any compound present in the source during 
the in-source CID process. Practically, this means that the product ions present in the in-source 
CID product ion spectra are not exclusively derived from analyte of interest. This fundamental 
principle limits the applicability of in-source CID for the structural elucidation of unknown 
compounds; however, in-source CID has demonstrated moderate success with the differentiation 
of structurally similar compounds such as synthetic cathinones [32, 156], synthetic cannabinoids 
[145] and fentanyl analogs [119]. One approach to determine which product ions in an in-source 
CID spectrum derive from which precursor ions in a mixture is to use chemometrics [157]. In the 
absence of more-extensive validation, beam-type isolation and fragmentation will continue to be 
required for potential unequivocal differentiation of isomers and isobars [158]. 
Two approaches that have been applied in an attempt to overcome the downfalls of in-source 
CID are the combination of chromatography and the generation of instrument specific in-source 
CID mass spectral libraries [130]. Chromatography allows for the separation of the analyte of 
interest from other potential interferences; however, chromatography does not address source-
specific contamination and co-elution. The application of in-source CID mass spectral libraries 
can be manufacturer specific—to account for the effects of source design—and, to have the highest 
power of discrimination, instrument specific [151]. When feasible, the generation of composite 





the capability to identify unknown compounds based on in-house generated in-source CID mass 
spectral libraries [130].  
6.4 Conclusions 
The analysis of a series of previously characterized fentanyl analogs [106] and synthetic 
cathinones [152] with a Q-TOF mass spectrometer allowed for a qualitative assessment of the 
similarities and differences in the product ion spectra generated with in-source CID and beam-type 
CID conditions. In this study, we demonstrate that, under certain conditions, it is possible to 
generate visually similar product ion spectra between in-source CID and beam-type CID of the 
same substance. However, although in-source CID and beam-type CID both encourage 
consecutive neutral losses at elevated collision energies, both techniques tend to produce 
kinetically favored fragments at lower masses relative to trapping-type CID. Of the three 
techniques, in-source CID seems to access the highest energy pathways and tends to show the 
greatest extent of peak drop-in/drop-out and elevated noise from contaminant ions. The subtle 
differences in relative ion abundances between in-source CID and beam-type CID can usually be 
explained by the preference for higher energy pathways in in-source CID, especially at elevated 
fragmentor voltages. In some cases, the abundance of peaks that are separated by only a few 
Daltons, such as m/z 165 and m/z 170 for alfentanil, can show ratios as disparate as 0.75:1 for 










Conclusions and Future Work 
Synthetic Cathinones 
This dissertation combined the use of multi-stage mass spectrometry (MSn), accurate mass 
measurements with high-resolution mass spectrometry (HRMS), isotopic labeling, density 
functional theory (DFT) calculations and gas-phase ion spectroscopy for the structural 
characterization of synthetic cathinones and FRCs. Through this work we have identified 
conserved fragmentation pathways for synthetic cathinones and FRCs, proposed mechanisms for 
the formation of characteristic ions through protonated tandem mass spectrometry (MS/MS) and 
electron ionization mass spectrometry (EI-MS) and provided examples of how to apply our now 
broadened understanding of the fragmentation behavior of these two classes of emerging synthetic 
drugs to the identification of novel synthetic cathinones and FRCs. 
The identification of the complex gas-phase rearrangements that occur for the formation of the 
tropylium ion (m/z 91) or substituted derivative ions from the α-pyrrolidinophenone class of 
synthetic cathinones is a significant contribution to our understanding of the protonated MS/MS 
fragmentation behavior of synthetic cathinones. Throughout literature the tropylium ion (m/z 91) 
or substituted derivative ions are observed among the most abundant peaks in protonated MS/MS 
spectra; however, prior to this work there has never been an explanation for this experimental 
observation that was supported with the use of MSn, HRMS, isotopic labeling, DFT calculations 
and ion spectroscopy. The identification of different oxygen containing intermediates that likely 
contain a phthalane-like core structure and the almost exclusive retention of the α-carbon in the 
tropylium ion has never been reported before in literature. Likewise, the identification of the 
competitive pathways for the loss of CO and ethylene (C2H4) from a primary intermediate ion 





A continuation of the tropylium ion project involved the analysis of 22 α-pyrrolidinophenone 
synthetic cathinones using three different ionization and fragmentation techniques commonly used 
for forensic toxicology, seized drug analysis and research at national laboratories. The 
identification of conserved tandem mass spectrometry fragmentation pathways through the loss of 
CH2CnH2n, H2O, ̇ C2H4CnHn2+1, C6H6, and NC4H9 from protonated molecular ions provides a series 
of diagnostic ions that can be used for the MS/MS identification of α-pyrrolidinophenone synthetic 
cathinones. Other identified fragmentation pathways are through the formation of iminium ions 
and the formation of tropylium and phenylethyl ions at m/z 91 (C7H7
+) and m/z 105 (C8H9
+). These 
pathways should assist practitioners with determining whether or not novel emerging synthetic 
drugs belong to the class of α-pyrrolidinophenone synthetic cathinones, and if so, the nature of 
their structure. 
Another major class of synthetic cathinones that was extensively characterized through this 
work is the N-alkylated class of synthetic cathinones. The use of GC-EI-MS, ESI-MS/MS, and 
DART-MS/MS enabled characteristic protonated MS/MS fragmentation pathways and 
mechanistic origins for the observed product ions. Specifically, diagnostic ions through the loss of 
H2O, CnH2n+3N, and C7H6O for 2° amines and the favored formation of iminium ions and 
alkylphenones for 3° amines. Likewise, the demonstration of the loss of alkyl radicals (˙CnH2n+1) 
from the amine and aliphatic chain and the loss of alkenes (CnH2n) from the amine moiety for all 
N-alkylated synthetic cathinones helps with the identification of future N-alkylated synthetic 
cathinones. Finally, the development of proposed mechanistic explanations for the observed 
protonated MS/MS and EI-MS fragmentation and examples of how to apply this knowledge to the 
identification of novel N-alkylated synthetic cathinones provides useful resources for forensic 





The application of our now-broadened understanding of the protonated MS/MS and EI-MS 
fragmentation behavior for α-pyrrolidinophenone and N-alkylated synthetic cathinones will help 
analysts to better understand and defend their observations and interpretations in existing and 
future casework. The development of characteristic fragmentation pathways for α-
pyrrolidinophenone and N-alkylated synthetic cathinones provides a template for the identification 
of novel synthetic cathinones through conserved fragmentation behavior. Likewise, the location 
of substitution for novel synthetic cathinones can be identified through divergence from the 
provided characteristic fragmentation pathways or the presence of characteristic product ions, such 
as the phenylethyl ion (C8H9
+) at m/z 105 for aromatic substituted synthetic cathinones. These 
manuscripts can be used as a series of guides or references for seized drug analysts and 
toxicologists in their pursuit of the identification of novel synthetic cathinones that arise in 
casework, similar to the work of Zuba for EI-MS [15].  
The demonstration that ESI and DART ionization sources on the same Q-TOF mass 
spectrometer produced even-electron protonated molecular ions and highly similar MS/MS spectra 
through the analysis of 40 synthetic cathinones further supports expansion of the use of ambient 
ionization sources. Likewise, the identification of the highly conserved fragmentation pathways 
between the LIT and Q-TOF mass spectrometers provides a measure of robustness of these 
characteristic fragmentation pathways. However, it is important to recognize that the multi-
collisional environment of the LIT tends to limit the extent of consecutive fragmentation relative 
to the Q-TOF [35]. The Q-TOF therefore favors the formation of lower mass ions relative to the 
LIT. Finally, knowledge about the systematic tendencies of high energy radical-driven 
fragmentation in EI-MS and lower energy collisional activation of protonated precursor ions in 





Future Work Following the Study on Synthetic Cathinones 
Future areas of research based on the synthetic cathinone portion of this work could include an 
expansion of this work from synthetic cathinones to other classes of emerging synthetic drugs, 
such as synthetic cannabinoids and benzodiazepines. Synthetic cannabinoids are a large class of 
emerging synthetic drugs that show promise for the identification of complex gas-phase 
rearrangements due to the presence of multiple basic sites and aromatic regions. In contrast, the 
diazepine functionality of the benzodiazepines class of emerging synthetic drugs could potentially 
support complex gas-phase rearrangements based on the presence of two nucleophilic nitrogen 
atoms in the core structure. Another example of a complex gas-phase rearrangement was 
introduced in Chapter 4 of this work, through the proposed R-group transfer for fentanyl, which 
represents the synthetic opioid class of emerging synthetic drugs. 
Fentanyl Analogs 
The second major portion of this work focused on the structural characterization of fentanyl 
and FRCs. The primary investigation revealed the identification of three isobaric fentanyl product 
ions at m/z 188 including a novel product ion formed through the intermediate product ion at m/z 
216. The identification of three isobaric fentanyl product ions at m/z 188 has a potential impact on 
the product ion selection for quantitative analyses because these isobaric product ions have 
different rates and energies of formation. Throughout literature, the product ion at m/z 188 is 
commonly reported as a product ion used for quantification based on monitoring the transition 
from m/z 337→m/z 188. However, differences in rates and energies of formation can lead to 
variation in ion abundances, which can affect the accuracy and precision of quantitative analyses 
[97]. From the point-of-view of structural characterization, the recognition of these different 
fragmentation pathways can help identify similar mechanisms in emerging FRCs. As new FRCs 





fragmentation mechanisms can assist medical examiners, toxicologists and seized drug analysts 
with the identification of novel FRCs. 
In an extension of Chapter 4, FRCs substituted at five common regions of substitution to the 
core fentanyl structure were analyzed to assess the influence of chemical modification to the core 
fentanyl structure on the observed protonated product ion spectra. The regions of substitution 
included the aniline ring, amide moiety, piperidine ring, N-alkyl chain, and cyclic substituent, 
which is typically a phenyl, thiol or tetrazole. This work provides an approach, based on the 
observed product ions from ESI-MS/MS, to identify the modification site(s) on the core fentanyl 
structure for FRCs. The determination that substitutions to the aniline ring and amide moiety result 
in remarkably conserved fragmentation pathways, whereas substitutions to the piperidine ring, N-
alkyl chain, and cyclic substituent result in distinct differences in fragmentation pathways, is a 
significant contribution from this study. Likewise, the relatively conserved nature of the five most 
abundant product ions between the LIT and Q-TOF instruments provides guidance to the forensic 
community about how to identify the location of substitution for FRCs that is applicable across 
different MS platforms. Finally, the identification of the conserved fragmentation pathways, when 
accounting for differences in the mass and location of the substituent for FRCs, provides an 
additional tool for the identification of novel FRCs to toxicologists and seized drug analysts. 
The final chapter of this dissertation involved a comparison between the MS/MS spectra 
generated from in-source CID and beam-type CID, where in-source CID involves fragmentation 
in the source region of the mass spectrometer as compared to isolation and fragmentation in the 
collision cell for beam-type CID. The application of in-source CID for single-stage HRMS 
instrumentation has grown in popularity within the forensic community because of the desire to 





chapter demonstrated that, under certain conditions, it is possible to generate visually similar 
product ion spectra between in-source CID and beam-type CID experiments. However, ion drop-
in and drop-out was observed for some of the comparisons, which highlights the need for caution 
when analyzing potential mixtures or complex biological samples where strict control of precursor 
ions present in the source region may not be possible. When combined with chromatography or 
ion mobility, and with the use of in-house generated mass spectral libraries, in-source CID has 
potential to become a reliable mainstream technique not just for screening, but for confirmatory 
identifications of seized drugs [130]. 
The identification of characteristic fragmentation pathways and the mechanistic origins of the 
observed product ions for fentanyl and FRCs is a significant contribution from this work. Likewise, 
the identification of the influence of chemical modification to the core fentanyl structure on the 
observed product ion spectra provides a valuable tool to seized drug analysts and toxicologists for 
the identification of emerging FRCs. Our now-broadened understanding of the propensity for 
certain chemical modifications to direct fragmentation down particular pathways will assist 
practitioners with the identification of novel FRCs. However, research within the area of FRC 
modifications will need to continue to further develop our understanding of the effect of 
modification on the fragmentation behavior of FRCs as the list of emerging FRCs continues to 
grow. 
Future Work Following the Study on Fentanyl Analogs 
One direction for future research with FRC modification is the development of an MS/MS 
mass spectral search algorithm that is capable of identifying emerging FRCs. The algorithm could 
make use of both absolute peak positions and the positions of peaks relative to the neutral losses 
from the precursor ion. In fact, an equivalent technique has already been developed for EI-MS 





Spectrometry Data Center at NIST [92]. The HSS algorithm shifts neutral loss peaks in the library 
spectrum to match the corresponding neutral loss peaks in the query spectrum and equally weights 
neutral loss and direct fragment matches, which allows for the identification of structurally similar 
compounds. However, the HSS algorithm struggles with the identification of structurally similar 
compounds that alter the fragmentation mechanism or contain more than one substitution from the 
closest compound in the reference library.  
To develop a similar algorithm for tandem mass spectra of protonated FRCs, one would have 
to examine the effects trap-, beam- and in-source CID and the effects of the applied collision 
energy on the MS/MS mass spectral search algorithm. The end goal would be to provide seized 
drug analysts and toxicologists with a MS/MS mass spectral search algorithm embedded directly 
in the instrument software that would aid with the identification of known and novel FRCs. 
Overall, the impact of this work will be determined by the willingness of seized drug analysts 
and forensic toxicologists to use these resources as guidelines for the identification of emerging 
synthetic cathinones and FRCs. The identification of conserved fragmentation pathways for 
synthetic cathinones and FRCs, as well as the development of proposed mechanisms for the 
formation of characteristic ions through protonated MS/MS and EI-MS helps broaden our current 
understanding of these two classes of emerging synthetic drugs. Likewise, providing an 
explanation for the formation of the tropylium ion (m/z 91) for protonated synthetic cathinones 
and the identification of three isobaric fentanyl product ions at m/z 188 will help analysts better 
understand and defend their observations and interpretations and potentially influence product ions 
selection for quantification with FRCs. Finally, an assessment of the impact of chemical 
modifications to the core fentanyl structure on the observed product ion spectra and a comparison 





determination of modification sites for FRCs and offers a word of caution for the use of in-source 
CID for structural elucidation. In conclusion, this work has provided seized drug analysts and 
toxicologists with additional tools to combat the ever-growing challenge of emerging synthetic 
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